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ABSTRACT 
 
Obesity prevalence is higher in Down syndrome (DS) than in the general population. Beyond 
metabolic alterations, individuals with DS present increased impulsivity, a trait observed in 
obese people and in compulsive eaters that may affect their control of food intake. In this 
Thesis, we used a trisomic DS mouse model (Ts65Dn) to understand the behavioral 
component of obesity in DS and explore some possible underlying mechanisms.  
Our meal pattern analysis revealed longer and slowly meals in Ts65Dn mice, leading to 
reduced eating rate, which may be associated to the mandible hypoplasia described in both 
human and mice. When exposed to obesogenic environments, Ts65Dn mice showed higher 
preference for energy-dense foods, gained more weight in specific conditions and scored 
higher in compulsivity and inflexibility tests than WT mice, as measured by binge eating 
during limited access and persistence of consumption of quine adulteration of energy-dense 
food. High performance liquid chromatography revealed reduced levels of dopamine in 
prefrontal cortex in Ts65Dn mice. This could lead to higher reward sensitivity that in turn 
would facilitate overeating as a compensatory response to restore optimal dopamine levels. 
Feeding behavior is also regulated by hormones and other circulating signals. We detected 
higher plasma leptin and glucose levels along with reduced insulin levels in Ts65Dn mice. 
Upon a glucose challenge, Ts65Dn mice showed reduced glucose-stimulated insulin response 
both in vivo and in vitro, suggesting a deficient insulin secretion or the reduced pancreatic 
mass. Indeed, we detected that Ts65Dn mice had altered plasma profile for some markers of 
inflammation and oxidative damage, in agreement with the high prevalence of autoimmune 
diseases and diabetes in DS people.  
We also explored the involvement of the serine/threonine kinase DYRK1A, a candidate DS 
gene, in obesity and feeding behavior. Dyrk1A overexpression was sufficient to recapitulate 
some behavioral aspects associated to overeating in DS, but with a distinct profile. We 
conclude that increased obesity prevalence in DS is explained by both metabolic and 
behavioral alterations, in part driven by a hypodopaminergic status, and that Dyrk1A 
overexpression is only involved in specific DS obesity phenotypes. 
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RESUMEN 
 
La prevalencia de obesidad es más alta en el síndrome de Down (SD) que en la población 
general. Más allá de las alteraciones metabólicas, los individuos con SD tienen mayor 
impulsividad, rasgo común en personas obesas y en comedores compulsivos, que pueden 
afectar el control de la ingesta de alimentos. En esta Tesis, se ha utilizado un modelo de ratón 
trisómico (Ts65Dn) para comprender el componente de comportamiento en el desarrollo de la 
obesidad en SD y explorar posibles mecanismos subyacentes.  
Nuestro análisis del patrón de ingesta mostró que los ratones Ts65Dn comen más lento que 
los euploides, lo que podría estar asociado con la hipoplasia mandibular descrita en ratones y 
humanos con SD. Cuando los ratones Ts65Dn son expuestos a ambientes obesogénicos, 
comen mayores cantidades de dietas hipercalóricas, engordan más en determinadas 
condiciones y puntúan más alto en pruebas de compulsividad e inflexibilidad que los ratones 
euploides. La cuantificación de los niveles de monoaminas mediante cromatografía líquida 
puso en evidencia que los ratones Ts65Dn presentan niveles más bajos de dopamina en 
corteza prefrontal. Dado que las dietas hipercalóricas promueven la liberación del 
neurotransmisor en el circuito de recompensa, el sobre consumo de las mismas podría indicar 
un intento de restaurar los niveles óptimos de dopamina. La regulación de la ingesta también 
depende de hormonas y otras señales circulantes. Detectamos que los ratones Ts65Dn tienen 
mayores niveles de leptina y glucosa en plasma y niveles más bajos de insulina que los 
ratones euploides. La administración exógena de glucosa produjo una menor respuesta 
secretoria de insulina en los ratones Ts65Dn in vivo e in vitro, lo que sugiere una secreción 
deficiente o una masa pancreática reducida. Además, diversos marcadores de inflamación y 
estrés oxidativo son más elevados en los ratones Ts65Dn que en euploides, en consonancia 
con la mayor incidencia de enfermedades autoinmunes y diabetes en personas con SD.  
En esta Tesis también se ha explorado la contribución de la proteína serina / treonina quinasa 
DYRK1A, un gen candidato para SD en la obesidad e ingesta. La sobreexpresión de Dyrk1A 
es suficiente para recapitular algunos comportamientos asociados a la ingesta compulsiva, 
pero con un perfil distinto al observado en el modelo trisómico. Concluimos que la 
prevalencia de la obesidad en SD se explica por alteraciones tanto metabólicas como 
conductuales, en parte como consecuencia de un estado de hipodopaminergia, y que la 
sobreexpresión de Dyrk1A está implicada en fenotipos específicos de la obesidad en SD. 
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PRESENTATION 
 
Individuals with Down syndrome (DS; trisomy HSA21), a neurodevelopmental disorder 
causing intellectual disability, are more likely to become obese. In this Thesis, we aimed at 
understanding the behavioral and metabolic mechanisms underlying increased prevalence of 
obesity in DS using a validated trisomic mouse model (Ts65Dn). 
 
In the first part of this work, we characterized the time-course and dynamics of obesity-related 
behavioral changes induced by the availability of energy-dense foods in Ts65Dn mice. We 
first studied how this “obesogenic” situation may affect the animal’s behavior, and 
specifically its meal pattern. The fine behavioral characterization of feeding behavior was 
performed in the Animal Facility of the Barcelona Biomedical Research Park (PRBB), using 
an analysis pipeline specially conceived for longitudinal data. In non-obesogenic conditions 
Ts65Dn mice showed a distinct eating pattern, characterized by increased energy intake with 
reduced eating rate and longer meals as compared to wild-type (WT) mice. Upon free choice 
exposure to highly palatable and high-caloric diets, that play a key role in the development of 
overweight, Ts65Dn mice showed higher preference for energy-dense diets than WT and 
scored higher in compulsivity and inflexibility tests (limited access to energy-dense food and 
food adulteration with quinine hydrochloride).  
 
To understand the mechanisms underlying the overeating phenotype, we studied the 
neurochemical correlates in basal conditions and upon long-term access to energy-dense diets. 
I performed this neurochemical characterization under the supervision of Professor Nathalie 
Janel, from the University of Paris Diderot during a short-term EMBO fellowship I benefited. 
High performance liquid chromatography revealed a selective reduction of the dopamine 
(DA) levels in the prefrontal cortex of Ts65Dn mice compared to WT, suggesting that trisomy 
may produce a reward-deficient phenotype. We also observed altered plasma levels of some 
anorexigenic and orexigenic signals such as leptin and ghrelin in Ts65Dn mice that might 
affect feeding behavior and energy balance inducing a pro-obesogenic state. Our work gave 
rise to a manuscript that is in preparation and will be submitted to Biological Psychiatry. 
 
A second mechanism that could be involved in the overweight phenotype is inflammation, 
which is common in obese people. DS is associated with increased prevalence of autoimmune 
disease and impaired inflammatory mechanisms. However, the link of these alterations with 
adiposity has not been explored. To do so, during my Thesis, I studied the obesity-related 
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inflammatory status in mice maintained in non-obesogenic (standard rodent chow) and 
obesogenic (mice receiving high-fat) conditions since mice receiving chocolate-mixture gain 
less weight with no genotype-dependent differences. We detected that Ts65Dn mice had 
altered plasma levels of some markers of inflammation and oxidative damage. The work 
entitled “Increased levels of inflammatory plasma markers and obesity risk in a mouse model 
of Down syndrome” is in second revision in Free Radical Biology and Medicine.  
 
Regarding the metabolic components of obesity in DS, thanks to an international 
collaboration with Professor Hervé Le Stunff from the University of Paris Diderot and 
Professor Latif Rachdi from the Institute Cochin (Paris), we explored how trisomy 21 affects 
the risk of diabetes mellitus. My work revealed morphological and functional deficiencies in 
exocrine pancreas of Ts65Dn mice that supports the higher prevalence of diabetes in DS 
people and we explored different mechanisms. These results will be submitted to 
Endocrinology. 
 
The second main aim of the Thesis was to narrow down the genetic dependence of some of 
the DS-obesity phenotypes. We focused on DYRK1A, a serine protein kinase relevant for DS 
brain and cognitive defects. To this aim, we used a monogenic transgenic mouse model of DS 
(mBACTgDyrk1A, kindly provided by Professor Jean-Maurice Delabar, Institut du Cerveau 
et de la Moelle Épinière) with 1.5-fold overexpression of Dyrk1A in an otherwise disomic 
context. Meal pattern analysis showed no differences in feeding behaviors in TgDyrk1A mice, 
but they had specific food preferences and were protected against diet-induced obesity. The 
behavioral characterization was conducted in the CRG and the neurochemical characterization 
will be done at the University Paris Diderot in collaboration with Professor Nathalie Janel. 
The results of this work will be submitted to Neurobiology of Disease. 
 
In summary, my work has shown central and peripheral obesity phenotypes in DS with 
feeding behavioral traits and region-specific neurochemical defects explaining overeating and 
overweight in DS. It has also narrowed down the genetic dependence of these phenotypes, 
showing the importance of Dyrk1A overexpression to drive reward-related food preferences. 
 
During my PhD experience, I had the opportunity to present my work in several national (16 
congress of the “Sociedad Española de Neurociencias, Granada and “VIII Cajal Winter 
Conference”, Salamanca) and international meetings (1st T21RS International Conference, 
Paris, France). I have also participated in a number of science dissemination activities and in 
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the Gender Balance Committee of the CRG. I had the specific support of a predoctoral 
fellowship of the Center for Genomic Regulation, and my project was funded by grants of the 
Jerome Lejeune Foundation, and the Spanish Ministry of Economy and Competitiveness. 
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1. INTRODUCTION 
  
1.1 Obesity in Down syndrome  
  
Down syndrome (DS) is a neurodevelopmental disorder caused by the partial or total 
trisomy of chromosome 21, leading to intellectual disability (Antonarakis et al. 2004). 
As a consequence of the extra genetic contribution, DS gives rise to a plethora of 
different alterations affecting both peripheral and central nervous system. Among those, 
the most common features having an impact in daily life of DS patients are the 
intellectual impairments, heart abnormalities and obesity (Roizen and Patterson 2003; 
Karmiloff-Smith et al. 2016). 
The prevalence of obesity is high in DS population. Bell and collaborators found that 
70.58% of males and 95.83% of females with DS were categorized as overweight and 
obese compared with 40% of males and 32% females in that category from general 
population (Bell 1992). Other studies have shown that the rate of obesity or overweight 
in DS was two to four times higher than in non-disabled youths matched by age and 
gender (Rimmer et al. 2010; Must et al. 2014). 
The identification of the causes leading to increased obesity risk in DS in human studies 
is complicated since existing data are for different countries with different dietary 
habits, making it difficult to compare populations. Traditionally, the increased obesity 
risk in DS individuals has been mainly attributed to their endocrine disturbances and 
reduced physical activity but feeding practices may also play an important role in the 
development of obesity in this population (Melville et al. 2005). In fact, there is an 
association between body mass index (BMI) and overeating (Mallan et al. 2017) and 
several reports suggest unhealthy dietary habits as an important factor for obesity risk in 
DS population (Grammatikopoulou et al. 2008). The management of the excessive 
weight gain has been usually focused on food restriction, and increased exercise that 
have proven moderate success in preventing or treating DS obesity (Spanos et al. 2013). 
 
 
 
2 
 
1.2 Metabolic and lifestyle factors contributing to obesity development in Down 
syndrome 
 
DS individuals have higher BMI and percentage of body fat (% BF) than age- and sex-
matched persons without DS (González-Agüero et al. 2011; Loveday et al. 2012). 
Within the DS population there is a sexual dimorphism with a higher value for BMI, % 
of BF and overweight prevalence in females than in males (Bell 1992; Slevin et al. 
2014). The mechanisms of this increased obesity risk have not been studied 
systematically in the DS population but genome wide association studies have found 
that the chromosome 21 (HSA21) shows overlap with quantitative traits loci (QTL) for 
body weight (BW276_H) and seven obesity related loci (Dasouki et al. 2011; Kunej et 
al. 2013). 
 
Energy expenditure and glucose homeostasis in Down syndrome 
Energy expenditure depends of the circulating messengers controlling energy balance 
(López et al. 2013). Among those circulating signals, leptin is secreted by adipocytes, 
acting in the hypothalamus to suppress appetite and regulate body weight (Considine et 
al. 1996). Obesity in the general population is associated with increased body fat 
accumulation. Leptin levels are positively correlated with the percentage of body fat so 
that it has been proposed that obese individuals have some degree of leptin resistance 
(Considine et al. 1996). Obesity in DS has been attributed partially to leptin resistance 
since blood levels are higher in this population compared to non-obese DS individuals 
(Proto et al. 2007; Magge et al. 2008). 
Another endocrine condition in DS that may affect body weight increase is 
hypothyroidism that is the most common endocrine alteration in the DS population, 
particularly in the form of subclinical hypofunction (Lavigne et al. 2017).  This 
endocrine abnormality might also directly affect fat accumulation since thyroid 
hormones are involved in the activation of gene pathways controlling thermogenesis, 
glucose homeostasis and fat oxidation (Mullur et al. 2014).  
Diabetes has also a higher prevalence in DS than in the general population. Diabetes is 
defined by reduced insulin secretion and insulin sensitivity, resulting in abnormally high 
blood glucose levels in plasma. Type 1 diabetes (T1D) is commonly associated to 
immunological problems leading to deficient insulin production whereas type 2 diabetes 
(T2D) is associated with insulin deficiency and insulin resistance (American Diabetes 
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Association). While obesity is mainly related to T2D, the clinical manifestation of DS 
diabetic patients usually is closer to a TD1, with an earlier onset peak compared to non-
DS children (Anwar et al. 1998; Rohrer et al. 2010) and with increased level 
concentrations of autoantibodies, which is a marker of β pancreatic cells damage (Steck 
et al. 2015). It has been shown that in general population the major genetic determinants 
of T1D are polymorphisms of class II HLA genes located in the human chromosome 6 
(Dean et al. 2004). One study conducted in DS patients detected an increase in the 
frequency of the classic risk allele compared to the neutral or protective ones when 
analyzing the usual major type 1 diabetes risk locus located in the HLA region 
(Bergholdt et al. 2006). Authors conclude that, besides HLA region of chromosome 6, 
other regions such as chromosome 21 (HSA21), might be contributing to type 1 
diabetes risk (Anwar et al. 1998). The increased risk of diabetes in DS could also be 
related to proteins encoded in the chromosome 21 that are expressed in pancreas 
(Esterhazy et al. 2011; Peiris et al. 2016; Rachdi et al. 2014a). It has been recently 
shown that basal insulin secretion by DS fetal pancreatic cells was drastically decreased 
compared to non-DS cells (Helguera et al. 2013) the secretory defects being attributed 
to RCAN1 overexpression (Peiris et al. 2016) that is located in the HSA21. 
  
Physical activity in Down syndrome individuals 
Physical activity is the main factor determining energy expenditure. Sedentarism has 
been positively associated to obesity in the general population (Jebb and Moore 1999). 
Many young people and adults with ID have a sedentary lifestyle (Dairo et al. 2016) and 
undertake low levels of exercise (Temple and Stanish 2008) compared to general 
population. Specifically, most of the studies show that DS population did not comply 
with the recommended physical activity (Izquierdo-Gómez et al. 2014; Phillips and 
Holland 2011). Independently of the age, people with DS spent more time in sedentary 
activities compared to people with intellectual disabilities without DS (Phillips and 
Holland 2011). Improving physical activity may require the involvement of family and 
carers, as there is a positive association with the implication of the parents and the 
healthy habits of the DS children (Spanos et al. 2013). 
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Mechanical problems affecting feeding behavior in Down syndrome 
Finally, it is also important to account for the mechanical aspects of feeding that may 
have an impact of the final feeding behavior phenotypes. Very often, DS children and 
adults present oral-motor difficulties (Faulks et al. 2008a-b) that produce feeding 
behavior disturbances. Although some are corrected during development, some persist 
to adulthood (Smith et al. 2014). The orofacial dysfunction has direct repercussions on 
mastication and swallowing and can potentially lead to texture selectivity but also lead 
to life-threatening conditions such as malnutrition and dehydration in the most severe 
conditions (Lazenby 2008). DS subjects present hypotonia of tongue and lips, 
underdeveloped facial mid-third and lax temporomandibular joints (Faulks et al. 2008a-
b). As a consequence, diverse problems such as delayed initiation and poor coordination 
and sequencing of oromotor movements and difficulty for chewing are common in DS 
individuals (Hennequin et al. 1999; Lazenby 2008). This might be a factor influencing 
the choice of softer food, such as high-fat food. 
 
1.3 Brain mechanisms of control of feeding behavior and their alterations in Down 
syndrome 
 
Energy intake depends on multiple and redundant signaling pathways modulated by 
interoceptive and exteroceptive cues (Figure 1). The nutritional information about food 
is mediated by gastric distension, release of hormones, neuropeptides whereas the 
hedonic value of the food requires sensorial information that is provided by our sensory 
organs (Morrison et al. 2012). Appetite and food preferences and choices depend on two 
distinct -though interconnected- pathways at the central nervous system (CNS) level: 
one related to the homeostatic control of energy balance and the other controlling the 
non-homeostatic or hedonic food intake. 
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Figure 1. Food selection is controlled by both energy requirements and reward-related 
mechanisms. In mammals, feeding is controlled by external factors such as food availability and internal 
factors such as the hormones produced in starvation and upon feeding by internal organs. Eating is 
decided by a homeostatic- based decision in which the hypothalamus acts as a “deficiency detector”. 
Moreover, there is a “reward-based decision making” controlled by prefrontal cortex and striatum that 
mediates feeding beyond energy demand. Our choices also depend on the sensorial experience and our 
memories and areas such as the hippocampus are also involved in feeding behavior. In the figure: 
orbitofrontal cortex (OFC), hippocampus (Hipp), amygdala (Amy), ventral tegmental area (VTA), 
nucleus accumbens (NAcb), prefrontal cortex (PFC), anterior piriform cortex (APC), taste receptors 
(T1R1/T1R3) (Morrison et al. 2012). 
 
Homeostatic control of feeding behavior 
The hypothalamus is the main region involved in homeostatic control of feeding 
behavior. It is critical in the relaying of afferent signals from the gut and brainstem as 
well as processing efferent signals that modulate food intake and energy expenditure. 
The hypothalamus is subdivided into interconnecting nuclei, including the arcuate 
nucleus (ARC), paraventricular nucleus (PVN), ventromedial nucleus (VMN), 
dorsomedial nucleus (DMN) and lateral hypothalamic area (LHA). Neuronal pathways 
between these nuclei are organised into a complex network in which orexigenic 
(promoting food intake) and anorexigenic (inhibiting food intake) circuits influence 
food intake and energy expenditure. The ARC is in contact with the circulating blood 
being key for the regulation of appetite, so that its lesion results in obesity and 
hyperphagia in mice (Olney 1969). It integrates circulating hormonal and chemical 
signals that act on neuronal populations that 1/ co-express neuropeptide Y (NPY) 
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/agouti-related protein (AgRP) and which activation increase food intake, or 2/ co-
express proopiomelanocortin (POMC) /cocaine- and amphetamine-regulated transcript 
(CART) that inhibit food intake (Figure 2) (reviewed in Waterson and Horvath 2015). 
Regarding the other nuclei, LHA receives neuronal projections from the ARC and 
contains the orexigenic neuropeptides melanin concentrating hormone (MCH) and 
orexins. It has been shown that microinjection of almost all known orexigenic peptides 
into the PVN stimulate feeding whereas the destruction of DMN and VMN results in 
hyperphagia and obesity (reviewed in Waterson and Horvath 2015). All these data 
suggest that the concerted action of central and peripheral orexigenic and anorexigenic 
signals is integrated at the hypothalamic level.  
The anatomical and functional integrity of the hypothalamic circuits have not been 
studied in depth in DS brains. However, one morphometric study has shown diminished 
number of neurons in the arcuate nuclei of the hypothalamus of DS patients 
(Wisniewski and Bobinski 1991). Deficits of other hypothalamic dependent functions 
such as sleep regulation and growth hormone secretion have been reported in DS, 
(Castells et al. 1992; Castells et al. 1996; Anneren et al. 1999) suggesting that the 
alterations of brain regions involved in homeostatic control of energy intake could be 
contributing to obesity in DS. 
 
 
 
  
 
 
                
 
 
 
 
Figure 2. Hypothalamic regulation of feeding and energy balance. Specific nuclei in the 
hypothalamus respond to alterations in food availability, energy stores, and nutritional requirements. In 
the arcuate nucleus (ARC), AgRP/NPY and POMC/CART neurons act as a hunger and satiety centers 
and elicit functional changes in a range of tissues including the liver, pancreas, muscle, adipose white 
adipose tissue (WAT) and brown adipose tissue (BAT) (López et al. 2013). 
7 
 
Hedonic control of feeding behavior 
The regulation of food intake involves a close interrelationship between homeostatic 
and nonhomeostatic factors. The former are related to nutritional needs and monitor 
available energy within the blood and fat stores, whereas the latter are considered 
unrelated to nutritional or energy requirements. Most nonhomeostatic mechanisms are 
related to the brain reward system (Kelley et al. 2005). Contrary to the hypothalamus 
which main role is the energy detection, regions such as the striatum and the prefrontal 
cortex are mostly implicated in the hedonic feeding and the behavioral control to eat. 
The mesocorticolimbic pathway is a central component of this system. It arises from 
dopaminergic neurons located in the ventral tegmental area of the midbrain that send 
projections to target areas in the limbic forebrain, particularly the nucleus accumbens, as 
well as the prefrontal cortex and the striatum. The prefrontal cortex, in turn, provides 
descending projections to the nucleus accumbens and the ventral tegmental area. 
Several reports have observed that obese patients had reduced orbitofrontal volume 
(Maayan et al. 2011; Cohen et al. 2011) suggesting its involvement in disinhibited 
eating and obesity. Also, lower baseline prefrontal cortex metabolism has been 
correlated to higher BMI (Kg/m
2
) in both PET (Wang et al. 2011) and SPECT 
(Willeumier et al. 2011). At the behavioral level, obese patients have worse 
performance in prefrontal cortex-dependent tasks requiring decision-making, response 
inhibition and cognitive flexibility, as compared to healthy controls (Lena et al. 2004; 
Fagundo et al. 2012). Inappropriate sensitivity to punishment and difficulties to focus 
on long-term goals has also been observed in compulsive eaters (Danner et al. 2012; 
Wolz et al. 2016; Navas et al. 2016). This mesocorticolimbic circuit, then, is a key 
player in the final common pathway that processes reward signals and regulates 
motivated behavior in rats and, according to imaging data, in humans. 
Other regions are also involved in the reward-related food consumption, including 
regions implicated in sensory reception (insular and gustatory cortex), attribution of the 
salience (orbitofrontal cortex) and emotion processing (amygdala and hippocampus) 
(Lee et al. 2012) (Figure 3). Obesity promotes changes in this circuit sustaining 
overeating (Volkow et al. 2013). Neuroimaging studies have shown that compared to 
lean controls, the striatum of obese adults show higher brain activation in response to 
food cues and lower brain activation upon feeding, respectively. This may suggest that 
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both increased reactivity to reward expectation but decreased sensitivity to food reward 
might underlie overeating (Volkow et al. 2011; Michaelides et al. 2012). 
A higher consumption of energy-dense foods has been reported in DS individuals 
(Grammatikopoulou et al. 2008; Nordstrøm et al. 2015) that could reflect alterations in 
the reward response to diet. In adulthood, the dietary intake is unbalanced in DS 
individuals with higher protein and fat intake and low carbohydrate intake than 
recommended (Sharav and Bowman 1992; O'Neill et al. 2005; Marin and Graupera 
2011). This leads to excessive intake of inappropriate nutrients, which is common in 
children with DS and may result in overfatness (Wong et al. 2014). These unhealthy 
food choices and the consequent body weight gain normally occur during adolescence 
or in adulthood, which coincides with the time when DS individuals leave their parental 
house and lose the dietary supervision (Sharav and Bowman 1992), which suggests that 
their autoregulatory mechanisms are impaired. In fact, lower food variety is also 
common suggesting a biased in food choices based on personal food preferences. As a 
consequence, dietary intake in DS adults used to be unbalanced with higher protein and 
fat intake (Marin and Graupera 2011).  
 
Figure 3. Schematic representation of brain circuits implicated in hedonic feeding. The nucleus 
accumbens (NAc) assess reward and saliency. The orbitofrontal cortex (OFC) is involved in sensory 
integration for decision-making and determining the expected rewards and punishments of an action. The 
amygdala (Am) and hippocampus (Hip) are involved in forming memories of the stimulus/reward 
relationship, whilst the prefrontal cortex (PFC) and the anterior cingulate gyrus (CG) are responsible of 
the inhibitory control and emotional regulation. The arrows in red depict the mesolimbic reward pathway. 
Energy-dense foods cause neurons from the ventral tegmental area to release dopamine in the nucleus 
accumbens. These regions regulate activity in the frontal cortical regions. Adapted from Lee et al. 2012. 
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In DS reduced frontal cortex volume (Whittle et al. 2007) and a decreased functional 
connectivity (Pujol et al. 2015) have been reported. This may compromise their 
executive functions and lead to impulsivity and motor abnormalities that require the 
integrity of the fronto-striatal network functioning (Brunamonti et al. 2011). In fact, 
difficulties in sustained attention, planning and problem-solving, working memory, 
inhibition and perseveration are common (Jernigan et al. 1993; de la Torre et al. 2016; 
Lanfranchi et al. 2010; Pritchard et al, 2015). However, no work has specifically 
address the striatal activation upon food stimuli in DS individuals and thus, the 
implications of an altered frontal-striatal in feeding control are unknown. 
 
1.4 Monoamines as regulators of homeostatic and reward aspects of feeding 
 
Among the multiple messengers that mediate and control feeding, monoaminergic 
neurotransmitters are especially relevant since they act both at the “energy-sensing” and 
at the “reward-based decision making” level. We will briefly review the involvement of 
each of the monoaminergic systems in feeding behavior.  
One of the main monoaminergic systems is the serotonin or 5-hydroxytryptamine (5-
HT). 5-HT is involved in both the modulation of feeding behavior and the regulation of 
glucose levels. It is synthesized from tryptophan by the enzyme Tryptophan 
Hydroxylase (TPH) and primarily degraded by the mitochondrial bound protein 
Monoamine Oxidase A (MAOA), leading to the generation of the metabolite, 5-
hydroxyindoleacetic acid (5-HIAA) (Lu 2017). Serotonergic neurons are located in the 
raphe nuclei send projections to the peripheral nervous system (Fuxe et al. 1988). The 
dorsal raphe (B7), in particular, is a midbrain nucleus that contains a substantial portion 
of the total brain 5-HT and has distinct projections to hypothalamic nuclei and feeding-
related forebrain areas such as the frontal cortex (Celada et al. 2013), supporting its dual 
role in energy-sensing and food-derived reward. This multifaceted control is reflected 
even at the molecular level with peculiar contribution of the serotonin receptor 5-
HTR2C in the hypothalamus (homeostatic control) and serotonin receptor 5-HTR4 in 
the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) (non-homeostatic 
control) (Compan 2013). In mice, constitutive activity of NAc-5-HTR4 triggers 
anorexia, while its inhibition leads to overeating (Compan 2013). In the hypothalamus 
5-HT acts as a satiety signal. Concretely, it has been shown that serotonin released from 
projections of the raphe innervating the hypothalamus serves for meal termination 
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(Leibowitz and Alexander 1998). Carbohydrate intake increases the levels of 5HT in 
hypothalamus probably by direct increase of 5-HT synthesis since tryptophan is a 
metabolite of carbohydrates but also a precursor of serotonin. The serotoninergic system 
is also implicated in the non-homeostatic feeding control. This might be related to their 
role in mediating behavioral flexibility (Puig and Gulledge 2011) since both increased 
(Dalley et al. 2002) and decreased (Harrison et al. 1997; Clarke et al. 2004) serotonin 
levels in prefrontal cortex are associated with increased impulsivity, impaired reversal 
learning and increased perseveration. Regarding obesity, it has been shown that humans 
with a higher BMI had increased density of 5-HTR4 in the NAc and orbitofrontal 
cortex, that has been explained as an adaptive mechanism in which upregulation of the 
5-HTR4 may result from the frequent lower levels of serotonin in obese individuals 
(Haahr et al. 2012).  
Dopamine (DA) has also a key role in functions related to feeding behavior. It mediates 
flexible behaviors (Winstanley et al. 2005) and participates in the control of impulsive 
choices and perseveration (Brozoski et al. 1979; Laskowski et al. 2016). DA is 
synthesized in the dopaminergic neurons located in the midbrain, specifically in the 
substantia nigra and the ventral tegmental area (VTA), and is mainly released in the 
striatum (Stott and Ang 2013). In the brain, there are three main DA pathways: the 
nigrostriatal, related to motor function, the tuberoinfundibular and mesocorticolimbic 
(Stott and Ang 2013). In the mesocorticolimbic pathway, the VTA projects to the 
cingulate gyrus and orbital and medial prefrontal cortex. This pathway is related to the 
cognition and motivation and has a main role in reward mechanisms controlling food 
intake (reviewed by Palmiter 2008). Striatal DA is necessary for food seeking and 
ingestive behavior as shown by previous reports in which DA depletion (genetically or 
pharmacologically by inhibiting their limiting synthesis enzyme) causes death by 
starvation in mice (Szczypka et al. 1999; Cannon et al. 2004; Palmiter 2008). In 
humans, ingestion of fatty or sweet foods has been shown to release dopamine (DA) in 
the dorsal striatum proportional to the self-reported level of pleasure derived from 
eating the food (Small et al. 2003). Probably because of that, humans overconsume 
pleasurable food in spite of the negative health consequences (Duffey et al. 2007; 
Schulze et al. 2004). Upon first exposure, a food reward activates the dopaminergic 
neurons in the ventral tegmental area (VTA), which leads to an increase of DA tone and 
release to the striatum and its ventral extension, the nucleus accumbens (NAc) (Volkow 
et al. 2013). Indeed, altered dopaminergic tone has been proposed as a vulnerability 
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factor to overconsumption (Mizoguchi et al. 2010). In obesity-prone rats there is a 
global presynaptic deficit in DA in prefrontal cortex, likely due to differences in the 
expression of genes that regulate dopamine exocytosis (Geiger et al. 2008). Conversely, 
DA injection in the hypothalamus inhibits eating in rats suggesting that it locally acts as 
a satiety signal (Leibowitz and Rossakis 1979).  
The brain noradrenaline (NA) system plays an important role in the central nervous 
control of energy balance and is thus implicated in the pathogenesis of obesity. The NA 
producing cells are mainly located in the locus coeruleus (LC) and send noradrenergic 
fibers that diffusely innervate areas such as cortex, thalamus, hypothalamus, 
hippocampus (Samuels and Szabadi 2008). Evidence for a direct involvement of NA in 
mediating food intake derives mainly from pharmacological and lesioning studies 
performed in animals. Noradrenergic fibers arriving to hypothalamus can either elicit 
hypophagia to hyperphagia, depending upon the subset of adrenoceptors they active 
(Wellman 2000). It has been shown in rats that NA acting in the hypothalamic arcuate, 
ventromedial and paraventricular nuclei stimulates feeding (Leibowitz 1970; Date et al. 
2006), whereas it inhibits feeding in the lateral hypothalamic area through α- and β-
receptors (Leibowitz 1970). Furthermore, ablating hindbrain noradrenergic neurons, 
which project to the hypothalamic ARC and PVN eliminates orexigenic and potentiates 
anorexigenic actions of feeding hormones in rats, respectively. The appetite-suppressing 
drugs amphetamine, methamphetamine and phentermine all possess a monoaminergic 
mechanism of action; in particular they potently cause release of NA from synaptic 
vesicles as well inhibiting/reversing extracellular NA reuptake by the NA transporter 
(NAT) at the synaptic cleft (Adan et al. 2008).  
Natural stimuli induced an increase in NA release in the mPFC of mice that is 
proportional to their salience (Ventura et al. 2007). In addition, the NA prefrontal 
transmission is a necessary condition for motivational processing of reward related 
stimuli probably through modulation of dopamine release within the NAc (Puglisi-
Allegra et al. 2012), including feeding stimuli. In fact, it has been suggested that 
excessive NA tone could be the starting point to aberrant motivation and leading to 
excessive palatable food intake (Latagliata et al. 2010). Critically, the NA system is a 
key substrate that mediates stress and emotional eating, so that food seeking despite 
harmful consequences is preventable by selective NA inactivation of the mPFC 
(Dallman 2010). Hence, prefrontal NA plays a critical role in maladaptive eating 
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behavior whislt prefrontal cortex and striatal NA transmission are required for food-
related motivated behavior.  
 
Monoaminergic profile in Down syndrome 
The monoaminergic systems have been explored in DS patients mainly in relation with 
age-related cognitive impairment and Alzheimer’s disease. Initial postmortem studies in 
older DS patients demonstrated reduced brain concentrations of serotonin (5-HT), and 
its metabolite 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA) and 
norepinephrine (NE) (Nyberg, et al. 1982; Yates et al. 1983; Reynolds and Godridge 
1985; Godridge et al. 1985; Seidl et al. 1999). This possibly results from the reduced 
cell numbers in the locus coeruleus and dorsal tegmental nucleus of the raphe complex 
(Mann et al. 1984; Mann et al. 1985) while the source of the dopaminergic deficits is 
unclear. More recent works have also shown monoamine reductions in entire brain or in 
different regions of DS younger adults (Mann et al. 1987; Risser et al. 1997). 
Significant reductions in tissue concentrations of serotonin, noradrenaline, and 
dopamine in the frontal cortex of fetal DS cases at a gestational age of approximately 20 
weeks have been also found compared to age-matched control fetuses (Whittle et al. 
2007).  
In biosamples, only few studies have explored monoaminergic biomarkers in DS. 
Plasma concentrations of homovanillic acid (HVA) and 5-HIAA have been reported to 
accurately indicate alterations in regard to DA and 5-HT metabolism in the brain. 
Moreover, the (nor) adrenergic metabolite 3-methoxy- 4-hydroxyphenylglycol (MHPG) 
diffuses freely over the blood-brain barrier, thereby reflecting central NA activity. 
Shapiro and collaborators reported that cerebrospinal concentrations of 5-HIAA, HVA, 
MHPG, and norepinephrine were significantly higher in young DS adults as compared 
to controls, while in serum concentrations were unchanged, suggesting increased 
turnover of monoamines in adults with DS (Schapiro et al. 1987; Kay et al. 1987). 
Several studies have implicated trait differences in DA signaling on executive 
functioning based on genetic polymorphisms (COMTVal158Met, VNTR-DAT1) in the 
catechol-O-methyltransferase (COMT) and in the gene encoding for the dopamine 
transporter (DAT, SLC6A3). Recently, a study of genetic polymorphisms of the 
enzymes related to the synthesis and disposal of dopamine (DA) in a cohort of DS 
adults (Del Hoyo et al. 2016) revealed that those individuals having better performance 
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in executive function tasks were those bearing the genotypes conferring higher DA 
availability, such as Met carriers and VNTR-DAT1 10-repeat homozygotes (del Hoyo 
et al. 2016). This study supports that problems in flexibility in DS patients could be 
partially due to dopaminergic alterations. Dekker and collaborators showed recently that 
serum concentrations of 3-methoxy-4-hydroxyphenylglycol (MHPG) the principal 
metabolite of NA, are significantly lower in demented and dementia converted DS 
subjects compared to non-demented DS individuals and healthy controls (Dekker et al. 
2017). The DS individuals with MHPG levels below median had a tenfold increased 
risk of developing dementia, suggesting that NA deafferentation is linked to dementia 
onset in DS (Dekker et al. 2017). However, no previous studies have linked the 
monoaminergic phenotypes with obesity.  
1.5 Narrowing the genetic dependence of Down syndrome obesity phenotypes: 
DYRK1A 
 
DS phenotypes are the result of a trisomy, and thus present overdosage of a large 
number of genes. Among the triplicated genes, accumulating evidences suggest that the 
gene encoding for the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A 
(DYRK1A), could be implicated in both homeostatic and non-homeostatic aspects of 
feeding behavior. 
DYRK1A is the homologue of the Drosophila minibrain (mnb), which was named from 
the description of the brain phenotype observed in hypomorphic mutant flies (Tejedor et 
al. 1995). The DYRK family includes four additional mammalian subtypes including 
DYRK1B, DYRK2, DYRK3, and DYRK4. DYRK proteins show little sequence 
homology with other kinases outside of their catalytic domains but are highly conserved 
across species (Becker et al. 1998). DYRK1A can catalyze its own activation through 
auto-phosphorylation of a single tyrosine residue in its activation loop (Lochhead et al. 
2005; Soundararajan et al. 2013; Soppa and Becker 2015).  
DYRK1A is highly expressed during embryonic development both in brain and outside 
the CNS in vertebrates (http://www.proteinatlas.org/ENSG00000157540-
DYRK1A/tissue). In the adult, its expression is reduced and restricted to certain regions 
such as cortex, hippocampus, cerebellum, deep motor nuclei, hypothalamic nuclei and 
olfactory bulb (Marti et al. 2003), part of which pertain to the brain circuits involved in 
both homeostatic and hedonic control of food intake. Outside the brain, DYRK1A is 
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highly expressed in tissues such as the gallbladder, the salivary gland, the intestine and 
the thyroid gland (Figure 4). 
 
Figure 4. DYRK1A is expressed in different organs across the body. The figure, adapted from human 
protein atlas (http://www.proteinatlas.org) depicts the DYRK1A expression across the human body 
ranked from higher (right) to lower (left) protein levels. 
 
Involvement of DYRK1A in hedonic feeding control  
Feeding control requires optimal executive capabilities, such as behavioral inhibition 
and flexibility to avoid hedonic overeating. The involvement of DYRK1A in reward 
related mechanisms implicated in the control of food intake has not been addressed 
before, but several studies suggest a relationship between DYRK1A and dopamine 
circuits. First, Dyrk1A dosage is relevant for the developing ventral mesencephalon 
since DYRK1A regulates the activity of the caspase 9 and thus controls the apoptotic 
wave of dopaminergic neurons during development (Barallobre et al. 2014). Second, 
Dyrk1A is highly expressed in the striatum (Marti et al. 2003) that receives numerous 
dopamine projections and is implicated in motor control, but also in compulsive 
behavior (O’Connor and Kenny 2016). Some of the DS-related corticostriatal-
dependent phenotypes of TgDyrk1A mice, such as hyperactive behavior, motor-
coordination defects and sensorimotor gating could be reversed or improved upon 
striatal injection of an inhibitory RNA against Dyrk1A (AAVshDyrk1A) (Ortiz-Abalia 
et al. 2008). Interestingly, Dyrk1A
(+/-)
 mice hypoactivity occurred along with decreased 
striatal dopamine levels, reduced number of dopaminergic neurons in the substantia 
nigra pars compacta, as well as altered behavioral responses to dopaminergic agents 
(Martinez de Lagrán et al. 2007). Whilst these data indicate that DYRK1A 
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 is essential for a proper function of dopaminergic neurons in nigrostriatal circuit 
(Martinez de Lagrán et al. 2007), the role of DYRK1A in mesolimbic circuits remains 
unknown. 
On the other hand, DYRK1A is also strongly expressed in prefrontal cortex (Marti et al. 
2003) where its correct levels of expression are necessary for several cortical dependent 
functions. Dyrk1A overexpression in mice leads to defective cortical pyramidal cell 
morphology (Martinez de Lagrán et al. 2012), synaptic plasticity deficits and altered 
excitation/inhibition balance in vitro (Thomazeau et al. 2014; Souchet et al. 2014). 
Recently, its relevance at the local cortical network dynamics has been demonstrated in 
TgDyrk1A and Ts65Dn mice (Ruiz-Megías et al. 2016). These mice have decreased 
prefrontal cortex excitability with decreased firing rate and gamma frequency power 
along with reduced vesicular GABA transporter (VGAT) punctae on parvalbumin-
expressing interneurons that suggest impaired modulation of inhibition (Ruiz-Megías et 
al. 2016). Along with these network alterations, TgDyrk1A mice show reduced 
cognitive flexibility (Altafaj et al. 2001) which could also be involved in the persistence 
of inadequate inhibition of feeding choices. Interestingly, some of those abnormalities 
are rescued using a DYRK1A kinase inhibitor (epigallocatechin-3-gallate) (De la Torre 
et al. 2014; Thomazeau et al. 2014). 
 
Involvement of DYRK1A in energy homeostasis  
Regarding the homeostatic brain circuits, Dyrk1A is expressed in hypothalamic nuclei 
controlling energy balance (Spiegelman and Flier 2001). Recent data showed that in the 
hypothalamus, DYRK1A activates a positive feedback loop where Sir2-dFOXO induces 
NPY gene expression through the PKA-CREB up-stream pathway (Hong et al. 2012). 
This might be relevant for feeding behavior, since NPY, as explained above, acts as an 
orexigenic signal promoting food intake. Accordingly, Dyrk1A transgenic mice 
exhibited decreased FOXO acetylation and increased NPY expression in the 
hypothalamus, as well as increased food intake compared to wild-type mice (Hong et al. 
2012). Since Dyrk1A is overexpressed in DS, one of the explanations of the propensity 
for excessive food intake could result from the reinforced DYRK1A-dependent positive 
NPY feedback mediated by the kinase leading to an orexogenic phenotype. 
Dyrk1A is also expressed in peripheral organs such as pancreas and adipose tissue, but 
the existing data suggest that it might not be involved in the metabolic phenotypes 
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associated to obesity in DS humans. In the adipose tissue Dyrk1A expression is not as 
relevant as in other organs (Figure 4), but some evidence suggests its role in adiposity 
through glycogen synthase kinase 3β (GSK3β) phosphorylation. GSK3β overexpression 
in mice induces adiposity and obesity (Pearce et al. 2004) and DYRK1A specifically 
inhibits GSK3β activity through phosphorylation of Thr (P)(356) (Song et al. 2015). 
Accordingly, mice overexpressing Dyrk1A show reduced fat mass along with increased 
Thr(P)(356)-GSK3β in the white adipose tissue and downregulation of adipogenic 
proteins, including peroxisome proliferator-activated receptor γ as compared to wild-
type mice (Song et al. 2015). Taking together, these results may suggest an obesity-
resistant phenotype in conditions of DYRK1A overexpression.  
Dyrk1A is highly expressed in pancreas where it induces the expression and nuclear 
accumulation of p27Kip1 (Rachdi et al. 2014a), which is a negative regulator of 
proliferation via the inhibition of cyclin-CDK activity (Lloyd et al. 1999). This could 
explain the increased β-cell mass and improved glucose homeostasis observed in mouse 
overexpressing Dyrk1A (Rachdi et al. 2014b), and that Dyrk1A-haploinsufficient mice 
show the opposite phenotype: they have severe glucose intolerance, reduced β-cell mass 
and decreased β-cell proliferation (Rachdi et al. 2014a). Surprisingly, recent in vitro 
studies in both mice and human cells have reported that the pharmacological inhibition 
of DYRK1A induces β-cell proliferation in vitro, likely by causing NFAT activation in 
beta cells along with other DYRK1A-independent effects, for example harmine 
activation of Myc signaling (Wang et al. 2015a; Wang et al. 2015b; Belgardt and 
Lammert 2016).  This led to the proposal that targeted modulation of the DYRK1A 
activity in pancreas could be a successful treatment for diabetic patients (Belgardt and 
Lammert 2016). In fact, this in vitro result would be in line with the finding that 
overexpression of human DYRK1A suppresses cell proliferation in multiple cell lines.  
Recent data have revealed the role of DYRK1A in thyroid development. Dyrk1A 
overexpression in mice is associated to the up-regulation of important transcription 
factors for early thyroid morphogenesis (Nkx2–1, Foxe1, and Pax8). As a consequence, 
young adult transgenic Dyrk1A mice show significant heavier, but dysgenetic thyroid 
glands, with large disorganized regions, consist of small follicles lacking colloid and are 
therefore non-T4-producing. Moreover, they are less functional since they have lower 
thyroxine (T4) hormone excretion than wild-type mice and increased level of plasma 
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Thyroid-Stimulating Hormone (TSH), although this did not reach statistical significance 
(Kariyawasam et al. 2015). 
 
1.6 Using mouse models to study feeding behavior abnormalities in Down 
syndrome 
 
In this Thesis, we were interested in analyzing the contribution of behavioral factors in 
DS obesity risk, and their possible mechanisms. To do so, we used a trisomic mouse 
model, the Ts(17
16
)65Dn mice (abbreviated Ts65Dn mice), one of the most commonly 
used mouse model of DS. The model carries a small chromosome derived primarily 
from mouse chromosome 16, causing dosage imbalance for approximately half of 
human chromosome 21 orthologues (Reeves et al. 1995). However, it also bears in 
triplicate a region that is not present in DS. Some interesting new models are being 
generated with better construct validity than the Ts65Dn mice (Birling et al. 2017), but 
in the context of the Thesis we had not access to those. 
A recent study has shown that Ts65Dn mice are hyperglycemic (Peiris et al. 2016) a 
phenotype that has been attributed the overexpression of the RCAN1 that is involved in 
the insulin secretion pathway and mitochondrial function (Peiris et al. 2016). Although 
other mechanisms controlling both homeostasis and no-homeostatic feeding have not 
been addressed before in this mouse model, behavioral and neurochemical alterations 
such as impulsivity, perseveration (Escorihuela et al. 1998; Driscoll et al. 2004; Heller 
et al. 2014) and cognitive inflexibility (Coussons-Read and Crnic 1996; Faizi et al. 
2011) may contribute to obesity development and overeating (Meule et al. 2014; 
Blanco-Gomez et al. 2015; Mallorqui-Bague et al. 2016). 
In this Thesis, we have also used a transgenic mouse model of Dyrk1A overexpression 
to narrowing-down the contribution of the kinase to overeating in DS. Several 
transgenic mice are available for scientific purposes (Altafaj et al. 2001; Yabut et al. 
2010; Guedj et al. 2012; Song et al. 2015). We chose mBACTgDyrk1A mice (Guedj et 
al. 2012) because this model uses the endogenous promoter of the gene and 
recapitulates several DS phenotypes at the behavioral and molecular level (Figure 5). 
The gene construct contains the Dyrk1A gene with their endogenous regulatory 
sequences that allow the interaction of the transcription factors and thus, mimics the 
best the endogenous Dyrk1A expression (Guedj et al. 2012). Also, several metabolic 
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contributors to obesity phenotypes have been already described (Rachdi et al. 2014b) so 
we can here concentrate in the behavioral dimension of feeding behavior. 
 
 
 
Figure 5. Schematic representation of the Murine BAC model of Dyrk1A overexpression. 
Comparison of the map and clone size of mBACTgDyrk1A transgenic mice with the coordinates on 
HSA21 and MMU16 (adapted from Guedj et al. 2012). 
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2. HYPOTHESIS AND OBJECTIVES 
 
2.1 Hypothesis 
 
Individuals with Down syndrome (DS; trisomy HSA21), a neurodevelopmental disorder 
leading to intellectual disability, are more likely to be obese. This higher obesity risk 
has been mostly related to lifestyle with deficient exercising and endocrine disturbances, 
such as leptin resistance or thyroid gland dysfunction. However, differences in feeding 
practices may also contribute to obesity, since there is an association between the body 
mass index and overeating and DS individuals consume more energy-dense foods, like 
snacks and sweets beverages than the general population. The working hypothesis of 
my work has been that, beyond the proposed homeostatic and lifestyle alterations 
leading to increased obesity risk, feeding behavior disturbances in DS might account for 
overeating contributing to obesity and could depend on reward sensitivity alterations. 
 
Among the hundreds of triplicated genes, the dual-specificity tyrosine-(Y)-
phosphorylated regulated kinase 1A (DYRK1A) is relevant for appetitive behavior 
regulation, insulin sensitivity and for the proper function of nigrostriatal dopaminergic 
neurons. Our secondary hypothesis was that Dyrk1A is a main player in this phenotype, 
and thus its overexpression could recapitulate some of the feeding behaviors associated 
to obesity in DS. 
 
2.2 Objectives 
 
The main objective of this work is to study the contribution of behavioral abnormalities 
to DS obesity risk using the Ts65Dn mice, a validated trisomic mouse model. To 
understand the underlying mechanisms we also studied possible metabolic and 
neurochemical players and pancreatic function in this model. Finally, we dissected the 
impact of in vivo Dyrk1A overexpression in DS-related obesity phenotypes using a 
mouse model overexpressing Dyrk1A in an otherwise disomic context. 
 
My specific objectives have been: 
1. To characterize the feeding behavior phenotypes associated to the trisomy in 
Ts65Dn mice. 
2. To study the behavioral adaptation of Ts65Dn mice to energy-dense foods and 
the appearance of compulsive overeating. 
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3. To determine the changes in key neurochemical players with a role in non-
homeostatic control of feeding, such as the monoaminergic systems in Ts65Dn 
mice. 
4. To determine the changes in key metabolic players with a role in homeostatic 
control of feeding such as leptin and ghrelin.  
5. To understand pancreatic function and peripheral control of glucose homeostasis 
in Ts65Dn mice. 
6. To elucidate the impact of DYRK1A on feeding phenotypes using a mouse 
model overexpressing Dyrk1A (mBACTgDyrk1A). 
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3. MATERIAL AND METHODS 
 
The main objective in this Thesis has been to investigate the contribution of abnormal 
feeding behaviors, such as compulsive overeating of energy-dense foods, in obesity 
development in Down syndrome (DS). To this aim we have used a well-validated 
mouse model of DS bearing a partial trisomy of chromosome 16, the Ts65Dn. We first 
characterized feeding behavior and obesity-related phenotypes in non-obesogenic 
conditions. Then, we induced obesity and compulsive overeating using a protocol 
previously validated in our group (Espinosa-Carrasco al. submitted) based on long-term 
free access to energy-dense diets. Mice exposed to those conditions were sacrificed for 
the neurochemical and histological analysis. The second objective of this Thesis was to 
study the implication of the tyrosine-(Y)-phosphorylation regulated kinase 1A 
(DYRK1A), an interesting candidate for DS obesity. We analyzed feeding behaviors in 
transgenic mice (mBACTgDyrk1A) only overexpressing Dyrk1A to determine if we 
could recapitulate trisomic obesity-related phenotypes. We used the same experimental 
design used for studies in Ts65Dn mice.  
 
3.1 Animals 
 
In this Thesis, we used two mouse models: a partial trisomic mouse model of DS 
(Ts65Dn) to define obesity-related DS phenotypes and a transgenic mouse model 
(mBACTgDyrk1A) overexpressing only Dyrk1A to confirm the implication of this DS 
candidate gene on the trisomic obesity phenotypes. 
Ts(17
16
)65Dn (Ts65Dn) and wild-type (WT) littermates were obtained crossing 
B6EiC3Sn a/A-Ts (17
16
)65Dn (Ts65Dn) females to B6C3F1/J males purchased from 
The Jackson Laboratory (refs. 001924 and 001875, the Jackson Laboratory Bar Harbor, 
Bar Harbor, ME, USA). In B6EiC3Sn a/A-Ts(17
16
)65Dn (Ts65Dn) female the 
chromosomal rearrangement was generated by radiation that induced a spontaneous and 
unplanned reciprocal translocation of the telomere proximal region of Mmu16 to the 
centromere and pericentromeric region of Mmu17 (Davisson et al. 1993).  
mBACTgDyrk1A mice were obtained crossings transgenic males overexpressing 
Dyrk1A (mBACTgDyrk1A) with C57BL6/SJL females. mBACTgDyrk1A (Tg189N3) 
mice were generated in the laboratory of Jean-Maurice Delabar (University Paris 
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Diderot, Sorbonne Paris Cité) as previously described (Guedj et al. 2012). Briefly, a 
bacterial artificial chromosome 189N3 (BAC-189N3) strain carrying the entire murine 
Dyrk1A gene with endogenous promoter and regulatory regions was introduced by 
electroporation in the HM-1 embryonic stem (ES). ES clone was selected for 
overexpression of Dyrk1A close to 1.5 times, and injected into blastocysts to generate 
the Dyrk1A overexpressing mouse. Of note, the WT controls of Ts65Dn and 
mBACTgDyrk1A are of different genetic backgrounds, and thus we specifically 
compared the wild-type mice of the two strains to control for strain-dependent effects. 
  
Genotyping 
Genotyping was performed by amplifying genomic DNA obtained from the tail. For 
Ts65Dn model, quantitative polymerase chain reaction (qPCR) was done following (Liu 
et al. 2003). The overexpression of Dyrk1A in mBACTgDyrk1A mice was confirmed as 
previously described (Guedj et al. 2012).  
 
Housing and husbandry 
The mouse colonies of Ts65Dn and mBACTgDyrk1A mice were bred in the Animal 
Facility of the Barcelona Biomedical Research Park (PRBB, Barcelona, Spain). Mice 
were housed individually in conventional (325 weight × 145 depth × 132 height mm 
Plexiglas cages; Figure 6A), in controlled laboratory conditions, with temperature 
maintained at 22 ºC ± 1
o
C and humidity at 55 ± 10% on a 12 hours light/dark cycle 
(lights off 20:00 hours). Prior to the study all mice were fed ad libitum on a standard 
rodent chow (SC, see composition below) with free access to clean drinking water. 
 
 
 
 
 
 
Figure 6. Representative images for housing cages used during the study. (A) Standard individualized 
cage for mouse housing and (B) a PheCOMP cage (Panlab-Harvard Instruments, Spain), the equipment 
used for automatically record the food/water intake and activity of individualized mice. 
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The characterization of the time-course and dynamics of obesity-related behavioral 
changes required isolation. For this reason, we selected male mice, since females show 
greater responses to stress than males (Senst et al. 2016) that may alter metabolism and 
lead to body weight loss being a potential confounder. Also, since some reports suggest 
that Ts65Dn mice have delayed growth (Davisson and Costa 1999), experiments were 
conducted in 5 months-old male mice once body weight had stabilized. Thus, we also 
used 5 months-old male mBACTgDyrk1A mice allowing comparison between the two 
models. Experiments and analysis were performed blind to genotype and experimental 
condition. 
 
Ethical statement 
All experimental procedures were approved by the local ethical committee (Comité 
Ético de Experimentación Animal del PRBB (CEEA-PRBB; procedure number MDS-
12-1464P3), and met the guidelines of the local (law 32/2007) and European regulations 
(EU directive n° 86/609, EU decree 2001-486) and the Standards for Use of Laboratory 
Animals n° A5388-01 (NIH). CRG is authorized to work with genetically modified 
organisms (A/ES/05/I-13 and A/ES/05/14). Methods and results have been written 
according to the ARRIVE Guidelines (Kilkenny 2010). 
 
3.2 Feeding behavior analysis 
 
We characterized behavioral, neurochemical and metabolic phenotypes in Ts65Dn mice 
to define DS-obesity phenotypes and unravel possible mechanisms. Two different 
models of diet induced obesity were used based in free access to standard chow (SC) 
and (i) a chocolate-mixture (CM) diet or (ii) or high-fat (HF) diet. 
We then investigated if the single overexpression of Dyrk1A could be sufficient to 
replicate the feeding behavior phenotypes detected in trisomic mice. For both mouse 
models, the experiments were performed in at least 4 batches of animals to get the 
sufficient number of mice and of technical replicates, and control for possible litter and 
mothering effects. The sample size of the groups was calculated based on similar 
experiments previously performed in our laboratory.  
For the study of feeding behavior and the influence of energy-dense diets, Ts65Dn mice 
were placed in the experimental cages (PheCOMP, Panlab-Harvard Instruments, 
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Barcelona, Spain) by randomization using Excel (RAND() function)  and were assigned 
to each experimental group balanced by body weight. PheCOMP cages (Panlab-Harvard 
Instruments, Barcelona, Spain) allowed the precise detection of food and water intake.  
We used a total of 19 wild-type (WT) and 16 Ts65Dn (TS) mice distributed in three 
groups: mice receiving only standard chow (SC, n = 8 per genotype), mice having free 
choice between standard chow (SC) and a chocolate-mixture (CM) diet, (SC+CM, n = 
10 per genotype) or mice having free choice between standard chow (SC) and high-fat 
(HF) diet, (SC+HF, n = 9 per genotype). However, along the experiment some of them 
registered “abnormal signals” (e.g. some cages registered continuous intake signals or 
showed values that were higher than the expected ones for a mouse’s consumption). For 
this technical reason, some mice were excluded of the meal pattern analysis and 
behavioral tests. The final number of mice analyzed was: SC group: WT n = 8, TS n = 
7; SC + CM group: WT n = 9, TS n = 10; SC + HF group WT n = 8, TS n = 7. 
For the characterization of the role of overexpression of Dyrk1A on obesity 
development and compulsive eating due to the mBACTgDyrk1A (TG) we isolated the 
mice in their home cages and performed the stand-alone tests of compulsivity 8 weeks 
after the continuous exposure to energy-dense food. TG mice and their WT littermates 
were also distributed in 3 experimental groups: SC (n = 8 per genotype), free choice 
SC+CM (n = 8 per genotype) or free choice SC+HF (n = 8 per genotype).  
In a separate group, we also characterized the meal pattern using PheCOMP cages, in n 
= 4 WT, n = 5 TG mice. Mice were given only SC for 2 weeks and then were switched 
to a free choice SC+CM diet. For this experiment, due to a breeding problem in our 
colony, the sample size of SC+CM group is small and we could not include a SC+HF 
group. However, we decided to include the results in the Thesis, since, although 
preliminary they shed light to Dyrk1A-dependent phenotypes. 
  
Body weight and feeding behavior analysis 
Short-term laboratory-based measures of eating in weight stable obese individuals may 
not be functionally relevant to understand long-term changes in body weight gain. To 
solve this, here we used longitudinal meal pattern analysis for the study of obesity 
development. Body weight was registered twice weekly for whole experimental period, 
always at the same time of the day. Body weight gain was determined by subtracting the 
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body weight on the 1st day of CM or HF exposure from the body weight on subsequent 
days. 
 
Apparatus 
For meal pattern studies, we used PheCOMP high-resolution monitoring system 
(Panlab-Harvard Instruments, Spain). The equipment contains experimental cages 
(Allentown Caging Equipment, ACE, 197 weight × 306 depth × 212 height mm, see 
Bura et al. 2010) provided with a grid floor and a filter top. The platform supporting 
each cage contains 2 infrared frames (16 × 16 beams, 16 mm spaced) allowing 
simultaneously recordings of horizontal activity and rearing. The system is equipped 
with 2 water and 2 food dispensers that continuously register food consumption with 20 
mg precision by means of weight transducers mounted into the platform supporting 
each cage. The quantity of water drunk from a nipple, and any possible dripping, are 
also accounted using the same system of transducers with 20μl precision. The modular 
structure allows multiple dispenser combinations made them suitable for our free-choice 
experiments. In our experiments of free choice, one dispenser always contained 
standard chow (SC) and the other a chocolate-mixture (CM) or a high-fat (HF) diet. The 
side was counterbalanced between cages and genotypes. Infrared beams allowed 
recording of locomotor activity and rearing. Animals were recorded uninterruptedly 
during periods of 3 or 4 days. Between these periods the system was paused during 
approximately one hour for refilling the feeders and the cleaning of the cages. 
The continuous signals from each weight transducer and the infrared frame are 
amplified, digitized and sent to the computer software for data acquisition and storage. 
Along the acquisition process, meal pattern analysis is performed using the 
COMPULSE software (Panlab-Harvard Instruments, Spain). Meal pattern analysis 
included recording duration and recurrence intervals of eating or drinking acts, to 
calculate circadian and ultradian periodicities, and event-related frequency distributions. 
Feeding/drinking acts were considered as a meal or a drinking bout when separated by 
more than 120 seconds from the next feeding/drinking act. Hence, feeding/drinking acts 
were merged into single food/water bouts when the intermeal interval was shorter than 
120 seconds (see Heyne et al. 2009). 
The feeding parameters computed by the COMPULSE software and their biological 
significance are listed in Table 1.    
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Table 1. Parameters defining meal pattern and its behavioral significance 
 
Besides we also calculated the preference (P) for energy-dense foods against standard 
chow is a measure of the rewarding and reinforcing effect of the energy-dense diets, and 
was calculated as: 
(i) 
  
                                                  
                                 
 
(ii)  
  
                                                          
                                     
 
 
Where estimated CM/HF is calculated as:  
 
                
                             
 
 
 
In (i) in grams and in (ii) in KJ corrected by the body weight (BW) of the animal in 
grams. 
Therefore P > 0 means preference for CM/HF whereas P ≤ 0 means no preference or 
preference for SC.  
For the visualization of the longitudinal data, and specifically of food consumption and 
temporal distribution of feeding events of each mouse, we used a customized open-
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source software developed in our laboratory (Pergola; http://cbcrg.github.io/pergola) 
designed for the manipulation, modeling, visualization and integration of (high-
throughput) longitudinal behavioral data. For quantification of locomotor activity, we 
used the ActiTrack software (Panlab-Harvard Instruments, Spain). 
 
Diets 
The diets used in this Thesis (Figure 7) were: 
(i) Standard chow (SC). This group had access only to standard chow. Standard chow 
(SDS, UK) contained 10.76 MJ kg−1 digestible energy (17.5 % coming from protein, 75 
% from carbohydrate and 7.4% from fat; Table 2). Typically, rodent chow carbohydrate 
is contributed to by 45% starch and approximately 4% simple sugars (monosaccharides 
plus disaccharides) as a proportion of total carbohydrates by weight.  
(ii) Pellets of a mixture of commercial chocolates (CM) made from equal amounts of 
Bounty®, Snickers®, Mars® and Milka ® chocolates. CM pellets contained 20.6 
MJ kg−1 digestible energy (17 % coming from protein, 52 % from carbohydrate and 
24% from fat; carbohydrate is contributed to by 8% starch and approximately 44% 
simple sugars (monosaccharides plus disaccharides, Table 2). 
(iii) High-Fat diet (HF) consisted of commercial pellets of purified diet w/60% energy 
from fat. HF pellets (58G9; Test Diet ®, USA) contained 22 MJ kg−1 digestible energy 
(24 % coming from protein, 30 % from carbohydrate and 35 % from fat; carbohydrate is 
contributed to by 5.4% starch and approximately 6.4 % simple sugars (monosaccharides 
plus disaccharides, Table 2).  
Food was renewed each of 3 - 4 days to ensure the maintenance of the organoleptic 
properties. 
 
Figure 7. Standard chow and energy-dense diets. Representative photographs showing the different 
diets used during this Thesis. (A) Control mice are fed with standard chow (SC). Free choice mice have 
always SC and (B) chocolate-mixture (CM), or (C) high-fat (HF) diet pellets. 
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Table 2. Nutritional composition and energy content of the experimental diets. The composition of 
the SC and HF diets was provided by the manufacturers. CM diet that was prepared in the lab and its 
composition was analyzed by Alquimisa laboratories S.L (Salamanca, Spain). 
Nutrients Standard chow 
(SC) 
Chocolate-mixture 
(CM)* 
High-fat diet   
(HF) 
Protein (%) 17.49 17 23.7 
Fat (%) 7.42 24 34.7 
Carbohydrates (%) 75.09 52 29.6 
Sugar (%) 4.05 44.4 6.36 
Starch – fiber (%) 44.97 7.6 5.4 
Energy (Kcal/g) 2.85 4.92 5.25 
Energy (KJ/g) 10.76 20.6 22 
 
Experimental design 
For the analysis of feeding behavior, at 5 months of age, animals were individually 
housed during 15 weeks (2 weeks for habituation, 8 weeks for obesity development and 
5 weeks of behavioral testing phase, Figure 8) in multi-take metabolism and activity 
cages (PheCOMP, Panlab-Harvard Instruments, Barcelona, Spain, Figure 6B). 
 
Figure 8. Experimental design. Mice were individually housed in PheCOMP cages to register 
longitudinal activity and meal pattern. During the habituation period, all mice received standard chow 
(SC). Then they were allocated to receive free access of chocolate-mixture (CM) or high-fat diet (HF) for 
the study of the obesity development. After animals gained stable overweight (8 weeks after introduction 
of energy-dense diets), a battery of behavioral tests was used to characterize the appearance of 
compulsive and inflexible behavior during 5 weeks. At the end of this experimental phase animals were 
sacrificed, and the prefrontal cortex (PFC), hypothalamus (HT) and striatum (ST) were dissected and 
collected for HPLC neurotransmitter measurements (Neurochemical studies). 
 
Habituation phase. All mice were individually housed in PheCOMP cages and 
provided with standard chow (SC) and water ad libitum during two weeks to allow 
habituation to the housing conditions and to define the baseline meal pattern. 
Obesity development phase. After habituation, mice were assigned to each diet-
condition, i.e. free access to either chocolate-mixture (CM) or high-fat chow (HF) and 
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standard chow (SC). Control group continued receiving sole access to standard chow. 
The development of overweight in the experimental groups was followed during 8 
weeks. 
Testing phase. At the end of the obesity development phase, we evaluated the 
appearance of diet-induced non-adaptive behaviors, such as compulsive behavior or 
behavioral inflexibility. Several behavioral tests were performed, usually one test per 
week to give the animals enough time to re-establish their regular food intake during the 
days between tests: starvation, limited access to energy-dense food, food adulteration 
and preference for sweet solutions. 
   
Starvation 
Mice of all groups (SC, SC+CM and SC+HF) were food deprived during 24 hours 
(water still provided ad libitum) and we calculated the increase in energy intake (KJ) 
after refeeding compared to their behavior in free feeding conditions. Energy intake 
after starvation provides information on the influence of hunger on food seeking and 
food taking.  
 
Limited access to energy-dense food 
Access to chocolate-mixture or high-fat diet was restricted to 1 hour during the light 
(resting) phase of the light-dark cycle (from 14:00 to 15:00h) for 3 consecutive days in 
overweight mice (SC+CM and SC+HF). Standard chow and water were provided 
unrestrictedly ad libitum. The test evaluates (i) inflexible behavior and (ii) compulsive 
intake binge-like eating episodes characterized by rapid consumption of high quantities 
of CM or HF during refeeding (Espinosa-Carrasco et al. submitted).  
(i) Behavioral flexibility is studied by measuring if the animals compensate for the 
restriction of access to the high caloric food by increasing the intake of standard chow. 
An inflexible response would be revealed by the neglect of standard chow. To this aim 
we compared the standard chow (SC) energy intake (KJ/grams of body weight) during 
periods where the CM/HF was not available with the SC energy intake in free feeding 
conditions.  
(ii) Binge-like eating episodes upon limited access are revealed by measuring the energy 
intake (KJ/grams of body weight) and the eating rate (mg/s) of CM and HF consumed 
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during the periods of CM/HF access (1h for 3 consecutive days). We also analyzed the 
evolution of binges, to analyze the effect of repetitive restriction to the preferred food. 
The measurements of each day of limited access where compared to the feeding 
behaviors at the same hour of the day (14:00 to 15:00h) in non-restricted conditions. 
The CM/HF energy increase between the ad libitum conditions and during the third day 
of the limited access was also calculated. 
 
Food adulteration with quinine hydrochloride 
Compulsive and inflexible components are also reflected by maintenance of 
consumption despite an adverse bitter taste. The protocol was adapted from Heyne and 
collaborators (Heyne et al. 2009). Briefly, for inducing bitter taste we used quinine 
hydrochloride (Sigma-Aldrich, UK). To adulterate the chocolate-mixture (CM), we 
added 3g of quinine hydrochloride per Kg of CM during the mash preparation. The 
high-fat (HF) pellets were triturated, we added 3g of quinine hydrochloride per Kg of 
HF to the mash, and then the pellets were reconstituted. To adulterate the standard 
chow, the quinine hydrochloride was diluted in water and then pellets were impregnated 
with the quinine solution. For two consecutive days, SC+CM mice received 
unpleasantly bitter-tasting CM and SC+HF mice received bitter-tasting HF. SC mice 
were given bitter-tasting SC as a control of taste detection. For all conditions, 
unadulterated SC and water were always available. We compared the average food and 
energy intake of bitter SC/CM/HF of the two days to the daily SC/CM/HF energy intake 
in non-adulterated conditions (in SC mice, SC+CM mice and SC+HF mice, 
respectively).  
 
Preference for sweets solutions 
The two-bottle test was used for assessing reward and taste perception. For 2 
consecutive days, all mice had the choice between water and a sweet solution: either 
0.05 % saccharin or 2 % sucrose solution (each sweet solution spacing of one week). 
Preference scores were calculated as the following ratio: 
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To prevent possible bias of side preference in drinking behavior, the position of the 
bottles was counterbalanced. No food or water deprivation was applied before the test. 
 
3.3 Neurochemical analysis in Ts65Dn mice 
 
At the end of the behavioral testing phase of the study, the monoamine content (NA 
(noradrenaline), AD (adrenaline), DA (dopamine), DOPAC (3-4dihydroxyphenylacetic 
acid), 5-HIAA (5-hydroxy-3-indolacetic acid), 5-HT (serotonin) and HVA 
(homovanillic acid) was measured in hypothalamus, prefrontal cortex and striatum of 
SC mice (WT n = 6, TS n = 6) to define genotype-dependent differences. We then 
measured changes induced by long-term free access to energy-dense food in SC+CM 
mice (WT n = 6, TS n = 6), and SC+HF mice (WT n = 5, TS n = 5).  
 
Tissue dissection and preparation 
Mice were sacrificed using carbon dioxide. The hypothalamus, prefrontal cortex and 
striatum were removed and stored at -80ºC until analysis. For monoamines 
measurements, the frozen tissues were weighed and suspended in 400 μl of ice-cold 
0.1M perchloric acid solution with 0.4% EDTA. Tissues were homogenized with 1.5 
mm diameter beads during 2 min using a tissue lyser II (Qiagen). The homogenates 
were centrifuged at 3000 rpm during 30 min at 4°C and the supernatants were collected 
and centrifuged at 16400 rpm during 2 min. 
 
High-performance Liquid Chromatography with Electrochemical Detection (HPLC-
ED) 
The HPLC–ED system was composed of Shimadzu apparatus equipped with a LC20AD 
pump, a SiL20AC auto-sampler coupled with an electrochemical detector (Waters 
2465). Separation was obtained using a 150 x 4.6 mm C18 5µM Beckman Ultrasphere 
column equipped with two Phenomenex C18 filters in a security guard system. The 
mobile phase which contains 150 mM ammonium acetate, 8.2 mM octane-sulfonic-acid, 
15% methanol (v/v) adjusted to a pH of 3.8 with glacial acetic acid, was filtered through 
a 0.2µM membrane filter, degassed before use and pumped at a flow rate of 0.8ml/min. 
Eluates were detected at an oxidation potential of 700 mV versus a reference electrode. 
The column and the detection cell were housed within the Faraday cage of the 
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electrochemical detector that was set at 25.5°C. Samples with an injection volume of 40 
μl were placed in the auto-sampler and kept at 4°C.  
The monoamines NA (noradrenaline), AD (adrenaline), DA (dopamine), DOPAC (3-
4dihydroxyphenylacetic acid), 5-HIAA (5-hydroxy-3-indolacetic acid), 5-HT 
(serotonin) and HVA (homovanillic acid) were purchased from (Sigma-Aldrich, UK). 
Ultrapure water was obtained with a Milli-Q system (Millipore, USA). Standards 
solutions of each monoamine or metabolite were prepared at a concentration of 50ng/ml 
in ultrapure water for indoleamines and in 0.1 N HCl solution for catecholamines and 
were stored at -20°C. The retention time allowed by this system was 7 min, 10 min, 
13.5min, 16.5 min, 21 min, 32 min and 42 min for NA, AD, DA, DOPAC, 5-HIAA, 5-
HT and HVA respectively. The peak areas of the external standards allow the 
metabolites quantification in the tested samples. The content of each monoamine was 
expressed as ng per mg of wet weight. The outlier values defined as above/below the 
group mean ± 2 x standard deviation were excluded of the analysis, concretely two 
samples from prefrontal cortex of SC mice (1 WT and 1 TS) were discarded. 
 
3.4 Metabolic studies in Ts65Dn mice 
 
The metabolic analysis was carried out in three different batches of Ts65Dn mice. For 
this experiment, we characterized (i) body composition, (ii) glucose homeostasis and 
(iii) pancreatic phenotypes in non-obesogenic conditions (standard chow, SC): WT n = 
10, TS n = 8. 
 
Body composition analysis in Ts65Dn mice 
Non-invasive analysis of body composition was estimated by nuclear magnetic 
resonance (NMR) technology via a scanner EchoMRI 900 (Echo Medical Systems, 
Houston, USA), that creates contrast between soft tissues taking advantage of the 
differences in relaxation times of the hydrogen spins and/or hydrogen density. Tissue 
contrast is high between fat, body free fluid, and muscle based on NMR signal 
amplitude and relaxation times, and can be further enhanced by application of certain 
radio frequency sequences (http://www.echomri.com/). Briefly, the mouse is placed in a 
specially sized, clear plastic holder without sedation or anesthesia. The holder is then 
inserted into a tubular space in the side of the EchoMRI™ system.  
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Lean mass is equivalent to muscle mass and organs. Body fat does not distinguish 
between different types of fat and fat depositions in every organ including the brain, 
muscles, other organs, bone marrow, and circulating blood lipids, and fatty acids. In our 
experiment, lean and fat body composition was directly obtained from EchoMRI™ 
measurements in grams. From this data, body composition was calculated for each 
mouse and corrected for body weight. 
  
Glucose homeostasis and insulin levels 
5-month old male mice fed with standard chow weeks were used for characterization of 
the glucose homeostasis using a glucose tolerance test.  
First for the study of the basal glucose and insulin blood levels, mice were food 
deprived for 5 hours. Blood samples were collected from the tail vein and blood glucose 
levels were measured using the OneTouch Vita blood glucose meter (LifeScan). Plasma 
levels of insulin were determined by using Ultra Sensitive Mouse Insulin ELISA Kit 
(France). 
Glucose tolerance test (GTT) was then performed to study the glycemic and insulinemic 
profiles after administration of a glucose load.  Mice were food deprived for 5 hours 
prior to an oral administration of 2g/Kg of 30% glucose (Lavoisier, France). Blood was 
sampled from the tail vein at 0, 10, 30, 60, 90 and 120 min in order to assay glucose 
concentration using OneTouch Vita blood glucose meter (LifeScan). At 0, 15, 60 and 
120 min blood was taken to measure plasma insulin concentration with Ultra Sensitive 
Mouse Insulin ELISA Kit (France). 
Morphological and functional studies of islets 
For immunohistochemistry, pancreases were immersed in 10% formalin and embedded 
in paraffin sections (4-μm-thick) as previously described (Rachdi et al. 2014a). Mouse 
anti-insulin (1:2000; Sigma) was used for quantification of insulin staining. We 
analyzed the pancreases of mice fed with standard chow (WT n = 4, TS n = 4). 5 
sections for each pancreas were used for the analysis. 
For in vitro insulin secretion study, islets from pancreases of WT and Ts65Dn 5-
months-old mice were isolated from by collagenase digestion followed by purification 
through a Histopaque gradient (Sigma-Aldrich, France). Insulin secretion was assessed 
by static incubation of isolated islets in Millicell insert (Millipore). Following overnight 
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culture in RPMI containing 5.6 mmol/l glucose, islets were pre-incubated for 1 hour in 
Krebs-Ringer medium containing 2.8 mmol/l glucose. Groups of 50 islets in triplicate 
were then incubated in Krebs-Ringer medium containing 2.8 mmol/l glucose or 20 
mmol/l glucose for 1 hour. Secreted insulin and insulin content were measured using an 
ultrasensitive mouse insulin ELISA (Mercodia AB, Sweden). 
 
3.5 Statistical analysis 
 
Different statistical methods were applied depending of the characteristics of each 
experiment. Mann-Whitney-U-test analysis was used for the comparison of feeding 
behavior and obesity phenotypes between genotypes (Ts65Dn/mBACTgDyrk1A vs. 
their wild-type littermates) in SC mice.  Paired sample Mann-Whitney-U-test test was 
used to compare feeding behaviors between CM/HF vs. SC in free choice mice, since 
they are two measures for the same subject. The time course evolution of body weight 
was analyzed by a mixed analysis of variance (ANOVA) repeated measures.  
For the analysis of meal pattern data, we used a linear mixed model in which we 
included the diet (SC from SC group, SC and CM separately from SC+CM group; SC 
and HF separately from SC+HF group) as a fixed effect. The variable 'Mouse ID' was 
included as a random effect since we disposed of repeated measures in the case of the 
free choice mice. Differences were considered significant at P< 0.05 upon subsequent 
Sidak post-hoc analyses. To quantify the circadian feeding rhythmicity loss, we used 
three-way repeated measures ANOVA (genotype, diet and phase). For analysis of 
energy compensation during the limited access to energy-dense food test and for the 
two-bottle tests with sweets solutions, we used two-way ANOVA with genotype 
(Ts65Dn/mBACTgDyrk1A vs. their wild-type littermates) and group (SC, SC+CM, 
SC+HF) as factors between subjects. For each test, significance was considered when 
P< 0.05. For ANOVA, subsequent Bonferroni post-hoc analyses were performed when 
required and differences were considered significant at P< 0.05. All results are 
expressed in mean ± SEM. The statistical analysis was performed using the Statistical 
Package for Social Science program SPSS® 12.0 (SPSS Inc., Chicago, USA). 
For the principal component analysis (PCA) we used physical, behavioral, and 
neurochemical data.  Physical data included body weight (BW, Kg; BWfinal, 
BWincrease, % of increase). Behavioral data included: locomotor activity during the 
light phase (beam cuts), locomotor activity during the dark phase (beam cuts); number 
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of meals (n_meals_total); food intake (Food_intake_(g)_total); energy intake (KJ/BW; 
Total_Intake_week8); meal duration (Meal_Duration_(min)_av); intermeal interval 
(Intermeal_Interval(min)_av); eating rate (Eating_Rate(mg/sec)_av); satiety 
(Satiety_(min/g)_av; increase of energy intake upon starvation (Energy after 
starvation_TOTAL); SC intake (KJ/BW) during the quinine hydrochloride adulteration 
test (Energy(SC)_adulteration_test);  SC/CM/HF intake (KJ/BW) during the quinine 
hydrochloride adulteration test (Energy (bitter SC/CM/HF)_adulteration_test); 
preference for saccharine (Pref_saccharine); preference for sucrose (Pref_sucrose). As 
neurochemical variables, we include the HPLC measurements (ng/g) in hypothalamus 
(HT), striatum (ST) and prefrontal cortex (PFC) of: NA (noradrenaline), AD/DOPAC 
(adrenaline/ 3-4dihydroxyphenylacetic acid); DA (dopamine), 5-HIAA (5-hydroxy-3-
indolacetic acid), 5-HT (serotonin) and HVA (homovanillic acid); 5-HIAA/5-HT levels. 
Before performing the PCA, we apply a log-transformation in case the transformation 
was improving the “normality” of the distribution (using the Shapiro test for testing the 
0 hypothesis of normality). PCA was performed using the R function prcomp, after 
shifting all variables to be zero centered and scaling them to have unit variance. We 
then looked at the correlation between our variables.  Spearman Rho’s were converted 
in P-values using the Fishers R-Z transformation (Myers and Sirois 2006). 
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4. RESULTS 
 
4.1 Behavioral contributors to obesity in Ts65Dn mice 
 
Obesity in people with DS has been traditionally attributed to endocrine issues such as 
leptin resistance and thyroid gland dysfunctions (Anwar et al. 1998; Bergholdt et al. 
2006) or to deficient exercising (Heller et al. 2003). However, differences in feeding 
practices may also contribute to obesity, since there is an association between body 
mass index and overeating (Mallan et al. 2017) and DS individuals consume more 
energy-dense foods like snacks and sweets beverages than the general population 
(Grammatikopoulou et al. 2008; Nordstrøm et al. 2015). In the first part of this Thesis 
we characterized feeding behavior and obesity-related phenotypes in a well validated 
mouse model of DS bearing a partial trisomy of chromosome 16, the Ts65Dn (Davisson 
et al. 1993). 
4.1.1 Somatometric characteristics and feeding behavior in Ts65Dn mice 
 
Since feeding behavior had not been characterized in Ts65Dn mice, we first had to 
establish the face validity of this model. The body weight and mass index of 5 months-
old Ts65Dn mice fed with standard chow was similar to WT littermates (Figure 9A and 
9B, respectively). Ts65Dn mice presented a significant reduction of body length (Mann-
Whitney-U-test, z = -3.12; P<0.01; Figure 9C). 
 
 
Figure 9. Somatometric characteristics of Ts65Dn mice. Bar blots represent (A) Body weight (grams),  
(B) body mass index (BMI; grams/cm
2
) and (C) body length (cm) in mice fed with standard chow (SC) of 
Ts65Dn (TS, n = 11) and wild-type mice (WT, n = 13). Data expressed as mean ± SEM. Mann-Whitney-
U-test for independent samples ** P<0.01. 
Using Nuclear Magnetic Resonance (NMR) we detected reduced lean body mass 
(Mann-Whitney-U-test, z = - 2.58; P<0.05; Figure 10A) and a higher percentage of 
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body fat per body weight in Ts65Dn as compared to their WT controls (Mann-Whitney-
U-test, z = -2.40; P<0.01; Figure 10B) suggesting increased risk for fat accumulation. 
 
 
Figure 10. NMR non-invasive analysis of body mass composition in wild-type (WT) and Ts65Dn 
(TS) mice. Bar blots show (A) body composition in lean mass (LM) and fat mass (FM) represented in 
grams, and (B) body composition corrected for body weight (BW in TS (n = 8) and WT (n = 10) mice. 
Data expressed as mean ± SEM. Mann-Whitney-U-test for independent samples * P< 0.05, ** P<0.01.  
 
Meal pattern analysis 
Meal pattern analysis revealed that Ts65Dn mice fed with SC have longer meals (Mann-
Whitney-U-test, z = P<0.01; Figure 11A) and reduced eating rate (milligrams of food 
eaten per second) compared to WT (Mann-Whitney-U-test, z = P<0.001; Figure 11B). 
Ts65Dn also showed reduced intermeal intervals (Mann-Whitney-U-test, z = - 2.47; 
P<0.05, Figure 11C) indicating higher frequency of refeeding. However, we detected 
only slight, non-significant differences in the total number of meals (Figure 11D). 
We also characterized drinking behavior. The total amount of fluid consumed was 
similar in both genotypes (Figure 11E), but Ts65Dn mice showed significantly longer 
(Mann-Whitney-U-test, z = -4.33; P<0.01, Figure 11F) and slowlier drinking events 
(drinking rate, Mann-Whitney-U-test, z = -5.72; P<0.001, Figure 11G) than WT.  These 
results could reflect oral-motor dysfunction in trisomic mice, similar to what has been 
described in humans that may lead to problems initiating and maintaining a smooth 
sequence of feeding actions (Hennequin et al. 2005). 
Finally, continuous recording of food intake and locomotor activity tracked by the 
actimeter in the PheCOMP cages showed similar circadian patterns in both genotypes 
(Figure 11H). Ts65Dn and WT littermate controls, showed normal photoentrainment 
45 
 
under a 12:12 light-dark cycle, with feeding events concentrated during the active 
period (the nocturnal phase, Figure 11H).  
 
 
 
 
46 
 
Figure 11. Meal pattern analysis and circadian rhythmicity in wild-type (WT) and Ts65Dn (TS) 
mice fed with standard chow (SC). Bar plot shows (A) the average duration (min), (B) the eating rate 
(mg/s), (C) the average intermeal interval (min) and (D) the number of meals in 24 hours at the end of the 
habituation period. Bar plots for (E) the amount of water consumed (ml), (F) the average duration of the 
drinking events (min) and (G) the drinking rate (ml/s) in 24 hours at the end of the habituation phase. (H) 
Longitudinal behavioral recordings. The figure depicts the feeding bouts along 3 consecutive days of 8 
WT (gray) and 7 Ts65Dn (orange) mice receiving standard chow (H1). Each line represents feeding bouts 
of individual mice. Each line depicts a meal along time as an indicator of meal frequency. The width of 
each bar represents the meal duration. Individual intakes corresponding to WT mice are depicted in the 
upper part of the graph and those corresponding to Ts65Dn (TS) mice in the bottom part. (H2) Each blue 
bar represents the cumulative value of food consumed in 30 minutes. Color intensity indicates the 
accumulated value of the intake (white = 0 grams, blue ≥ 0.5 grams). (H3) Time course of the average SC 
intake in 30 minutes of WT (grey) and TS (orange). Metadata in the figure include: (i) identifiers (left bar 
in H1 and H2) of each WT (gray) and Ts65Dn (orange) mice and (ii) dark (active) periods (light-dark 
phase track) represented as grey rectangle on the top of H1-H2 and on the bottom of H3. Data from A-G 
are expressed as mean ± SEM. WT mice (n = 19), TS mice (n = 16). Mann-Whitney-U-test for 
independent samples * P<0.05; ** P<0.01; *** P<0.001. 
 
4.1.2 Changes in feeding behavior upon exposure to free access to energy-dense 
food in Ts65Dn mice 
 
To determine if voluntary consumption of energy-dense foods, reported to be increased 
in DS patients, may lead to obesity, overeating and compulsive-like behaviors, we used 
an experimental diet-induced obesity model based on free choice of standard chow 
(SC), and chocolate-mixture (CM) or high-fat diet (HF). We continuously recorded 
feeding behavior during eight weeks and the changes of feeding behavior upon exposure 
to the test diets. After long-term access to CM or HF we evaluated the appearance of 
compulsive and inflexible feeding responses in stand-alone laboratory tests (starvation, 
limited access to energy-dense food, quinine adulteration and preference for sweet 
solutions).  
 
Body weight gain 
No changes in body weight of mice fed with only SC along 8 weeks were observed, but 
upon free access to CM or HF, all mice showed an increase of body weight (Repeated 
measures ANOVA, F(2,47) = 5.34; P<0.05), and the effects were more marked in 
SC+HF group (genotype effect: Repeated measures ANOVA F(2,47) = 8.31; P<0.01; 
Figure 12A). In SC+HF group weight gain significantly differ between both genotypes 
being the percentage of body weight increase after 8-weeks exposure to HF significantly 
higher in Ts65Dn mice than in WT (diet x genotype effect: two way ANOVA F(1,52) = 
4.74, P<0.05; Bonferroni as post-hoc: P< 0.05; Figure 12B). 
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Figure 12. Body weight increase upon 8 weeks of free access energy-dense diets in wild-type (WT) 
and Ts65Dn (TS) mice. (A) Time course of body weight increase along the 8 weeks of exposure to 
energy-dense foods. (B) The plot represents the percentage of body weight gain at the end of the 
experiment. Genotypes are represented as dots (WT) and squares (TS), diet conditions are shown as 
colors (SC = black; SC+CM = brown and SC+HF = blue). (A) Depicts the mean of the group whereas in 
(B) each dot/square represents one individual. SC group: WT n = 9, TS n = 9; SC + CM group: WT n = 
10, TS n = 10; SC + HF group WT n = 9, TS n = 9.  (A) ANOVA Repeated measures diet effect ω 
P<0.01, genotype effect π<0.05. (B) Two-way ANOVA, Bonferroni as a post-hoc, * P<0.05. 
 
Feeding behavior and locomotor activity changes 
At the end of the obesity development phase we observed that both WT and Ts65Dn 
mice receiving SC+CM and SC+HF increased their energy intake compared to SC mice 
(diet effect ANOVA F(1,48) = 13.67, P<0.001; Figure 13A). SC+HF mice consumed 
more HF than SC (in WT, HF vs. SC, Paired Mann-Whitney-U-test, z = -2.67, P<0.01, 
in Ts65Dn, HF vs. SC, Paired Mann-Whitney-U-test, z = -2.52, P<0.001), being the 
grams of HF consumed significantly higher in Ts65Dn mice (Ts65Dn vs. WT, HF 
intake (g) Mann-Whitney-U-test, z = -2.32, P<0.05; Figure 13B), suggesting increased 
preference for HF. However, the intake in grams of CM was similar to SC indicating 
less preference for this food when given in a free choice access (Figure 13B).  
Energy consumed (KJ of food consumed/ grams of body weight) from CM and HF was 
significantly higher in Ts65Dn mice than in WT (Ts65Dn vs. WT, CM intake (KJ/BW) 
Mann-Whitney-U-test, z = -3.03, P<0.01; Ts65Dn vs. WT HF intake (KJ/BW), Mann-
Whitney-U-test, z = -2.46, P<0.01, Figure 13C). Whereas in WT mice the energy intake 
from HF was significantly higher than CM (HF vs. CM intake, Mann-Whitney-U-test, z 
= -2.53; P<0.01, Figure 13), the energy intake of CM and HF was similar for Ts65Dn 
mice. 
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Finally, regarding energy expenditure, we observed hyperactivity in Ts65Dn 
independently of the diet compared to WT mice (genotype effect F(1,50) = 33.87, 
P<0.001, Figure 13D). 
 
Figure 13.  Energy intake, food consumption and locomotor activity in wild-type (WT) and Ts65Dn 
(TS) mice. (A) Bar plots shows the daily total energy intake (KJ consumed) by genotype of each group: 
SC (yellow), SC+CM (brown) and SC+HF (blue). Bar plots show separately (B) the daily intake (g) and 
(C) energy intake (KJ/g body weight (BW) of SC (yellow segment of the bar) and CM (brown segment of 
the bar) in SC+CM mice of either genotype (left panel) and of SC (yellow segment of the bar) and HF 
(blue segment of the bar) in SC+CF mice of either genotype. (D) Daily locomotor activity measured as 
beams cuts in PheCOMP cages. Data are expressed as mean ± SEM. SC group: WT n = 8, TS n = 7; SC + 
CM group: WT n = 9, TS n = 10; SC + HF group WT n = 8, TS n = 7. (A) ANOVA diet effect ω 
P<0.001. (B, C) Mann-Whitney-U-test for TS vs. WT comparisons, * P<0.05, * P<0.01. (C) Two-way 
ANOVA genotype effect π P<0.05. 
 
In terms of food intake, neither WT nor Ts65Dn mice showed a clear preference for 
consuming CM (grams) along the experiment. Even so, Ts65Dn mice showed higher 
preference for CM than in WT that consumed less CM than SC showing a negative 
preference (P<0) value (see material and methods for calculation of preference, Figure 
14A). We then calculated the preference corrected per body weight and observed that in 
Ts65Dn mice their main source of energy comes from CM along time while in WT the 
preference is close to zero, although the difference did not reach statistical significance 
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(Figure 14C). For SC+HF mice, the preferred food and the main energetic source was 
HF for both genotypes along the whole experiment (Figure 14B-D). 
 
Figure 14.  Preference for energy-dense foods in wild-type (WT) and Ts65Dn (TS) mice. (A) Time 
course of the CM and (B) HF preference in grams across the experimental time. (C) Time course of the 
preference for CM and (D) HF relative to the energy intake (KJ) per grams of body weight. Data are 
expressed as mean ± SEM.  In (A-C) WT mice are depicted as brown dots and Ts65Dn (TS) mice as 
brown squares. In (B-D) WT mice are depicted as blue dots and Ts65Dn (TS) mice as blue squares. SC 
group: SC + CM group: WT n = 9, TS n = 10; SC + HF group WT n = 8, TS n = 7. ANOVA Repeated 
measures.  
 
Meal pattern analysis 
We detected similar diet-induced changes in meal pattern in both genotypes compared 
to baseline (SC) feeding behaviors (Figure 15). Diet has an effect on duration of meals 
(diet effect, F(4,83) = 15.14; P <0.001, Figure 15A-B), being CM and HF meals shorter 
than SC meals for both genotypes (Sidak as a post-hoc; P<0.05). The eating rate was 
also influenced by diet (diet effect, F(4,83) = 20; P<0.001, Figure 15C-D), thus, for both 
genotypes, CM and HF meals were consumed faster than SC meals (Sidak as a post-
hoc; P<0.05). Although energy-dense diets had reduced average meal duration and 
increased their eating rate as compared to SC meals, Ts65Dn still ate slowlier than WT 
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mice, (genotype effect for meal duration, F(1,83) = 13.63; <0.001; genotype effect for 
eating rate, F(1,83) = 19.85; <0.001). 
Energy-dense diets had an effect on the number of meals (diet effect, F(4,83) = 21.76; 
<0.001, Figure 15E-F). The number of HF meals in SC+HF mice was significantly 
higher compared to their SC meals (Sidak as a post-hoc; P <0.001) and to CM meals of 
SC+CM group (Sidak as a post-hoc; P<0.05). Compared to the SC meals of SC mice 
both CM and HF meals were reduced (Sidak as a post-hoc; P<0.05). 
Energy-dense diets had differential effect on satiety since we observed a diet effect on 
the time between meals (diet effect intermeal interval, F(4,83) = 2.79; P <0.001, Figure 
15 G-H). In SC+CM mice the intermeal interval was higher for CM than for SC meals 
(Sidak as a post-hoc; P<0.05) but no changes were observed in SC+HF mice. 
Conversely, SC+HF mice had increased satiety for SC than for HF (diet effect F(2,83) = 
5.12; P<0.001, Sidak as a post-hoc; P<0.05, Figure 15 I-J).  
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Figure 15. Meal pattern changes upon free access to energy-dense diets in wild-type (WT) and 
Ts65Dn (TS) mice. Bar plots represent the meal patterns for each type of food for each experimental 
group [yellow (SC), in brown (CM) and in blue (HF)] left panel shows WT mice values, and right panel 
results of TS. (A-B) Average meal duration (min) of SC, CM and HF meals in WT (A) and in TS mice 
(B). (C-D) Eating rate (min) of WT (C) and TS (D) mice. (E-F) Number of meals in WT (E) and TS (F) 
mice. (G-H) Average intermeal interval (min) in WT (G) and in TS (H) mice. (I-J) Satiety (min/g) in WT 
(I) and in TS (J) mice.  Data are represented as mean ± SEM. SC group: WT n = 8, TS n = 7; SC + CM 
group: WT n = 9, TS n = 10; SC + HF group WT n = 8, TS n = 7.  Linear mixed model analysis, Sidak as 
a post-hoc, * P< 0.05. In the figures only the significance of the intra-genotype CM vs. SC (in SC+CM 
mice) HF vs. SC (in SC+HF mice) is depicted. 
 
Circadian feeding pattern  
In mice, feeding is a patterned activity subject to well-controlled daily oscillations with 
feeding bouts accumulated over the dark (active) phase of the light/dark cycle 
(nocturnal meals) and almost absent during the light (resting) phase. However, when 
mice have access to energy-dense foods, these foods are also consumed during the 
resting phase, which causes early and stable circadian activity disruption, as it has been 
previously shown (Espinosa-Carrasco et al. submitted). To capture long-term fine-
grained pattern of feeding changes promoted by CM and HF, we used Pergola 
(http://cbcrg.github.io/pergola) an open-source software developed in our group for the 
visualization and explorative analysis of (high-throughput) longitudinal behavioral data. 
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Pergola allows the interactive visualization of a complete experiment of each individual, 
which makes easier the detection of phenotypic quantitative and qualitative differences 
within subject. Figure 16A-C shows the amount of food intake and the temporal 
distribution of feeding events along 3 weeks. We selected 3 representative periods of the 
early (1st week), mid (4th week) and late time changes (8th week) of the circadian 
feeding activity. 
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Figure 16. Longitudinal behavioral recordings from the 1st, 4th and 8th week of free access to energy-dense 
food in wild-type (WT) and Ts65Dn (TS) mice. Pergola visualization of feeding bouts along time for (A) SC mice 
(WT n = 8, TS n = 7); (B) SC+CM mice (WT n = 9, TS n = 10) and (C) SC+HF mice (WT n = 9, TS n = 7). Metadata 
included in the figure are: (i) identifiers for each mouse. In A we depict SC mice: WT (grey) and TS (orange); B 
represents SC + CM mice WT (light blue for SC and green for CM); TS (yellow for SC and dark blue for CM); C 
represents SC + HF mice: WT (orange for SC and pink for HF), TS (black for SC and blue for HF). (ii) Dark (active) 
periods (light-dark phase track) represented as grey rectangle on the top of each panel. (iii) The weeks of the 
longitudinal recordings are written on the bottom of panel. (A) SC meals of the SC group, (B) SC and CM meals of 
the SC+CM group and (C) SC and HF meals of the SC+HF group. Each row corresponds to one animal. For each 
group, in the upper part of the figure (A1, B1, and C1) each bar represents a feeding bout and its size corresponds to 
meal duration. WT mice are depicted in the upper panel and those corresponding to Ts65Dn mice in lower panel. For 
the same mice, in A2, B2 and C2 each line shows the accumulated intake (g) of the individual during a period of 30 
minutes. The intensity of the blue indicates the value of the accumulated food intake (white = 0 grams, blue ≥ 0.5 
grams). 
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The visualization of the longitudinal behavioral data showed, from the first week and 
along all the experiment, increased feeding events in the inactive period in mice given 
free-choice access to energy-dense food (Figure 16B-C).  
We detected that in WT the SC mice had the highest intake, followed by SC+CM mice 
> SC+HF mice (Figure 17). In Ts65Dn, we observed that SC and SC+CM groups had 
similar SC intake whereas in SC+HF group the SC was almost neglected (Figure 17). 
Compared to SC group-genotype matched, WT mice consumed les grams of CM and 
HF whereas Ts65Dn mice showed equivalent intake. 
 
 
Figure 17. SC and energy-dense foods circadian intake in wild-type (WT) and Ts65Dn (TS) mice 
during the 8th week of the obesity development phase. Active (dark) phases are marked by a grey line 
in the bottom of the plot. The plot depicts, the group average of the WT (on the right) and Ts65Dn (TS, 
on the left), of the amount (in g) of SC (in the upper part) and CM or HF (in the lower part). In the bottom 
are the code colors for each diet of each group.  
 
To quantify the circadian feeding rhythmicity loss, we calculated the number of 
accumulated meals within 30 minutes time windows distinguishing the light and dark 
phases during each week of the obesity development (Figure 18).  
In non-obesogenic conditions, both WT and Ts65Dn mice concentrate their meals 
during the nights (SC number of meals light vs. dark phase, Bonferroni as a post-hoc, 
P<0.001 in WT, P<0.001 in Ts65Dn) without differences among genotypes (Figure 18). 
Statistical analysis revealed that diet had an effect on the meal frequency in both 
genotypes (Three-way repeated measures ANOVA (genotype, diet and phase), F (9,75) 
=10.48; P< 0.001). 
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In SC+CM group the meals were also concentrated during the active (dark) phase. The 
number of SC meals was higher compared to CM meals in both genotypes (Bonferroni 
as a post-hoc, P<0.001 in WT, P<0.001 in Ts65Dn, Figure 18) but Ts65Dn mice 
showed significantly higher number of CM meals than WT mice (Bonferroni as a post-
hoc, P<0.001). During the inactive phase, the number of CM meals was similar to the 
number of SC meals in both genotypes and the total number of meals was not different 
from the number of meals of SC group (Figure 18). 
In the SC+HF group, during the inactive period, the number of HF meals was higher in 
both genotypes as compared to SC meals (Bonferroni as a post-hoc, P<0.001 for WT 
and for Ts65Dn). WT mice showed an increased number of HF meals as compared to 
SC group (Bonferroni as a post-hoc, P<0.001) during the dark (active) phase. However, 
the number of HF meals was similar in both active and inactive phases of the dark/light 
cycle (Figure 18), suggesting a loss of rhythmicity. This circadian rhythm disturbance 
was not detected in Ts65Dn mice that showed a significantly higher number of HF 
meals during the dark phase (Bonferroni as a post-hoc, P<0.001). In this genotype, we 
detected a significantly higher number of HF than SC meals (Bonferroni as a post-hoc, 
P<0.001, Figure 18).  
 
Figure 18. Quantitative measure of the circadian feeding activity along the experiment during the 
day and nights in wild-type (wt) and Ts65Dn (trisomic) mice. The figure depicts for each diet group 
(in columns) and genotype (upper part WT and Ts65Dn, trisomic, in the bottom) the number of meals 
consumed in a time window of 30 min across the whole experiment during the day (triangles) and during 
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the nights (squares). The color code for the foods is as follows: SC (orange), CM (grey) HF (blue). Three-
way ANOVA was used for statistical analysis. Bonferroni was used as a post-hoc. *** P< 0.001. Only the 
significant comparison intra genotype and group are depicted in the figure. 
 
Our analysis confirmed that WT mice have a more severe circadian feeding disruption 
than Ts65Dn when HF is provided ad libitum (Figure 17, 18). Interestingly, the 
disruptive behavior was food specific since circadian rhythmicity for SC meals was 
affected neither in SC+CM nor in SC+HF mice (Figure 16). 
 
4.1.3 Testing phase 
 
Consumption of energy-dense foods led to addictive-like behaviors such as inflexible 
food choices and compulsive (binge-like) eating as previously described (Heyne et al. 
2009; Espinosa-Carrasco et al. submitted). The evaluation of these compulsive 
components of feeding was performed at the end of the obesity development phase, 
after 8 weeks of exposure to energy-dense foods. We limited the access and adulterated 
the flavor of the energy-dense foods to evaluate the appearance of diet-induced non-
adaptive behaviors, such as compulsive intake or behavioral inflexibility. 
 
Starvation 
24 h starvation lead to increased energy intake (KJ) upon refeeding in all mice 
compared to their energy in ad libitum free feeding conditions (Two-way ANOVA, (F 
(1,44) = 67.51, P<0.001). In the SC group, upon refeeding Ts65Dn compensated more 
their energy intake than WT mice (Ts65Dn vs. WT, Mann-Whitney-U-test, z = -2.32, 
P<0.05, Figure 19A). In SC+CM mice the increase of SC intake upon refeeding was 
similar between genotypes but WT mice tended to consume more CM than Ts65Dn, 
although the difference did not reach statistical significance (Figure 19B). In SC+HF 
mice, starvation preferentially increased HF intake in both genotypes but the increase 
was only significant in Ts65Dn mice (paired Mann-Whitney-U-test, SC vs. HF in 
Ts65Dn z = -4.07, P<0.01, Figure 19C). 
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Figure 19. Energy intake upon 24 hours of starvation in wild-type (WT) and in Ts65Dn (TS) mice. 
Bar plots show the increase in energy intake calculated as the KJ consumed 24h after refeeding - KJ 
consumed in 24 hours in free feeding conditions. (A) Increase in daily energy upon refeeding in the SC 
group (B) the SC+CM group, and (C) the SC+HF mice. Data are expressed as means ± SEM. SC group: 
WT n = 8, TS n = 7; SC + CM group: WT n = 9, TS n = 10; SC + HF group WT n = 8, TS n = 7. Mann-
Whitney-U test for genotype comparisons, Paired Mann-Whitney-U-test for within genotype comparisons 
(SC vs. CM and SC vs. HF), * P<0.05 ** P<0.01. 
 
Limited access to energy-dense food  
Access to HF or CM diet was restricted to 1 hour during the light (resting) phase of the 
light-dark cycle (from 14:00 to 15:00h) for 3 consecutive days in overweight mice 
(SC+CM or SC+HF; Figure 20A). SC and water were provided unrestrictedly ad 
libitum. 
We observed that during the periods of CM/HF restriction, the SC energy intake 
(KJ/body weight) of free choice mice was increased as compared to ad libitum feeding 
condition (SC+CM, SC+HF; (F(1,30) = 129.55; P<0.001, Figure 20B). Two-way 
ANOVA analysis revealed that during the periods where the energy-dense foods were 
not available, the energy intake from SC was different between the free choice groups 
(diet effect, F(1,33) = 10.015; P<0.01) and between the genotypes (genotype effect, 
F(1,33) = 5.345; P<0.05). However, mice from any group were able to increase SC 
intake to compensate their basal energy levels (Figure 20C). 
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Figure 20. SC energy intake during the periods of absence of energy-dense foods wild-type (WT) 
and in Ts65Dn (TS) mice. (A) Schedule of the three days of limited access experiment.  (B) The bars 
plots show the mean values of energy intake of SC in ad libitum feeding conditions (when CM and HF 
are freely available, “ad lib”) and when energy-dense foods are not available (limited, “LMT”). (C) The 
bars plots show the mean values of total energy intake in ad libitum feeding conditions (SC+CM or 
SC+HF according to the experimental group) and the SC intake when energy-dense foods are not 
available (limited, “LMT”). Wild-type mice (WT) are depicted in white and Ts65Dn mice (TS) in black. 
Data are expressed as mean ± SEM. SC + CM group: WT n = 9, TS n = 10; SC + HF group: WT n = 8; 
TS n = 7. ANOVA Repeated measures, factor (test day) *** P< 0. 001; Two-way ANOVA, genotype 
effect π P<0.05; diet effect ω P<0.05. 
  
Binge-like eating episodes upon limited access are revealed by measuring the energy 
intake and the eating rate (mg/s) of CM and HF consumed during the periods of CM/HF 
access. Since mice have continuous access to standard chow, the increased energy 
intake of energy-dense foods during the 1h access compared to ad libitum conditions, 
when they have both SC and CM/HF access are indicators of a compulsive like intake 
rather than a hunger effect.  
When analyzing separately the consumption of energy-dense foods and SC along the 
three days of the experiment, we found a nonsignificant trend for increasing the 
consumption of CM and HF in the limited access periods along the test days in Ts65Dn 
and in WT mice (Figure 21A-B), suggesting that this schedule of access was not 
sufficient to induce strong binge-like episodes. Even so, the increase in energy intake 
between the ad libitum conditions and the third day of the limited access to energy-
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dense food, was significantly increased and was higher in Ts65Dn compared to WT for 
both CM (Ts65Dn vs. WT, Mann-Whitney-U-test, z = -2.98; P<0.01) and HF (Ts65Dn 
vs. WT Mann-Whitney-U-test, z = -2.23; P< 0.01; Figure 21C). 
We also calculated the eating rate as a measure of the avidity since more rapid intake 
would be an indicator of a compulsive-like feeding. The eating rate for CM intake 
showed a nonsignificant tendency to increase in WT mice (Repeated measures 
ANOVA, genotype effect F (1,17) = 3.95; P = 0.06, Figure 21D) but not in Ts65Dn 
mice. In SC+HF mice, WT mice showed a significant increased eating rate as compared 
to Ts65Dn mice the second and the third day of the test (Repeated measures ANOVA, 
genotype effect F(1,13) = 8.09; P<0.05, Figure 21E). 
 
 
Figure 21. Energy intake and eating rate during limited access to energy-dense food in WT and 
Ts65Dn (TS) mice. Time course of the energy intake of (A) CM and (B) HF during the periods of access. 
(C) CM/HF energy increase between the ad libitum conditions and during the third day of the limited 
access. Time course of the eating rate of CM (D) and (E) HF intake during the periods of limited access.  
ad lib= ad libitum; Day 1, Day 2 and Day 3 are the three consecutive days of restricted access (1h) to 
CM/HF. Data are expressed as mean ± SEM. SC + CM group: WT =9, TS = 10; SC + HF group: WT = 7; 
TS = 7. * P<0.05 in (E) genotype effect, Repeated measures ANOVA, Bonferroni as a post-hoc. (C) 
Mann-Whitney-U-test ** P<0.01. 
 
Food adulteration with quinine hydrochloride 
The inability to neglect the preferred food after the modification of its hedonic 
properties (i.e. the taste) is a sign of inflexibility (Heyne et al. 2009). Here, food was 
manipulated with quinine hydrochloride to address if Ts65Dn mice still consumed 
energy-dense foods in spite of their aversive taste.  
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In the SC group, mice were given free choice between SC and SC adulterated with 
quinine hydrochloride and both genotypes showed reduced energy intake of adulterated 
SC as compared to non-adulterated chow (paired Mann-Whitney-U test, z = -2.02 in 
WT; P<0.05 and z = -2.36; P<0.05 in Ts65Dn, Figure 22A, 23A) suggesting no 
problems in bitter taste detection. WT mice slightly increased their intake of non-
adulterated SC (Figure 22 A-B), but not significantly. 
 
Figure 22.  Energy compensation during quinine adulteration test in non-obesogenic conditions in 
wild-type (WT) and in Ts65Dn (TS) mice. (A) Percentage of reduction of adulterated and increased of 
non-adulterated SC consumption (percentage of KJ/g of body weight/day) in WT and TS mice. (B-C) 
Individual values of 24 hours intake of non-adulterated SC (KJ/g of body weight) in basal conditions 
(black symbols) and upon presentation of quinine adulterated SC (grey symbols) in WT (B) and TS (C) 
mice. Data are expressed as mean ± SEM. SC group, WT n = 8, TS n =7. Paired Mann-Whitney-U-test. 
 
In the SC+CM group, 30% of mice ate adulterated CM despite the bitterness. The rest 
of mice reduced its consumption, but the reduction was not significant as compared to 
non-adulterated conditions although it was more important in WT than Ts65Dn (Figure 
23B).  
In the SC+HF group, quinine adulteration reduced HF intake in 80% of mice (8/9 WT 
and 6/7 Ts65Dn). However, whereas WT mice ate 50% less compared to non-
adulterated conditions (paired Mann-Whitney-U-test, HF vs. bitter HF intake in WT, z = 
-2.253; P<0.01), the reduction of adulterated HF intake in Ts65Dn mice (30%) was not 
significant compared to non-adulterated conditions (Figure 23C).  
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Figure 23. Energy intake of quinine-adulterated food in wild-type (WT) and Ts65Dn (TS) mice. Bar 
plots show food intake (KJ/g of body weight) in 24 hours in non-adulterated conditions (ad libitum, “ad 
lib”) and the energy intake after quinine hydrochloride adulteration (Quin) of (A) SC , (B) CM (C) and 
HF. Adulterated food is marked by “*” . In (A) light orange SC* = bitter SC; in (B) dark orange CM* = 
bitter CM and in (C) light blue HF* = bitter HF. (A) SC adulteration in SC group. (B) CM adulteration in 
SC+CM group. (C) HF adulteration in SC+HF group. In each boxplot, the horizontal line corresponds to 
group median and individual dots are also plotted. SC group, WT = 8, TS = 7; SC + CM group: WT = 9, 
TS = 10; SC + HF group: WT = 8; TS = 8. Mann-Whitney-U-test ** P< 0.01; ** P< 0.001. 
 
Preference for sweet solutions 
The two-bottle test was used for assessing reward and taste perception. Ts65Dn mice 
showed similar preference for sweets solutions than WT in non-obesogenic conditions 
(Figure 24).  
Compared to SC mice, mice on free choice access to energy-dense diets reduced the 
preference for saccharin different between the genotypes (genotype effect Two-way 
ANOVA, F(1,52) =5.67; P<0.05) and diet condition (diet effect Two- way ANOVA 
F(1,52) = 6.24; P<0.01, Figure 24A). Also compared to SC mice, the preference for 
sucrose was reduced in free choice groups (diet effect Two- way ANOVA F(1,52) = 13. 
13; P<0.001; Figure 24B). In WT mice SC+HF group showed the lowest preference for 
sucrose whereas in Ts65Dn mice both SC+CM and SC+HF groups shower similar 
sucrose preferences but the diet x genotype interaction was not significant (genotype x 
diet interaction, Two- way ANOVA F(2,52) = 2.75 ; P= 0.07). 
 
 
Figure 24. Preference for sweets solutions upon long-term access to energy-dense diets in wild-type 
(WT) and Ts65Dn (TS) mice. (A) Bar blots show the preference for (A) saccharin and (B) sucrose 
against water [ml sweet solution/ total liquid intake (water + sweet solution)] in SC, SC+CM and SC+HF 
mice. Data are expressed as mean ± SEM. SC group: WT = 8, TS = 8; SC + CM group: WT = 10, TS = 9; 
SC + HF group: WT = 9; TS= 8. Two-way ANOVA, genotype effect π p<0.05; diet effect ωω <0.01; 
ωωω < 0.001. 
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4.2 Monoaminergic profile in brain regions related to feeding behavior in Ts65Dn 
mice in basal and obesogenic conditions 
 
Since brain monoamines are key modulators of feeding behavior, we used HPLC-ED in 
hypothalamus, striatum and prefrontal cortex, brain structures related to food intake and 
reward, of Ts65Dn and their respective WT mice to determine the monoaminergic 
profile under obesogenic conditions. 
 
Hypothalamus 
We did not detect genotype-dependent differences in monoamine levels in the 
hypothalamus. Long term access to energy-dense food also did not lead to significant 
changes in the monoamine profile in hypothalamus (Table 3) in either genotype, 
suggesting that the mild feeding behavior differences between WT and Ts65Dn mice in 
non-obesogenic conditions are not dependent on this mechanism.  
 
Table 3. Levels of monoamines in the hypothalamus of wild-type (WT) and Ts65Dn (TS) mice. NA: 
noradrenaline; AD: adrenaline; DA: dopamine, DOPAC: 3,4-Dihydroxyphenylacetic acid, a metabolite of 
DA; 5HT: serotonin; HVA: Homovanillic acid, a metabolite of DA; 5HIIA: 5-Hydroxyindoleacetic acid, 
a metabolite of 5HT. The ratios between the neurotransmitters and their metabolites are also presented. 
Data are presented as mean ± SEM, of ng/mg total tissue. WT: SC (n = 6), SC + CM (n = 6), SC + HF (n 
= 5), TS: SC (n = 4), SC + CM (n = 6), SC + HF (n = 5). 
 
Striatum 
The striatum is a key area for goal directed behavior and for assignation of the correct 
value of a reward, and thus, has a major role in seeking behaviors (Kessler et al. 2016). 
Again we did not observe genotype-dependent differences in striatal monoamines. Mice 
NA AD DOPAC DA 5HIAA 5HT HVA HVA/DA
5HIAA/5H
T
NA/DA
SC 37.47±19.10 4.08±2.83 5.16±4.54 22.54±14.99 31.34±17.45 0.00 0.00 0.87±0.55 11.64±9.01
SC +CM 48.22±922.19 3.96±1.94 6.61±4.46 29.83±12.71 64.35±35.17 4.09±10.02 1.97±4.81 0.50±0.12 8.94±3.78
SC+HF 51.65±12.67 4.13±2.38 3.69±3.04 24.32±9.00 35.08±19.10 0.00 0.00 0.74±0.37 18.72±8.26
SC 45.82±20.73 3.70±2.21 5.45±4.37 28.67±13.03 57.20±33.52 0.00 0.00 0.56±0.19 139.19±291.44
SC +CM 32.36±7.86 2.27±0.64 5.07±2.59 24.73±10.43 43.76±12.92 2.77±6.79 1.18±2.90 0.55±0.08 7,55±3.32
SC+HF 38.08±13.03 3.57±1.47 7.63±4.21 32.63±10.14 38.26±13.98 0.00 0.00 0.93±0.30 5.89±3.21
Region genotype diet
(ng/mg)
HT
WT
TS
NA AD DOPAC DA 5HIAA 5HT HVA HVA/DA 5HIAA/5HT NA/DA
SC 6.23±5.82 42.70±8.75 194.43±66.63 44.88±13.31 35.48±8.60 5.58±6.36 0.04±0.04 1.39±0.74 0.05±0.06
SC +CM 4.58±2.26 53.00±20.01 294.95±116.86 89.24±42.23 43.49±27.49 32.06±26.78 0.12±0.11 3.01±3.08 0.02±0.01
SC+HF 13.05±12,17 71.09±21.30 295.88±44.98 72.23±18.43 42.06±12.71 13.34±13.38 0.04±0.04 2.04±1.48 0.04±0.03
SC 11.44±12.42 45.10±15.18 193.80±73.58 62.89±21.62 57.33±28.88 5.88±9.15 0.02±0.04 1.39±0.60 0.06±0.06
SC +CM 8.35±5.90 55.16±15.48 249.90±71.72 67.36±20.20 48.35±8.32 33.29±28.60 0.16±0.14 1.45±0.63 0.04±0.04
SC+HF 8.98±5.12 46.61±10.24 200.66±32.03 54.33±9.30 36.22±21.58 13.47±8.01 0.06±0.04 1.65±0.58 0.05±0.03
Region genotype diet
(ng/mg)
ST
WT
TS
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having access to energy-dense diets showed higher levels of DA and HVA, a metabolite 
of DA, in the striatum as compared to SC mice (Two-way ANOVA, diet effect, DA, 
F(1,2) = 3.46,P<0.05; HVA, F(2,34) = 6.94, P<0.01). Consequently, diet also changed 
the HVA/DA ratio (Two-way ANOVA, diet effect, F(2,34) = 6.15, P<0.01; Table 4). 
These changes were detected in both WT and Ts65Dn mice, with no differences 
between genotypes. 
 
Table 4. Tissue levels of monoamines in the striatum of wild-type (WT) and Ts65Dn (TS) mice. NA: 
noradrenaline; AD: adrenaline; DA: dopamine, DOPAC: 3,4-Dihydroxyphenylacetic acid, a metabolite of 
DA; 5HT: serotonin; HVA: Homovanillic acid, a metabolite of DA; 5HIIA: 5-Hydroxyindoleacetic acid, 
a metabolite of 5HT.The ratios between the neurotransmitters and their metabolites are also presented. 
Data are presented as mean ± SEM, of ng/mg total tissue. WT: SC (n = 6), SC + CM (n = 6), SC + HF (n 
= 5), TS: SC (n =4), SC + CM (n = 6), SC + HF (n = 5).  
 
Prefrontal cortex 
The prefrontal cortex (PFC) is a key region for executive and reward processes (Ballard 
et al. 2011). Altered monoaminergic input and/or alteration in the monoamine receptors 
in the PFC could lead to disinhibited eating associated to executive dysfunction and thus 
to obesity (Cohen et al. 2011).  
A genotype x diet interaction was observed in PFC for dopamine (DA) levels (Two-way 
ANOVA, diet x genotype interaction, F(2,33) = 5.02, P<0.05). In non-obesogenic 
conditions, Ts65Dn mice had lower DA concentration than WT mice (Bonferroni as a 
Post-hoc P<0.01, Table 5). In SC+CM group, the DA levels in PFC were higher in 
Ts65Dn mice (Bonferroni as a Post-hoc P<0.01), whereas in SC+HF group were lower 
compared to their respective WT mice (Bonferroni as a Post-hoc P<0.05). As a 
consequence of the changes in DA in PFC, the NA/DA ratio, a measure of DA turnover, 
also showed a significant diet x genotype interaction (diet x genotype interaction, F 
(2,33) = 7.55, P<0.01, Table 5). In non-obesogenic conditions, Ts65Dn mice showed a 
significant higher NA/DA ratio than WT mice (Bonferroni as a Post-hoc P<0.05). A 
similar increase was observed in SC+HF Ts65Dn mice (Bonferroni as a Post-hoc 
P<0.01). On the contrary, in SC+CM group, the NA/DA ratio was lower in Ts65Dn 
than in WT mice (Bonferroni as a Post-hoc P<0.05).  
Regarding serotonin and its metabolites, mice having access to energy-dense food 
showed lower concentrations of HIAA as compared to SC mice (Two-way ANOVA, 
diet effect, F(1,33) = 4.07, P<0.05), but not significant changes in serotonin (5HT) were 
observed. This change was independent of the genotype. 
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Table 5. Tissue levels of monoamines in the prefrontal cortex of wild-type (WT) and Ts65Dn (TS) 
mice. NA: noradrenaline; values for AD: adrenaline and DOPAC: 3,4-Dihydroxyphenylacetic acid, a 
metabolite of the neurotransmitter dopamine (DA) were given together, since 2 species could not be 
quantified separately due to similar elution times; 5HT: serotonin; HVA: Homovanillic acid, a metabolite 
of DA; 5HIIA: 5-Hydroxyindoleacetic acid, a metabolite of 5HT. The ratios between the 
neurotransmitters and their metabolites are also presented. Data are presented as mean ± SEM, of ng/mg 
total tissue. WT: SC (n = 5), SC + CM (n = 6), SC + HF (n = 5), TS: SC (n = 5) SC + CM (n = 6), SC + 
HF (n = 5).  
 
4.3 Principal component analysis and correlation of the monoaminergic changes 
with behavioral variables 
 
The monoamine measurements in the brain regions related to feeding behaviors did not 
reveal significant differences between genotypes besides from the lower dopamine 
levels in PFC of Ts65Dn mice. However, it is well known that the simplification of the 
variables of the analysis in a complex system reduces the chances to capture existing 
differences (Catuara-Solarz et al. 2015). For this reason, and taking advantage of the 
physical and behavioral data, we had from the same mice used for monoamine 
quantification, we performed principal component analysis to identify the relationship 
between the obesity phenotypes and the neurochemical changes upon energy-dense food 
free access in wild-type and Ts65Dn mice. 
 
Principal component analysis (PCA) using behavioral data 
We performed a principal component analysis (PCA) using the neurochemical data and 
behavioral variables that defined the obesity phenotypes to explore what were the 
variables explaining most of the variance between animals. The first principal 
component (PC1) explained 32.22% of the variance and was separated mainly the diet. 
“SC group” of both genotypes had negative values whereas free choice energy-dense 
foods groups showed positive values, having the “SC+HF group” the most extreme 
NA AD DOPAC DA 5HIAA 5HT HVA HVA/DA 5HIAA/5HT NA/DA
SC 40.10±18.41 6.94±4.65 6.2±1,41 37.33±9.45 81.78±33.13 0.00 0.00 0.56±0.36 7.70±6.47
SC +CM 54.29±14.12 6.38±3.88 2.30±0.99 27.91±6.97 96.15±41,92 16.59±19.83 6.20±8.09 0.33±0.15 29.97±14.63
SC+HF 35.10±11.25 3.55±2.11 4.82±1.21 29.09±8.67 61.74±20.33 0.00 0.00 0.56±0.38 7.84±3.79
SC 43.76±17,28 5.23±2.80 2.27 ±0.56 36.98±10.05 63.03±19.54 0.00 0.00 0.65±029 24.52±21.15
SC +CM 34.70±15,50 6.02±2.89 5.37±2.38 29.88±15.45 70.01±26.61 16.78±21,50 2.96±5.46 0.53±0.43 7.52±4.67
SC+HF 36.05±5.93 5.03±1.88 1.68±1.36 22.03±4.19 55.45±15.77 0.00 0.00 0.41±0.09 36.97±28.80
Region genotype diet
(ng/mg)
PFC
WT
TS
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phenotypes. On the other hand, wild-type and Ts65Dn mice were mainly separated by 
the second principal component (Figure 25). 
 
Figure 25. Physical, behavioral and neurochemical data are mainly different between diets, but also 
explain difference associated with the trisomy. (A) Principal component analysis (PCA) using as 
variables physical, behavioral and neurochemical data of all conditions. (B) Same as (A) but using the 
mean value of each group of animals instead of the individual values. WT = wild-type; TS = Ts65Dn. SC 
mice in yellow, SC+CM mice in brown, SC+ HF mice in blue. 
 
When dissecting the differences between both genotypes upon different diet conditions, 
in non-obesogenic conditions (SC), a clear separation of genotypes was observed by the 
PC1 (Figure 26A), contributed by the serotonin, noradrenaline and dopamine content of 
different brain areas and behavioral variables related to flexibility (energy intake upon 
starvation and energy intake of adulterated chow during the quinine adulteration; Figure 
26B). 
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Figure 26. Physical, behavioral and neurochemical data are able to explain difference between 
wild-type and Ts65Dn mice in SC condition. (A) Principal component analysis (PCA) with physical, 
behavioral and neurochemical data. WT = wild-type; TS = Ts65Dn. (B) Loading for principal component 
1. (C) Loadings for principal component 2. 
 
Upon long-term access to CM diet, the genotypes separated along the PC1 (Figure 27A) 
mainly contributed by the monoaminergic profile in the hypothalamus and behavioral 
parameters related to satiety (intermeal interval, satiety ratio, number of meals (Figure 
27B).  
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Figure 27. Physical, behavioral and neurochemical data are able to explain difference between 
wild-type and Ts65Dn mice in the SC+CM condition. Principal component analysis (PCA) using as 
variables behavioral and neurochemical data of SC +CM mice. (A) Principal component analysis (PCA) 
with physical, behavioral and neurochemical data. WT = wild-type; TS = Ts65Dn. (B) Loading for 
principal component 1. (C) Loadings for principal component 2. 
 
Finally, in SC+HF group, genotypes were separated by a principal component (Figure 
28A) contributed by dopamine levels in prefrontal cortex, and behavioral parameters 
such as food intake during the quinine adulteration test (Figure 28B). 
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Figure 28. Physical, behavioral and neurochemical data are able to explain difference between 
wild-type and Ts65Dn mice in the SC+HF condition. Principal component analysis (PCA) using as 
variables behavioral and neurochemical data of SC +HF mice. (A) Principal component analysis (PCA) 
with physical, behavioral and neurochemical data. WT = wild-type; TS = Ts65Dn. (B) Loading for 
principal component 1. (C) Loadings for principal component 2. 
 
Correlations of behavioral variables with neurochemical measurements  
The most informative variables were selected from the PCA analysis. Then, we 
performed a correlation matrix that revealed different phenotypic sets strongly 
correlated with monoamine composition in the three different brain regions in all our 
samples or in a cluster separated by diet. Here, we show for each group, some selected 
examples for their biological and statistical significance (p-value < 0 upon z fisher 
transformation).  
Our matrix of correlating variables revealed that in SC group the energy intake of 
adulterated SC in the quinine adulteration test strongly correlated with body weight 
increase (Spearman’s rho of 0.6, Figure 29A) which suggest that behavioral inflexibility 
might account for body weight gain. Among the different variables strongly correlating 
in mice with free access to energy-dense diets, we observed that those mice that had 
higher preference for CM and HF had also higher intake of those diets during quinine 
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adulteration test (Spearman’s rho of 0.9, Figure 29B). When we studied the free-choice 
groups separately, we observed a strong negative correlation between the CM intake (g) 
and the serotonin levels in hypothalamus (Spearman’s rho of - 0.9) in SC+CM group 
which may be related to satiety (Figure 29C). However, in SC+HF mice, we found 
several behavioral variables related to inflexibility strongly correlated with dopamine 
levels. For example, low dopamine levels in prefrontal cortex correlated with the intake 
of bitter HF during the quinine adulteration test (Spearman’s rho of   and - 0.8, Figure 
29D). 
 
Figure 29. Some behavioral variables strongly correlated with neurochemical measurements 
showing a diet dependency. (A) Dot plot showing the relationship between energy intake of adulterated 
SC in the quinine adulteration test on the x-axis and the body weight increase on the y-axis in SC group. 
(B) Dot plot showing the relationship between Preference CM/HF (g) on the x-axis and Energy (bitter 
SC/CM/HF) adulteration test on the y-axis in free-choice mice. (C) Dot plot showing the relationship 
between serotonin levels in the hypothalamus on the x-axis and food intake on the y-axis in SC+CM 
group. (D) Dot plot showing the relationship between bitter HF consumed during the quinine adulteration 
test on the x-axis and dopamine levels in PFC on the y-axis in SC+HF. SC group in yellow, SC+CM 
group in brown and SC+HF group in blue. WT mice are depicted as dots and Ts65Dn mice as squares.  
 
4.4 Glucose homeostasis and pancreatic function in Ts65Dn mice 
 
Besides the behavioral component, a disrupted control of food intake through metabolic 
mechanisms, such as glucose homeostasis or pancreatic pathology could also play a role 
in the higher prevalence of obesity in DS population (Fonseca et al. 2005). In this part 
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of the Thesis, we explored the glucose homeostasis and pancreatic phenotypes in non-
obesogenic conditions (standard chow, SC).  
 
Glucose homeostasis and insulin levels 
Circulating blood glucose levels were higher in Ts65Dn than in wild-type mice 
(Ts65Dn vs. WT, Mann-Whitney-U-test, z = -3.15, P = 0.01, Figure 30A) after 5 hours 
of fasting, while plasma insulin levels were non-significant reduced (Figure 30B). We 
used the oral glucose tolerance test (OGTT), a widely used procedure to classify 
carbohydrate tolerance measuring plasma glucose and insulin responses upon a glucose 
load. OGTT revealed that Ts65Dn mice showed high glucose levels during longer time 
upon glucose load, indicating impaired recovery of basal glycaemia (Repeated measures 
ANOVA, F(1,11) = 7.25; P<0.05; Bonferroni as a post-hoc at 60 and 90 min after 
glucose administration, P<0.05 Figure 30C). Concomitantly, insulin levels in Ts65Dn 
mice were markedly lower compared to WT mice (Repeated measures ANOVA, F(1,8) 
= 9.24; P<0.05; Bonferroni as a post-hoc; Figure 30D). These results suggested an 
impaired regulation of glucose homeostasis probably due to a dysfunction at the 
pancreas level.  
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Figure 30. Glucose and insulin levels in starving conditions and upon a glucose load. (A) Blood 
glucose and (B) insulin concentrations in fasted wild-type (WT) and Ts65Dn (TS) mice at 5 months old. 
(C) Glucose and (D) insulin levels during oral glucose tolerance test (OGTT).  Data are shown as the 
mean ± SEM. (A-B) WT = 11, TS = 9. Mann-Whitney-U-test for independent samples ** P<0.01. (C-D) 
WT = 5, TS = 5; ANOVA Repeated measures, Bonferroni as a post-hoc; * P<0.05; P **<0.01. 
 
Morphological and functional studies of islets of Langerhans 
To analyze pancreatic function, we focused on the morphology and functionality of 
pancreatic beta cells involved in insulin production. Immunostaining for insulin 
revealed less insulin-positive cells in Ts65Dn than in WT pancreas (Figure 31A). The 
lower insulin content in Ts65Dn pancreases along with the lower plasma levels could be 
a consequence of a secretory problem in the islets of Langerhans. To confirm that 
possibility, we evaluated glucose-induced insulin secretion in islets isolated from WT 
and Ts65Dn mice under basal (2.8 mM glucose) and stimulating conditions (16.7 mM 
glucose). Basal insulin secretion was significantly decreased in Ts65Dn islets compared 
to WT (Mann-Whitney-U-test, z = -2.65, P< 0.01; Figure 31B). In stimulating 
conditions, incubating with 16.7mM of glucose, islets of both genotypes increased 
insulin secretion. However, although non-significant, the glucose-induced insulin 
secretion in Ts65Dn was lower compared to WT islets (Figure 31B). 
 
 
Figure 31. Representative images of sections of pancreases and in vivo insulin secretion in 5 months-
old wild-type (WT) and Ts65Dn (TS) mice. (A) Representative images of sections of pancreases 
immunostained against insulin. The lower panel shows magnifications of insulin islets. (B) For the in 
vitro insulin secretion study, pools of 50 islets from 3 experimental replicates were used. Insulin secretion 
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was measured under basal (2.8 mM glucose) and stimulating conditions (16.7mM glucose). Data are 
shown as the mean ± SEM. Mann-Whitney-U-test for independent samples **P<0.01. 
 
4.5 Role of DYRK1A in the Down syndrome obesity phenotypes  
 
In the first part of this Thesis we showed that Ts65Dn recapitulates obesity-related DS 
phenotypes, such as high adiposity, feeding behavior perturbations and higher intake of 
energy-dense foods. However, using a trisomic model does not allow to establishing the 
genetic dependence of these phenotypes.  
Among the hundreds of genes triplicated in DS individuals and Ts65Dn mice, the 
tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) is one of the best 
candidates to explain brain alterations and cognitive impairment. Moreover, previous 
studies have reported its implication in obesity-related phenotypes. In mice, its 
overexpression resulted in reduced fat mass along with reduced expression of 
adipogenic proteins, including peroxisome proliferator-activated receptor γ (Song et al. 
2015) and increased pancreatic β-mass leading to improved insulin sensitivity (Rachdi 
et al. 2014b). Based on previous data showing the Dyrk1A dosage sensitive influence on 
the nigrostriatal dopaminergic system (Martinez de Lagrán et al. 2007), we propose that 
Dyrk1A overexpression could affect the sensitivity to natural rewards that could lead to 
compensatory overeating. Also, that the implication of Dyrk1A in craniofacial 
development (Arron et al. 2006) could be involved in the altered feeding observed in 
Ts65Dn mice (see above). 
We have used mBACTgDyrk1A mice (Guedj et al. 2012) to explore whether the sole 
overexpression of Dyrk1A is sufficient to recapitulate the feeding behavior perturbations 
associated to the trisomy and the compulsive-like phenotypes in an obesogenic 
environment 
4.5.1 Somatometric characteristics and feeding behavior in mBACTgDyrk1A 
mice   
 
No differences were detected in body weight, nor body length of mBACTgDyrk1A 
(TG) mice fed with SC compared to their WT littermates (Figure 32A-B).  
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Figure 32. Somatometric characteristics of mBACTgDyrk1A mice. (A) Body weight (grams), (B) 
body length (cm) in mice fed with balanced diet (standard chow) in mBACTgDyrk1A (TG) and wild-type 
(WT). Data expressed as mean ± SEM. WT (n = 13), TG (n = 12). Mann-Whitney-U-test for independent 
samples.  
 
Meal pattern analysis 
Meal pattern analysis upon SC consumption revealed no differences in average meal 
duration, eating rate, meal number or intermeal interval (Figure 33A-D). No differences 
in total food intake were observed (Figure 33E). Drinking behavior was also similar 
between genotypes (not shown). These results indicate that Dyrk1A overexpression does 
not recapitulate Ts65Dn feeding behavior disturbances. 
 
Figure 33. Meal pattern analysis of mBACTgDyrk1A and wild-type (WT) mice fed with standard 
chow (SC). (A) Bar plot shows the average duration (min), (B) eating rate (mg/s), (C) the number of 
meals, (D) the average intermeal duration (min) and (E) the total SC consumed (in grams) in 24 hours. 
Wildtype (WT) n = 5; mBACTgDyrk1A (TG) n = 4. Data are expressed as mean ± SEM. Mann-Whitney-
U test for independent samples.   
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4.5.2 Changes in feeding behavior upon exposure to free access to energy-dense 
food in mBACTgDyrk1A mice 
 
To determine if overexpression of Dyrk1A has an effect on behavioral phenotypes 
driving overeating, we used the same experimental diet-induced obesity model based on 
free choice of SC, and CM or HF used in Ts65Dn mice. After long-term access to CM 
or HF we also evaluated the appearance of compulsive and inflexible feeding responses 
in stand-alone laboratory tests (starvation, limited access to energy-dense food, quinine 
adulteration and preference for sweet solutions) to determine the in vivo role of Dyrk1A 
on those traits.  
 
Body weight gain 
Upon free choice access to energy-dense food, two-way ANOVA revealed a significant 
effect of genotype and diet on body weight gain (genotype effect: Two-way ANOVA F 
(1,42) = 14.47, P<0.001, and diet effect: Two-way ANOVA, F(2,48) = 101.68; 
P<0,001; Figure 34A). We also observed a non-significant trend for a diet x genotype 
interaction (Two-way ANOVA F (2,47) = 3.154, P = 0.053). In WT mice, free access to 
both CM and HF lead to significant body weight increase compared to mice fed with 
SC. Conversely, mBACTgDyrk1A mice showed a slight, though not significant, body 
weight reduction upon free access to CM, but upon free access to HF, transgenic mice 
gained significantly more weight than mice receiving SC only. In SC+HF mice, 
although the percentage of increase of body weight was not different between 
genotypes, WT mice gained slightly more weight than mBACTgDyrk1A (34% and 26% 
body weight increase, respectively, Figure 34B). 
 
Figure 34. Body weight increase upon energy-dense diets in wild-type (WT) and mBACTgDyrk1A 
(TG) mice. (A) Time course of body weight increase along the 8 weeks of exposure to energy-dense 
food. (B) The plot represents the percentage of body weight gain at the end of the experiment. Genotypes 
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are represented as dots (WT) and triangles (TG), diet conditions are shown as colors (SC = black; 
SC+CM = brown and SC+HF = blue). (A) Depicts the mean of the group whereas in (B) each dot/triangle 
represents one individual. SC group: WT n = 8, TG n = 8; SC+CM group: WT n = 8, TG n = 8; SC + HF 
group n = 8, TG n = 8. Repeated measures, Ω for genotype x diet interaction, Bonferroni as a post-hoc 
*** P<0.001; Two-way ANOVA genotype effect π P<0.001; diet effect ω P<0.001. 
 
Feeding behavior and locomotor activity changes  
At the end of the obesity development phase, energy intake increased in mice receiving 
SC+CM and SC+HF compared to SC mice (diet effect ANOVA F(1,48) = 58.65, 
P<0.001; Bonferroni as post-hoc: P<0.001, Figure 35A) regardless of the genotype. 
Two-way ANOVA revealed a significant genotype effect, with mBACTgDyrk1A mice 
exposed to CM showing the highest energy intake (ANOVA F(2,48) = 5.65, P<0.01; 
Bonferroni as post-hoc: P<0.001, Figure 35A). The increased energy intake was not 
only due to the higher energy content of both CM and HF (Table 2), but to the increase 
in absolute food intake (paired Mann-Whitney-U-test, CM vs. SC, z = -2.38, P<0.01; 
paired Mann-Whitney-U-test, HF vs. SC z = -2.51, P<0.01, in WT; paired Mann-
Whitney-U-test CM vs. SC, z = -2.52, P<0.01; paired Mann-Whitney-U-test, HF vs. SC, 
z = -5.21, P<0.01 in TG; Figure 35B). mBACTgDyrk1A mice had higher net intake of 
CM than WT mice (CM intake, TG vs. WT, Mann-Whitney-U-test, z = -2.486, P<0.05). 
Interestingly, while mBACTgDyrk1A consumed more KJ of CM than WT mice (TG vs. 
WT Mann-Whitney-U-test, z = -2.84, P<0.01), no differences were detected in the KJ of 
HF consumed (Figure 35C). Regarding energy expenditure, no changes in locomotor 
activity between genotypes were found (Figure 35D). 
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Figure 35. Energy and net intake of energy-dense foods in wild-type (WT) and mBACTgDyrk1A 
(TG) mice. (A) Bar plots represent the gross daily energy intake (KJ) of the SC (yellow bars), SC+CM 
(brown bars) or SC+HF (blue bars) groups of mice. (B) Bar plots show separately the daily food intake 
(g) of SC (yellow segment of the bar) and CM (brown segment of the bar) in SC+CM mice of either 
genotype (left panel) and of SC (yellow segment of the bar) and HF (blue segment of the bar) in SC+HF 
mice of either genotype. (C) Bar plots show separately the daily intake (KJ/g body weight (BW) of SC 
(yellow segment of the bar) and CM (brown segment of the bar) in SC+CM mice of either genotype (left 
panel) and of SC (yellow segment of the bar) and HF (blue segment of the bar) in SC+CM mice of either 
genotype. (D) No differences in activity were found between genotypes. Data are expressed as mean ± 
SEM. SC group: WT n = 8, TG n = 8; SC + CM group: WT n = 8, TG n = 7; SC + HF group n = 8, TG n 
= 8. Two-way Repeated measures ANOVA genotype effect ππ P<0.01; diet effect ωωω P<0.001, 
Bonferroni as a post-hoc ***P<0.001. (B, C) Mann-Whitney-U-test for TG vs. WT comparisons, * 
P<0.05, ** P<0.01. 
 
In both genotypes, we detected preference for the energy-dense food respect to SC. 
However, mBACTgDyrk1A mice preferred CM more than WT (Figure 36) while the 
preference for HF (Figure 36B-D) was similar.  
78 
 
 
Figure 36.  Preference for energy-dense foods in wild-type (WT) and mBACTgDyrk1A (TG) mice. 
(A) Time course of the CM and (B) HF preference in grams across the experimental time. (C) Time 
course of the preference for CM and (D) HF relative to the energy intake (KJ) per grams of body weight. 
Data are expressed as mean ± SEM. in (A-C) WT mice are depicted as brown dots and mBACTgDyrk1A 
mice as brown squares. In (B-D) WT mice are depicted as blue dots and mBACTgDyrk1A mice as blue 
squares. SC + CM group: WT n = 8, TG n = 8; SC + HF group WT n = 8, TG n = 8. ANOVA Repeated 
measures. 
  
Meal pattern analysis 
As occurred in Ts65Dn mice, free choice access to CM lead to changes of feeding 
behavior in both genotypes (Figure 37A-E). SC meals were longer than CM meals 
(paired Mann-Whitney-U-test, average meal duration CM vs. SC, z = -2.03; P<0.05 in 
WT and z = 4.71; P<0.05 in TG, Figure 37A) and CM was consumed quicker than SC 
(paired Mann-Whitney-U-test, eating rate CM vs. SC, z = -3,03; P<0.05 in WT and z = 
-5.66; P<0.05 in TG, Figure 37B). The total number of meals and the time between 
meals was similar for SC and CM in both WT and mBACTgDyrk1A mice (Figure 37C-
D). Even though the satiety ratio of SC was not different from CM in any genotype 
(Figure 37E), there was a trend for lower CM satiety only in mBACTgDyrk1A mice. 
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For this experiment, due to a breeding problem in our colony, the sample size of 
SC+CM group is small and we could not include a SC+HF group.  
 
Figure 37. Meal pattern changes upon free access to CM in wild-type (WT) and mBACTgDyrk1A 
(TG) mice. Bar plots represent the meal patterns for each type of food for each experimental group: 
yellow (SC) and in brown (CM). The upper panel shows TG mice values, and lower panel results of WT. 
(A) The average duration (min) of meals. (B) The eating rate (mg/s). (C) The number of meals. (D) The 
intermeal interval (min). (E) Satiety ratio after correcting for body weight (BW) of the animal (g) for CM 
and SC (min/KJ/g). Data are expressed as mean ± SEM. WT = 5, TG = 4. Paired Mann-Whitney-U-test 
for within genotype comparisons (SC vs. CM) * P<0.05, ** P<0.01, *** P<0.001. 
 
Circadian feeding pattern 
Similar to what we did with Ts65Dn mice, we used Pergola 
(http://cbcrg.github.io/pergola) to visualize food intake and the temporal distribution of 
feeding events along time at the single mouse level. Figure 38 depicts a simplified 
output of 3 weeks. The 3 intervals depicted were selected as a representative scenario of 
the immediate (1st week), the middle time (4th week) and late changes (8th week) in 
circadian feeding activity. We have discussed above that feeding behavior is subjected 
to well-controlled daily oscillations with feeding bouts mainly accumulated over the 
dark (active) phase (see the SC group behavior Figure 38). However, energy-dense 
foods are usually also consumed during the light (inactive) phase. CM leads to a subtle 
increase of feeding events during the inactive phase in both genotypes from the first 
week of access and was maintained across the experimental time (Figure 38).   
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Figure 38. Longitudinal behavioral recordings from the 1st, 4th and 8th week of free access to CM 
in wild-type (WT) and mBACTgDyrk1A (TG) mice. Snapshots Pergola representations of SC+CM 
mice feeding bouts along time (WT n = 5, TG n = 4). Each row corresponds to one animal and food 
channel except the last track that represents light (white bar) and dark (grey bar) periods of the light/dark 
cycle. Metadata included in the figure are (i) identifiers for each mouse. SC + CM mice WT (grey for SC 
and orange for CM), TG (blue for SC and green for CM) (ii) Dark (active) periods (light-dark phase 
track) represented as grey rectangle on the top of the figure. (iii) The weeks of the longitudinal recordings 
are written on the bottom of the figure. (A) In the upper part of the figure, each bar represents a feeding 
bout and its size corresponds to meal duration. WT mice are depicted in the upper panel (gray SC channel 
and orange CM channel) and those corresponding to mBACTgDyrk1A (TG) mice in lower panel (blue 
SC and green CM). For the same mice, in (B) each line shows the accumulated intake (g) of each 
individual during a period of 30 minutes. The intensity of the blue indicates the value of the accumulated 
food intake (white= 0 grams, blue ≥ 0.5 grams). 
  
To quantify this circadian disruption, we calculated the number of accumulated meals in 
30 min windows for each week of the obesity development phase (Figure 39). The diet 
(SC/CM) and the phase (active/inactive) had a different effect on the number of meals 
in each genotype (Three-way ANOVA (genotype, diet and phase), F(7,44) =6.37). 
During the active (dark) phase, the number of SC meals was significantly higher than 
the CM meals in WT mice (Bonferroni as a post-hoc, P < 0.001) whereas 
mBACTgDyrk1A showed equivalent number of SC and CM meals (Figure 39). 
Although non-significant, mBACTgDyrk1A showed an increased number of CM meals 
compared to WT (Bonferroni as a post-hoc, P = 0.09). During the inactive (light) phase, 
the number of CM meals was equivalent in both genotypes. However, WT showed 
similar number of SC and CM meals whilst mBACTgDyrk1A mice showed a non-
significant higher number of CM meals (Bonferroni as a post-hoc, P = 0.07). 
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Figure 39. Quantitative measure of the circadian feeding activity for day and nights upon CM free 
access in wild-type (wt_dyrk) and mBACTgDyrk1A (dyrk) mice. The figure depicts the mean of the 
accumulated number of meals in time windows of 30 min across the whole experiment during the inactive 
(triangles) and during the active (squares) phases for WT and mBACTgDyrk1A (TG) mice. SC is 
represented in orange and CM in grey. Three-way ANOVA (diet x genotype x phase); Bonferroni as a 
post-hoc *** P< 0.01. 
 
4.5.3 Testing phase 
 
After 8 weeks of free access to CM/HF, mice underwent the same test battery as 
Ts65Dn mice to understand the contribution of the overexpression of Dyrk1A on 
compulsivity, inflexibility and reward. 
Starvation 
24h starvation lead to increased energy intake (KJ) upon refeeding in all mice compared 
to their energy in free feeding conditions (genotype x diet interaction, ANOVA F (2,42) 
= 6.43, P<0.01). In the SC group, upon refeeding mBACTgDyrk1A compensated more 
their energy intake than WT mice (TG vs. WT, Mann-Whitney-U-test, z = -2.63, 
P<0.001, Figure 40A). 
In SC+CM mice the increase of SC intake upon refeeding was similar between 
genotypes, but WT mice tended to consume more SC whereas mBACTgDyrk1A tended 
to consume more CM (Figure 40B), although the difference did not reach statistical 
significance. In SC+HF mice, starvation preferentially increased HF intake in both 
genotypes (Figure 40C) but the increase was only significant in mBACTgDyrk1A mice 
(paired Mann-Whitney-U-test, SC vs. HF z = 0.40, P<0.01, in TG). Starvation led to a 
significant higher SC energy intake in WT mice (TG vs. WT, Mann-Whitney-U-test, z 
= -2.93, P<0.01). 
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Figure 40. Energy intake upon 24 hours of starvation in wild-type (WT) and in mBACTgDyrk1A 
(TG) mice. Bar plots show the increase in energy intake calculated as the KJ consumed 24h after 
refeeding - KJ consumed in 24 hours in free feeding conditions. (A) Increase in daily energy upon 
refeeding in the SC group (B) the SC+CM group, and (C) the SC+HF mice. Data are expressed as mean ± 
SEM. SC group: WT = 8, TG = 8; SC + CM group: WT n = 8, TG n = 8; SC + HF group n = 8, TG n = 8. 
Mann-Whitney-U-test for genotype comparisons, Paired Mann-Whitney-U-test for within genotype 
comparisons (SC vs. CM and SC vs. HF), ** P<0.01; *** P<0.001. 
 
Limited access to energy-dense food 
Access to HF or CM diet was restricted to 1 hour during the light (resting) phase of the 
light-dark cycle (from 14:00 to 15:00h) for 3 consecutive days in overweight mice 
(SC+CM and SC+HF; Figure 41A). SC and water were provided unrestrictedly ad 
libitum. 
During the periods of CM/HF restriction (Figure 41B), the SC energy intake (KJ/body 
weight) was increased as compared to the SC intake in ad libitum feeding condition 
(SC+CM, SC+HF; F(1,27) = 224.716; P<0.001). However, the SC energy intake during 
the periods of restriction of energy-dense foods was different between SC+CM and 
SC+HF groups (two-way ANOVA, diet effect, F (1,30) = 57.50; P<0.001), being higher 
in mice from SC+CM group. When we compared the SC intake during the periods of 
energy-dense foods restriction with the total energy intake calculated as the energy 
intake from SC, was lower (paired Mann-Whitney-U-test, z = -2.66; P<0.01 in WT; z = 
- 2.70; P<0.01, in TG) in both groups. However, both genotypes of SC+CM group 
showed a tendency for increase SC intake during limited HF/CM access phase that may 
reflect energy compensation (Figure 41C). 
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Figure 41. SC energy intake during the periods of absence of energy-dense foods in wild-type (WT) 
and in mBACTgDyrk1A (TG) mice. (A) Schedule of the three days of limited access experiment.  (B)  
The bars plots show the mean values of energy intake of SC in ad libitum feeding conditions (when CM 
and HF are freely available, “ad lib”) and when energy-dense foods are only available for 1 hour each day 
(limited, “LMT”).(C) The bars plots show the mean values of total energy intake in ad libitum feeding 
conditions (SC+CM or SC+HF according to the experimental group) and when access to energy-dense 
food is limited considering only the SC intake (LMT). WT are depicted in white and TG in black. Data 
are expressed as mean ± SEM. SC + CM group: WT n = 8, TG n = 8; SC + HF group: WT n = 8; TG n = 
8. ANOVA Repeated measures, factor (test day) *** P< 0.001. Two-way ANOVA, genotype effect π 
P<0.05. 
 
We studied the presence of binge-like episodes during the 1h access of CM and HF to 
analyze the compulsive behavior.  
In SC+CM group, we found a significant increased consumption of CM during the 
limited access periods along the test days in mBACTGDyrk1A mice (Repeated 
measures ANOVA, F (1,14) = 22.27, P<0.001; Figure 42A). Moreover, although no 
significant, energy increase for CM between the ad libitum conditions and during the 
third day of the CM limited access was higher in mBACTGDyrk1A compared to WT 
(Figure 42C). On the contrary, Dyrk1A overexpression did not lead to a HF escalation 
across the days (Figure 42B). 
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Figure 42. Energy intake during limited access to energy-dense food in wild-type (WT) and in 
mBACTgDyrk1A (TG) mice. (A) Time course of the energy intake of CM (A) and (B) HF during the 
periods of access. (C) CM/HF energy increase between the ad libitum conditions and during the third day 
of the limited access. ad lib = ad libitum; Day 1, Day 2 and Day 3 are the three consecutive days of 
restricted access (1h) to CM/HF. Data are expressed as mean ± SEM. SC + CM group: WT n = 8, TG n = 
7; SC + HF group n = 8, TG n = 8. Repeated measures ANOVA, Bonferroni as a post-hoc * P<0.05 ** 
P<0.01 *** P<0.001.  
Since mice have continuous access to chow, rather than a hunger effect, the increased 
energy intake of CM during limited access compared to ad libitum conditions, suggest 
an increased compulsive like intake in mBACTGDyrk1A compared to WT mice.  
 
Food adulteration with quinine hydrochloride 
Food was manipulated with quinine hydrochloride to address if mBACTgDyrk1A mice 
still consumed energy-dense foods in spite of their aversive taste as a sign of 
inflexibility (Heyne et al. 2009). 
In the SC group, mice were given free choice between SC and SC adulterated with 
quinine hydrochloride and both genotypes showed reduced their intake of adulterated 
SC as compared to non-adulterated chow (paired Mann-Whitney-U-test, z = -2.52; 
P<0.01 in WT and z = -2.52; P<0.01 in TG, Figure 43A, 44A) suggesting adequate 
bitter detection. Moreover, both genotypes increased their SC intake for the SC non-
adulterated compared to their 24h average SC energy intake in non-adulterated 
conditions (paired Mann-Whitney-U-test, z = -2.52; P<0.01 in WT and, z = -2.51, 
P<0.01 in TG, Figure 43B-C). 
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Figure 43. Bitter detection in non-obesogenic conditions in wild-type (WT) and in mBACTgDyrk1A 
(TG) mice. (A) Percentage of reduction of adulterated and non-adulterated SC consumption (percentage 
of KJ/g of body weight/day) in WT and Ts65Dn (TS) mice. (B-C) Individual values of 24 hours intake of 
non-adulterated SC (KJ/g of body weight) in basal conditions (black symbols) and upon presentation of 
quinine adulterated SC (grey symbols) in WT (B) and in TG (C). Data are expressed as mean ± SEM. SC 
group, WT n = 8, TG n = 8. Paired Mann-Whitney-U-test ** P<0.01. 
 
In the SC+CM group, CM intake was reduced upon quinine hydrochloride adulteration 
in WT mice (paired Mann-Whitney-U-test, intake of bitter CM vs. CM intake, z = -
2.51; P<0.001). However, 38 % of the mBACTgDyrk1A mice still ate bitter CM 
(Figure 44B). 
In the SC+HF group, quinine adulteration reduced HF intake in both WT and 
mBACTgDyrk1A mice compared to free feeding conditions (paired Mann-Whitney-U-
test, intake of bitter HF vs. HF intake, z = -2.52; P<0.01 in WT; and paired Mann-
Whitney-U-test, intake of bitter HF vs. HF intake, z = -2.37; P<0.01 in TG, Figure 
44C). 
 
Figure 44. Energy intake of quinine-adulterated food in wild-type (WT) and mBACTgDyrk1A 
(TG) mice. Bar plots show food intake (KJ/g of body weight) in 24 hours in non-adulterated conditions 
(ad libitum, “ad lib”) and the energy intake after quinine hydrochloride adulteration (Quin) of (A) SC , 
(B) CM  (C) and HF. Adulterated food is marked by “*” . In (A) light orange SC* = bitter SC; in (B) dark 
orange CM* = bitter CM and in (C) light blue HF* = bitter HF. (A) SC adulteration in SC group. (B) CM 
adulteration in SC+CM group. (C) HF adulteration in SC+HF group. Data are expressed as mean ± SEM. 
SC group: WT = 8, TG = 8; SC + CM group: WT = 8, TG = 8; SC + HF group: WT = 8; TG = 8. Paired 
Mann-Whitney-U-test ** P<0.01. 
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Preference for sweet solutions 
The two-bottle test was used for assessing reward and taste perception. The 
overexpression of Dyrk1A had no effect on the preference for sweets solutions in non-
obesogenic conditions (Figure 45). 
The preference for saccharin was similar to SC mice (Figure 45A). Energy-dense diets 
only had a significant effect on the preference for sucrose solution, being lower for SC 
+ HF mice (diet effect ANOVA F (2,46) = 4.15; P<0.05, Figure 45B).  
 
Figure 45. Preference for sweets solutions upon long-term access to energy-dense diets in wild-type 
(WT) and in mBACTgDyrk1A (TG) mice. Bar blots show the preference for (A) saccharin and (B) 
sucrose against water [ml sweet solution/ total liquid intake (water + sweet solution)] in SC, SC+CM and 
SC+HF mice. Data are expressed as means ± SEM. SC group: WT n = 8, TG n = 8; SC + CM group: WT 
n = 8, TG n = 8; SC + HF group = WT n = 8, TG n = 8. Two-way ANOVA, diet effect ω <0.05. 
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5. DISCUSSION 
 
The prevalence of obesity in DS individuals is higher than in general population (Bell 
and Bhate 1992; Melville et al. 2005; Must et al. 2014). However, the underling 
mechanisms and factors behind are not well understood. The main goal of this Thesis 
was to determine the contribution of abnormal feeding behavior to obesity development 
and investigate the possible underlying mechanisms. We also explored peripheral 
obesity phenotype, analyzing glucose metabolism and pancreatic phenotypes. To 
explore these aspects, we used Ts65Dn mice, a mouse model of DS that has been 
extensively validated for the study of diverse features of DS related to learning and 
memory (Escorihuela et al. 1995; Escorihuela et al. 1998; Catuara-Solarz et al. 2016), 
attention (Moon et al. 2010), impulsivity (Whitney and Wenger 2013) and motor 
dysfunction (Hampton et al. 2004; Altafaj et al. 2013), among others. The present work 
confirmed the face validity of the Ts65Dn mice for the investigation of DS obesity 
phenotypes. Concretely, Ts65Dn mice showed a tendency to adiposity, and meal pattern 
disturbances. When exposed to an obesogenic environment, we detected increased 
preference for energy-dense foods and Ts65Dn mice gained more weight than WT when 
exposed to HF. Part of these phenotypes may be due to a deficient dopaminergic tone in 
prefrontal cortex, which is a risk factor for overeating. At the peripheral level, we 
observed that Ts65Dn pancreas had reduced β-cell mass along with diminished insulin 
secretion, which is in agreement with the increased risk of autoimmune diseases 
associated to trisomy of 21, like diabetes mellitus type 1. We also detected increased 
levels of circulating signals associated to immunologic and oxidative damage 
suggesting that obesity development in DS could be facilitated by a sustained 
inflammatory state.  
In the second part of this thesis, our goal was to narrow down the genetic dependency of 
the behavioral and metabolic abnormalities, and thus we used the mBACTgDyrk1A 
mice, overexpressing only Dyrk1A since previous works suggested that the encoded 
kinase could be involved in reward related mechanisms and behavioral control. 
However, the majority of the obesity phenotypes were opposite to those found in 
Ts65Dn mice. Although our results suggest that DYRK1A may have a role on energy-
dense foods preference and overeating, it is possibly not involved in DS-related obesity 
phenotypes.  
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5.1 Face validity of the Ts65Dn mice for the study of Down syndrome obesity  
 
5.1.1 Ts65Dn mice recapitulate obesity-related Down syndrome metabolic 
phenotypes 
 
Body weight, adiposity and leptin resistance 
Adults with DS are more likely to be obese than euploid population. Proposed causes of 
their obesity risk are reduced physical activity (Phillips and Holland 2011), a reduced 
basal metabolic rate (Luke et al. 1996), and increased risk of subclinical hypothyroidism 
(Murray and Ryan-Krause 2010). More generally, though, weight management issues in 
most individuals with DS are due to the intake of too many calories in relation to the 
level of physical activity.  
Here we did not detect increased body weight in trisomic mice as compared to their 
WT, when they were maintained in non-obesogenic conditions (standard chow), and 
supporting this finding, also in the PCA analysis body weight was not contributing to 
genotype differences in baseline conditions. The lack of overweight in trisomic mice fed 
with standard chow could be seen as opposite to the human phenotype, since a high 
percentage of individuals with DS present overweight and obesity, but we propose that 
this might simply reflect the fact that current human diets are obesogenic by definition 
since they contain high amounts of fat and sugar (Williams 2001), and thus in humans 
we are studying obesity phenotypes in an obesogenic environment. In support of this 
assumption, previous investigations reported that community-dwelling individuals with 
DS experience greater prevalence of obesity than do those living in institutions. 
Compared to institutionalized population, community-dwelling individuals met less the 
current guidelines for fruit and vegetable intake (Braunschweig et al. 2004), presenting 
higher intake of soft drinks, precooked meals, and meals often not adjusted to the 
reduced energy needs (Nordstrøm et al. 2015). Our results thus reinforce the concept 
that a balanced diet would result in normal body weight in trisomic individuals. 
Even though trisomic mice were not overweighed in non-obesogenic conditions 
(standard chow), Ts65Dn displayed increased percentage of body fat compared to WT 
mice. This increased adiposity observed in Ts65Dn mice was accompanied by higher 
leptin levels compared to WT mice (Annex III). Again, this is consistent with 
accumulating data showing that DS individuals display abnormally high levels of total 
and regional fat mass than their counterparts without DS (Gonzalez-Agüero et al. 2011; 
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Loveday et al. 2012). Also increased leptin levels (Magni et al. 2004; Tenneti et al. 
2017) have been detected in this population that correlate with adiposity in obese people 
with DS (Proto et al. 2007). Leptin is a proteo-hormone encoded by the “ob” gene, and 
secreted in adipocytes that acts in the hypothalamus to suppress appetite and regulate 
body weight (Considine et al. 1996). In our work, this increased level of leptin was 
observed in lean Ts65Dn mice which is in agreement with the findings of a recent study 
in non-obese DS children (Tenneti et al. 2017). This increased leptin might be 
interpreted as a predictor of higher obesity risk, as shown in a prospective population-
based human study in which baseline leptin levels significantly predicted the 
development of obesity and metabolic syndrome (Franks et al. 2005). In fact, in the 
general population leptin concentrations correlate with adiposity and body mass index 
in both lean and obese subjects (Ahima and Flierer 2000).  
Thus, we can speculate that chronic hyperleptinemia in Ts65Dn mice could reflect 
diminished leptin sensitivity that, when exposed to an obesogenic environment, might 
increase the risk of obesity development. In support of this hypothesis, Ts65Dn gained 
more weight than WT when given free-choice access to high-fat. According to our 
results, DS is a case of leptin resistance phenotype and thus healthy dietary habits could 
be a key strategy in preventing obesity development of obesity in DS despite their 
higher propensity to adiposity. 
 
Glucose homeostasis and diabetes-like pancreatic phenotypes 
Obesity induces insulin resistance and involves a plethora of molecules that predispose 
individuals to an inflammatory state and metabolic complications. In fact, a direct 
relationship between BMI and diabetes has been demonstrated, which pathogenesis has 
been demonstrated to be a resistance to insulin action in peripheral tissues. DS is 
associated to a higher prevalence of diabetes compared to general population (Anwar et 
al. 1998; Bergholdt et al. 2006; Lammer and Weimann 2008; Rohrer et al. 2010). 
However, the mechanisms remain understudied. Reduced insulin secretion, reduced 
insulin sensitivity, or both characterize diabetes. Type 1 diabetes (T1D) is commonly 
associated to immunological problems leading to deficient insulin production and β-cell 
death, whereas type 2 diabetes (T2D) is associated with insulin deficiency and insulin 
resistance. The majority of studies of diabetes in DS did not differentiate between T1D 
and T2D (Rohrer et al. 2010), but those that specifically were done in type 1 diabetes, 
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showed that DS has a prevalence of 0.38-0.7%, compared with 0.17% in the general 
population (Bergholdt et al. 2006). 
Trisomy 21 mouse models, Ts65Dn and Ts16 (a complete mouse chromosome 16 
trisomy) are hyperglycemic, and Ts65Dn mice have impaired glucose tolerance (Peiris 
et al. 2016). Here we confirmed this previous study, showing higher levels of plasma 
glucose in Ts65Dn mice compared to WT in starved conditions. Moreover, the 
postprandial glucose homeostasis was altered, so that Ts65Dn mice were unable to 
recover the basal glycaemia upon oral administration of glucose in the tolerance test 
(OGTT) similar to the previous reports (Peiris et al. 2016). 
In our study, hyperglycemia in Ts65Dn mice occurred concomitantly with low insulin 
plasmatic levels during the OGTT, suggesting pancreatic β-cell dysfunction that would 
lead to a deficient insulin production or to reduced secretory capacity of islets of 
Langerhans in Ts65Dn. In fact, we detected less insulin-positive cells and reduced total 
insulin pancreatic content (insulin (ng/ml)/mg of pancreatic tissue), along with reduced 
β-cell mass calculated as the number of β-cell per mg of pancreas (work by Dr. Rachdi). 
Our results in Ts65Dn mice suggest that β-cell loss could be a mechanism leading to 
diabetes type 1 in DS. However, we did not find any report quantifying β-cell mass in 
DS humans, although several studies have reported increased levels of insulin 
autoantibodies, which is an indication of autoimmune damage of pancreatic β-cells 
(Steck et al. 2015). Further experiments would be needed to explore this possibility as a 
mechanism underlying β-cell death in Ts65Dn. 
Besides the deficient β-cell mass in Ts65Dn pancreas, hyperglycemia could also be 
related to secretory problem of the islets of Langerhans. To confirm this aspect, we 
evaluated insulin secretion in isolated islets under basal (2.8 mM glucose) and 
stimulating (16.7 mM glucose) conditions, and observed decreased basal and glucose-
induced insulin secretion in Ts65Dn islets. Our results are in agreement with the study 
of Helguera and collaborators showing that basal insulin secretion by fetal human 
pancreatic cells with DS was drastically decreased compared to non-DS cells (Helguera 
et al. 2013).  
Taken together, these results suggest that both β-cell expansion and secretory 
mechanisms are altered in Ts65Dn mice compared to WT. Previous studies have 
suggested that these phenotypes arise from the overexpression of chromosome 21 genes 
such as RCAN1 and DYRK1A, which are expressed in pancreas where they have 
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functional roles. A microarray analysis in islets from Ts65Dn and WT mice (work by 
Dr. Rachdi) confirmed that both genes contained were upregulated in Ts65Dn (RCAN1 
= 1.2; DYRK1A = 1.3 with respect to WT). In fact, the overexpression of RCAN1 in 
mice causes the reduction on the glucose-stimulated insulin secretion along with a 
mitochondrial dysfunction in β-cells (Peiris et al. 2012; Peiris et al. 2016), but 
overexpression of DYRK1A in transgenic mice promotes β-cell mass expansion 
(Rachdi et al. 2014b), opposite to what we detected in Ts65Dn. Of course, the combined 
effect of the overexpression of these two proteins could be different to the impact of 
their single overexpression in transgenic mice, since RCAN1 activity is regulated by 
DYRK1A protein-mediated phosphorylation (Jung et al. 2011). 
Besides the predicted overexpression of HSA21 genes, we also found a significant 
downregulation of HSPA1A/Hsp72 in trisomic islets of Langerhans as compared to WT 
(Dr. Rachdi, personal communication). HSPA1A/Hsp72 encodes for a heat shock 
protein that prevents the aggregation of multiple proteins. Among those, the misfolded 
human islet amyloid polypeptide hormone (h-IAPP, also called amylin), which forms 
toxic aggregates, destroys pancreatic β-cells (Rosas et al. 2016). On the other hand, 
Hsp72 blocks apoptosis primarily by inhibiting Bax activation and thereby preventing 
the release of proapoptotic factors from mitochondria (Stankiewicz et al. 2005). Thus, 
we could speculate that the net effect of reduced levels of HSP1A/Hsp70 in Ts65Dn 
islets could be an increase of apoptosis through increased aggregation of amylin along 
with reduced inhibition of Bax (Figure 46). Accordingly, the pancreatic duodenal 
homeobox 1 (Pdx1) transcription factor, which plays a central role in pancreatic β-cell 
function and survival (Fujimoto and Polonsky 2009) was reduced in Ts65Dn β-cell 
compared to WT (Dr Rachdi, personal communication).  Downregulation of HSPA1A 
has been reported before in brain of DS fetus (Seidl et al. 2001), and in DS astrocytes 
cultures (Helguera et al. 2013) suggesting that altered antiapoptotic mechanisms in DS 
could play a role in the pathogenesis of diabetes.   
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Figure 46. Proposed model of the effects of HSPA1A downregulation in DS diabetes. Lower levels 
HSPA1A might contribute to the impaired glucose homeostasis (1) by interfering in the antiapoptotic β-
cell program or (2) through impaired regulation of protein folding that might cause aggregate 
accumulation. 
 
5.1.2 Ts65Dn mice recapitulate Down syndrome-related feeding problems 
 
Our meal pattern analysis in mice given standard chow revealed that Ts65Dn mice 
present slower and longer meals as compared to WT mice, confirming a previous 
observation (Turner et al. 2001). In humans, DS is associated with high incidence of 
feeding abnormalities. Between 31% and 80% of children with DS have eating or 
drinking difficulties (Pipes and Holm 1980; Field et al. 2003) with abnormal-tongue/jaw 
function and difficulty in initiating and maintaining the feeding sequence (Kumin and 
Bahr 1999; Cooper-Brown et al. 2008). Some of these feeding abnormalities, such as 
reduced chewing frequency and increased mastication time, persist to adulthood 
(Hennequin et al. 2005; Smith et al. 2014) leading to prolonged meals. The slower and 
longer meals observed in Ts65Dn mice thus reproduce the DS phenotype, and may 
result of the complex interactions between anatomical, medical, physiological, and 
behavioral factors.  
One important factor could be related to mastication and deglutition alterations that 
depend on the coordination of mouth and tongue movements. Poor coordination and 
sequencing of oral-motor movements, weak lip closure and weak and reduced tongue 
movements have been reported in DS patients (Faulks et al. 2008a-b; Smith et al. 2014). 
We did not explore these biomechanic phenotypes in the context of the present work. 
However, recently Glass and collaborators found significantly lower expression of 
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myosin heavy chain subunit 2 (MyHC-2b) protein levels in the anterior digastric and 
posterior digastric muscles, which are involved in jaw movement, in Ts65Dn mice 
compared to WT. In wild-type mice, MyHC-2b expression in the tongue (Maejima et al. 
2005) and in digastric muscles (Yoshii et al. 2008) is required for the correct transition 
from suckling to swallowing solid food. However, despite this reduced MyHC-2b 
expression, Ts65Dn mice did not show swallowing or inter-swallow intervals (Glass 
and Connor 2016), suggesting that the developmental aspects leading to reduced tongue 
movements and swallowing difficulties in DS humans may not be attributed to MyHC-
2b. Even though the authors did not directly evaluate meal duration, this result may 
suggest that swallowing difficulties are not contributing significantly to prolonged 
meals in Ts65Dn mice. Other factors such as the relative macroglossia and reduced 
mandibular volume found in DS (Cooper-Brown et al. 2008) may be also important for 
explaining swallowing difficulties, but could be only partially replicated in Ts65Dn 
embryos (Billingsley et al. 2013). Taken together, these results suggest that factors other 
than these oromotor deficits should be involved.  
Anatomical constraints such as retrognathia have been recognized as important in 
feeding biomechanics, as acknowledged for diverse syndromes with craniofacial 
alterations that lead to feeding problems (Cooper-Brown et al. 2008). DS patients 
present a small jaw (micrognathia) or a chin jaw posteriorly displaced (retrognathia) 
causing the tongue to fall backward toward the posterior pharyngeal wall (glossoptosis) 
(Levine and Simpser 1982; Limbrock et al. 1991; Guimaraes et al. 2008). Some of these 
phenotypes are recapitulated in Ts65Dn mice that show craniofacial dysmorphology 
and mandible hypoplasia (Richtsmeier et al. 2000), results that were also replicated in 
our laboratory (Annex II). Briefly, compared to euploid mice, trisomic mice showed 
smaller, thicker and more curved mandibles, with smaller and less pronounced coronoid 
and condylar processes, which correspond to the most common craniofacial traits in DS 
individuals. Given the role of the mandible in mastication and deglutition, we speculate 
that the observed craniofacial alterations may have functional implications in feeding 
behavior of Ts65Dn mice.  
5.1.3 Ts65Dn mice present brain monoamine alterations involved in feeding 
behaviors 
 
In the brain, the initiation, termination, and choice of meals is controlled by distinct and 
interconnected neural circuits that use a variety of neurotransmitters and neuropeptides 
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and that receive input on the status of energy balance via endocrine factors and 
peripheral nerves (Lutter and Nestler 2009). Among those, the involvement of brain 
monoamines in the control of food intake is well established, although how 
monoamines such as dopamine, serotonin, and noradrenaline are involved in energy 
balance is only partly understood. Through massive projections to the entire cortex and 
hippocampus, the monoaminergic systems exert a powerful modulatory effect on brain 
regions vitally important for cognition, motivation and behavioral control. Thus, it is 
assumed that monoamines specifically participate in the modulation of reward aspects 
of food intake. 
We first had to define how the monoaminergic status in our mouse model was. Under 
standard chow diet, we did not find statistical differences between genotypes for 
monoamine concentrations in the hypothalamus and the striatum. These results do not 
replicate previous experiments in Ts1Cje mice, another segmental trisomy 16 mouse 
model (Sago et al. 1998), that had higher levels of dopamine and serotonin in striatum 
than their wild-type littermates (Shimohata et al. 2017). One possible cause of this 
discrepancy is technical, since Sago and collaborators used microdialysis along with 
other complementary techniques such as western blot, and immunohistochemistry, 
while here we exclusively used HPLC analysis in postmortem tissues. Also, the 
different genetic background and age of the animals could be confounding factors.  
Interestingly, in our experiments we detected lower levels of dopamine (DA) in the 
prefrontal cortex (PFC) of Ts65Dn mice compared WT, a result that replicates previous 
DS human studies (Yates et al. 1983; Risser et al. 1997; Whittle et al. 2007) showing 
reductions in dopamine and its acidic metabolites DOPAC and HVA, in fetal and adult 
postmortem brains of individuals with DS. The PFC hypodopaminergic phenotype 
detected in Ts65Dn mice is possibly linked to the executive dysfunction detected in 
mouse behavioral studies (Coussons-Read and Crnic 1996; Escorihuela et al. 1998) and 
in DS individuals (Pueschel et al. 1991; Jernigan et al. 1993; Ball 2008). In a previous 
study of the laboratory, in young adults with DS, we found that genotypes conferring 
higher DA availability, such as Met carriers and VNTR-DAT1 10-repeat homozygotes, 
resulted in improved performance in executive function tasks that require mental 
flexibility (Del Hoyo et al. 2016). This deficit could also underlie a tendency toward 
perseveration and impulsive behaviors that could be a predisposing factor for 
compulsive overeating, so that reduced dopamine in the PFC, strongly involved in 
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inhibitory control, may contribute to behavioral disorders of loss of control such as 
overeating (Volkow et al. 2008).  
Different mechanisms could explain the low DA concentration detected in the PFC of 
trisomic mice. The most obvious could be alterations in dopaminergic nuclei. We found 
one report (Mann et al. 1987) showing that DS individuals have reduced number of 
surviving thyroxin hydroxylase positive cells in the ventral tegmental area (VTA) which 
is the main region containing the dopaminergic neurons projecting to the PFC (Oades 
and Halliday 1987). Even though this was not seen in Ts65Dn mice that have similar 
number of dopaminergic cells in this region compared to WT (Megías et al. 1997), the 
dopamine synthesis, transport or the number of projections from VTA-dopaminergic 
cell bodies to cortical areas have not been studied and could be different. However, in 
our previous studies, although we detected important alterations in cAMP accumulation 
upon dopaminergic (D1) receptor stimulation with the D1 agonist SKF 38393 in 
postmortem cortical human samples of individuals with DS, these alterations were not 
detected in the hippocampus of trisomic mice (Baamonde et al. 2011).  
Given that PFC-DA is implicated in self-control behaviors and reward sensitivity 
(Kehagia et al. 2010), the reduced DA tone detected in Ts65Dn PFC might impair 
inhibitory control of food intake. In DS people, this would imply a high risk of 
overeating driven by the availability of energy-dense foods in our obesogenic 
environments. 
 
5.2 Obesogenic environments lead to genotype-specific obesity phenotypes and 
monoaminergic changes in Ts65Dn mice 
 
In this Thesis, we selected a validated diet induced obesity paradigm that provides free 
access to energy-dense diets (chocolate-mixture diet, CM; or high-fat diet, HF), while 
maintaining standard rodent chow (SC) availability, thus mimicking in a more 
naturalistic way the human situation than forced diets (La Fleur et al. 2014). This 
paradigm has been previously validated as a powerful tool to induce obesity in mice and 
to provoke inflexible and compulsive behaviors associated to overeating (Heyne et al. 
2009; Espinosa-Carrasco et al. submitted). Given that both sweets and fatty diets have 
the ability to induce overeating in both humans and mice (Avena et al. 2009; Volkow et 
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al. 2011) and DS show a marked tendency to consume energy-dense foods, would also 
allow to studying behavioral changes promoted by energy-dense diets.  
5.2.1 Ts65Dn mice show increased preference and overeat energy-dense foods  
 
In both WT and Ts65Dn mice body weight was significantly increased upon energy-
dense diets, though it was more marked upon free-choice access to HF than to CM even 
though the digestible energy of both energy-dense diets is similar (20.6 MJ kg−1 for CM 
and 22 MJ kg−1 for HF). However, HF diet has a 60% of fat content and 6.4% simple 
sugars whereas CM contains 24% fat carbohydrate and approximately 44% simple 
sugars (Table 2). Whilst carbohydrate overfeeding produces progressive increase in 
carbohydrate oxidation and total energy expenditure, fat overfeeding has minimal 
effects on fat oxidation and total energy expenditure leading to adipocytes hyperplasia 
(Surwit et al. 1995). This different composition and metabolism may have an effect on 
weight gain, as has been demonstrated in both humans and mice excess of fat leads to 
greater fat accumulation than excess of carbohydrate (90-95% versus 75-85%) (Surwit 
et al. 1995; Buettner et al. 2007). Moreover, carbohydrate stimulates sympathetic 
nervous system activity and thermogenesis, while fat inhibits this effect by decreasing 
hypothalamic corticotropin releasing factor release (Surwit et al. 1995), which could 
also impact weight gain. 
Ts65Dn mice gained significantly more weight than WT upon free access to HF. This 
effect is driven by the amount of HF consumed, since Ts65Dn showed higher intake of 
HF (1.42 ± 0.06 KJ/body weight) than WT mice (1.12 ± 0.05 KJ/body weight) in our 
free access paradigm. Interestingly, compared to their WT counterparts, trisomic mice 
gain significantly more weight than what would be expected from the increase of energy 
intake. This finding is in accordance with human reports showing that for the same 
amount of energy consumed, individuals with DS are more prone to present positive 
energy balance and increased fat storage (Wong et al. 2014). This effect may partially 
be driven by the high frequency of hypothyroidism that is a common clinical 
comorbidity in DS (Lavigne et al. 2017). Although we found no data on thyroid 
function in Ts65Dn mice, in the Ts1Cje E15.5 brains there is an up-regulation of Slc7a5 
(Lat1), involved in the transport of thyroid hormones T3 and T4 across the cell 
membrane (Guedj et al. 2015). 
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Upon free access to CM, also both genotypes gained weight, though less markedly than 
upon HF. When comparing both diets, we detected that mice of both genotypes tend to 
consume less chocolate than HF. These differences between HF and CM diets support 
previous observations that mice learn quickly to prefer flavors associated with high-
energy content and select high-fat foods when available (Johnson et al. 1991; Sclafani et 
al. 2007; Rapp et al. 2009), but when it comes to sweet foods, the preference follows an 
inverted U-shaped curve with a sensory optimum, and both lower and upper 
concentrations reduced the hedonic response (Drewnowski 1995).  
Ts65Dn consumed significantly more energy from the chocolate-mixture than WT mice 
(1.29 ± 0.10 and 0.84 ± 0.09 KJ/BW, respectively) also indicating a clear preference for 
sweet foods. However, opposite to what we observed in HF conditions, the body weight 
gain was similar in both genotypes, even though Ts65Dn mice consume more 
chocolate-mixture. We cannot explain this effect, but we could speculate that this less 
important than expected weight increase upon free access to CM could be related to 
abnormal carbohydrate metabolism, with impaired glucose tolerance, as observed in DS 
patients (Yasuda et al. 1979).  
In both experiments trisomic mice showed increased preference for energy-dense (HF 
and CM) foods. This preference would parallel the human phenotype. DS individuals 
consume considerable amounts of highly processed foods such snacks and sweets 
beverages, especially when the meals depend on their choices (Nordstrøm et al. 2015). 
In a study conducted in DS teens (aged between 11 and 18 years old), 58% of the 
participants chose foods high in fat and sugar when asked about favorite foods and 81% 
reported to consume those foods every day.  
A number of studies strongly argue in favor of the involvement of the brain reward 
circuit in the preference for energy-dense diets and in compulsive overeating. Those 
have led to the concept of Reward Deficiency Syndrome (RDS) which is a genetic and 
epigenetic phenomenon leading to impairment of the brain reward circuitry resulting in 
a hypo-dopaminergic function (Blum et al. 2000) that results in abnormal food 
preferences and in craving behavior (Blum et al. 2012). Thus we speculate that the 
trisomic phenotypes could be driven by the reduced dopamine levels detected in the 
prefrontal cortex (PFC) of Ts65Dn mice. Geiger and collaborators showed that obesity-
prone rats present lower extracellular dopamine levels and lower evoked dopamine 
release in the nucleus accumbens, the dorsal striatum and PFC. They suggest that 
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obesity-prone rats have a global presynaptic deficit in central dopamine likely due to 
differences in the expression of genes that regulate dopamine exocytosis (Geiger et al. 
2008). Thus, the hypodopaminergic state of trisomic mice would lead to 
overconsumption of energy-dense foods altering food inhibition responses to obtain 
stimulatory effects on otherwise sub functional reward circuits (Johnson et al. 2011; 
Leigh and Morris, 2016).  
 
5.2.2 Obesogenic environments induce similar meal pattern changes in Ts65Dn 
and WT mice 
 
When comparing CM and HF diet to standard chow (SC), we observed that Ts65Dn 
mice increased eating rate and reduced meal duration for both HF and CM. Similar 
effects were observed also in WT mice and have been reported before in previous 
studies (Espinosa-Carrasco et al. submitted). Above, we suggested that the slower and 
prolonged meals detected in Ts65Dn mice might be partially explained by mechanical 
difficulties due to the orofacial characteristics linked to trisomy 21. That fact that CM 
and HF foods are softer would certainly contribute to this finding, as in DS humans, 
viscoelastic foods, like cheese, need fewer cycles of mastication than brittle foods, like 
bread (Hennequin et al. 2005). Therefore, the increased feeding rates observed for HF 
and CM, could at least partially depend on the physical characteristics of energy-dense 
foods.  
 
5.2.3 Ts65Dn mice are less vulnerable to high-fat diet induced circadian rhythm 
changes  
 
It has been demonstrated that free access to energy-dense food promote changes in 
circadian activity characterized by an increased food intake during the inactive periods 
(Oike 2017), by advancing the phase of the liver molecular clock and altering daily 
rhythms of eating behavior and locomotor activity (Arble et al. 2009; Honma et al. 
2016). In our experiments, consumption of HF or CM diet disrupted this temporal 
coordination in WT and in Ts65Dn mice, but with a diet- and genotype-specific pattern. 
Here we defined the loss of rhythmicity as the increase of the number of meals during 
the inactive period of the light/dark cycle.  
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In conditions of free access to CM, independently of the genotype, mice showed only 
subtle circadian rhythmicity changes. This result is in agreement with Espinosa and 
collaborators that also observed only a slight impact of chocolate diet in promoting 
circadian rhythm changes (Espinosa-Carrasco et al. submitted).  
Instead, under free access to HF, we detected an important loss of circadian rhythmicity 
in WT mice that did not show the expected reduction of meals during the resting (light) 
phase, as shown by the similar number of HF meals in the light and dark phase cycle. 
This phenotype has already been described by other studies (Pendergast et al. 2013; 
Kohsaka et al, 2007; Espinosa-Carrasco et al. submitted) with ad libitum access to only 
HF. Those paradigms showed overeating of HF both during the active and inactive 
periods. In our experiments we extend these observations, demonstrating that not only 
forced HF regimes, but also free access to HF and SC lead to circadian rhythm 
disturbances.  
Interestingly, no major changes in feeding behavior were detected in Ts65Dn, which 
concentrated their meals during the dark (active) phase, suggesting that high-fat diet 
affects less the central clock and/or eating behavior in Ts65Dn than in WT mice. We 
lack an interpretation for this finding, as on the basis of the obesity phenotype of 
Ts65Dn such differences could be hardly justified. In fact, previous reports provided 
evidence that mice fed a high-fat diet only during the 12-hour light phase gain 
significantly more weight than mice fed only during the 12-hour dark phase (Arble et al. 
2009), but our result suggests that light phase feeding is not a critical component of 
weight gain in trisomic mice. It could be speculated that circulating satiety hormones, 
such as leptin, that we found significantly increased in Ts65Dn mice, may have a 
circadian variation independent of meal timing and be contributing to obesity as seen 
with humans on a circadian misaligned schedule. Also, several HSA21 genes encode for 
several proteins involved in circadian clocks (Kurabayashi et al. 2010), but their 
putative effect in the control of the circadian feeding behavior and the resistance to 
high-fat induced loss of feeding circadian rhythm in trisomic mice needs to be defined. 
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5.2.4 Ts65Dn mice show an increased risk for developing inflexible and 
compulsive-like overeating 
 
Starvation promotes similar responses in WT and Ts65Dn mice 
Food restriction has been shown to increase the risk of compulsive eating in non-clinical 
populations as well as to prolong compulsive eating in individuals with eating disorders 
(Stice et al. 2000). In our experiments, we used a starvation protocol of 24h fasting to 
analyze the compensatory responses to a mild energy deficient state but also to evaluate 
the hunger effect on energy-dense foods seeking. 
To understand the effect of the trisomy in energy compensation, we first analyzed the 
energy intake in mice fed only with SC. In non-obesogenic conditions, WT mice fed 
similar amount of SC after starvation compared to their energy intake in free feeding 
conditions, similar to what has been previously reported in C57Bl/6 mice following 
alternate-day fasting (Anson et al. 2003). However, we observed Ts65Dn mice slightly 
increased their energy intake during the day after refeeding suggesting that mice 
overcompensate for the energy deficit.  
It has been shown that glucose is a potent meal inducer when the levels in plasma are 
low. However, according to our results, Ts65Dn have impaired glucose buffering from 
blood both in starved and feeding conditions, suggesting circulating glucose may not 
explain this behavior. Indeed, the concentration of many hormones and peptides change 
upon starvation and also modulate feeding responses. Among them, the gut peptide 
ghrelin is reduced on feeding and has been implicated in the regulation of feeding 
behavior and energy balance. We have shown that circulating ghrelin is low in Ts65Dn 
compared to WT (Fructuoso et al.  submitted). Similar to what we found, obese subjects 
have lower fasting ghrelin concentrations than do lean subjects (Tschöp et al. 2001). 
Ghrelin is increased after weight loss in obese subjects, and this change has been 
proposed to be related to weight regain (Heilbronn et. 2005). Although we here did not 
measure the circulating levels after this test, we speculate that differences in ghrelin 
could potentially mediate energy imbalance and thus increase food intake after a period 
of food restriction in Ts65Dn mice.  
In obesogenic conditions, both WT and Ts65Dn mice showed similar amount of 
consumed energy the day of refeeding compared to a day on free-feeding conditions. 
This result suggest that overweight mice had not major problems in adapt their energy 
balance upon a mild food restriction. Although we have not previous data about the 
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hormone concentration in our free choice mice, from our result, it seems that trisomy 
don’t further compromise energy compensation in overweight mice.  
It has been shown that starvation increases the desire for palatable and energy-dense 
foods (Di Segni et al. 2014) (Berridge et al. 2010). Upon starvation, we found a similar 
increase of HF, but not of CM intake in both genotypes with respect to non-starved 
conditions. This result was contrary to our expectations. Indeed, we hypothesized that 
Ts65Dn would show increased CM/HF intake against SC than WT since Ts65Dn mice 
already showed higher preference for both energy-dense foods in free feeding 
conditions.  
In mice compulsive-like intake after food deprivation occurs immediately after 
refeeding and decreases along time (Bake et al. 2014). For this reason, we analyzed 
energy intake during the first hour of refeeding after starvation. We observed that during 
this first hour Ts65Dn mice showed a compulsive-like intake of energy-dense foods. 
However, a similar phenotype was observed also in WT, suggesting that the trisomy 
does not have major effects in promoting the rebound consumption of palatable foods.  
We did not found reports in DS humans for compulsive eating episodes upon a short 
period of food restriction. However, according to our results, a mild energy-deficit 
would thus not be an important contributor to energy-dense foods overeating in Ts65Dn 
mice. However, we don’t know if the hunger-induced seeking effect would be different 
in a protocol using repeated cycle of food restriction, which indeed is a better approach 
to model dieting in humans.  
Limited access to energy-dense food promotes increased compulsive-like overeating 
and reveals inflexibility in Ts65Dn mice   
Dieting and food restriction have been demonstrated to increase the risk of compulsive 
eating in non-clinical populations as well as to prolong compulsive eating in individuals 
with eating disorders (Stice et al. 2000). In mice, compulsive-like intake after food 
deprivation occurs immediately after refeeding and decreases along time (Bake et al. 
2014). Since mice have continuous access to standard chow, the increased energy intake 
of energy-dense foods during the 1h access compared to ad libitum conditions, when 
they have both SC and CM/HF access are indicators of a compulsive like intake rather 
than a hunger effect.  
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Limited access to CM and HF increased intake of energy-dense food in both genotypes 
though less than what is reported in binge-eating models (Avena 2010; Bake et al. 2014) 
suggesting that our schedule only induced moderate compulsive-intake. This is probably 
due to the fact that, opposite to classical methods, in our experiment mice were not food 
deprived (Corwin and Buda-Levin 2004). We purposely chose this design to avoid the 
hunger-based seeking bias of classical paradigms. Our model measured reward-driven 
intake since mice had always access to SC. With these conditions, CM induced stronger 
compulsive-like responses than HF. This was expected since only rodent models having 
intermittent sugar have shown strong binge-behaviors (Avena 2008; Avena 2010), 
which would agree with our observations (CM diet has much higher sugar content 
(44%) than HF (6.4 %).  
Even though, as discussed, compulsive-like eating behavior was not very strong, 
Ts65Dn mice showed a more marked rebound consumption of energy-dense foods after 
restrictive access to energy-dense diets than WT, in both CM and HF groups. This 
rebound effect was only detected at the end of the experiment. This increased 
compulsiveness in trisomic mice could result from the hypodopaminergic phenotype we 
detected in trisomic prefrontal cortex. Although compulsive overeating has not been 
studied systematically in people with DS, the intensity of routinized and compulsive–
like behaviors is higher in individuals with Down syndrome than in healthy population 
(Glenn and Cunningham, 2007; Glenn et al. 2012), and is not related with psychiatric 
diagnosis (Glenn and Cunningham 2015) suggesting that it is a DS personality trait. 
Our protocol also allows to measuring flexibility, here defined as the ability to 
compensate the energy intake by increasing standard chow consumption during limited 
access. Neither WT nor Ts65Dn mice compensated the intake of energy coming from 
CM or HF by increasing the SC energy intake. This lack of adaptation reflects a lack of 
flexibility and has been previously reported in mice and rats using similar paradigms 
(Heyne et al. 2009). Even though we did not find significant genotype-dependent 
differences, the fact that DS humans, especially in childhood, consume a limited variety 
of foods and express strong likes and dislikes for food could be considered as an 
inflexible behavior (Marchi et al. 1999).  
Thus, we also assessed inflexibility using an adulteration paradigm that allows to test 
ability to modify behaviors, such as avoiding the preferred food when is unpleasant, 
which is considered a sign of inflexibility. Briefly, quinine hydrochloride is used to 
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adulterate the organoleptic properties of energy-dense foods that become bitter (Sclafani 
1976). Flexible mice would neglect or significantly reduced the intake of the craved 
food (CM/HF) when is bitter, while inflexible individuals would still consume these 
foods in spite their unpleasant taste (Heyne et al. 2009). 
In most of the mice adulteration with quinine hydrochloride reduced the CM intake 
(Bruinsma and Taren 1999) (Patrono et al. 2015). However, independently of the 
genotype, some 30% of mice still consumed biter CM in spite of the lack of the 
rewarding effects (sweetness) but the amount of intake varied, in agreement with 
previous reports (Heyne et al. 2009). 
HF adulteration with quinine hydrochloride lead to a stronger reduction of HF 
consumption in both genotypes compared to adulterated CM. Interestingly, Ts65Dn 
mice consumed equivalent amounts of bitter HF than non-adulterated in spite of its 
unpleasant taste, indicating that trisomy predisposes to more inflexible behavior that is 
only revealed for HF diets. It could be argued that, instead of inflexibility, the taste 
and/or olfactory deficits described in DS humans (McKeown et al. 1996) and the 
olfactory deficits reported in Ts65Dn mice (de Souza et al. 2011) could account for this 
effect. However, Ts65Dn and WT mice avoided equally adulterated SC and CM, and 
we observed similar preference for sweets solutions in the two-bottle preference test. 
Thus, rather than a gustatory dysfunction, this lack of avoidance of HF reflects in fact 
inflexible behavior in Ts65Dn mice. 
Our results show that overeating of high-fat foods might be more detrimental for 
behavioral control (e.g. flexibility, impulsivity management) in Ts65Dn mice. 
 
5.2.5 Energy-dense foods induce neurochemical changes that may participate in 
the observed behavioral abnormalities 
 
In baseline conditions, we could not detect significant changes in brain monoamines in 
Ts65Dn mice. This is in contrast with previous studies showing monoaminergic deficits 
in DS (Yates et al. 1983; Risser et al. 1997; Whittle et al. 2007). However, we found 
low dopamine levels in prefrontal cortex. Interestingly those were correlated with the 
amount of HF eaten during the quinine adulteration test. Specifically, we observed that 
trisomic mice were those having lower DA values and the lower the PFC DA levels, the 
higher the amount of bitter HF intake and that those Ts65Dn fed with adulterated CM, 
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that did reduce consumption, increased the DA levels. In WT mice both long-term 
access to HF and CM, reduced DA levels in PFC in agreement with other studies 
(Carlin et al. 2013) (Wakabayashi et al. 2015). Again, those WT that showed inflexible 
behavior also presented the strongest reduction in the PFC-DA levels. These results 
strongly support the conclusion that DA-PFC levels modulate inflexibility, and that 
inflexible behavior is a manifestation of the hypodopaminergic syndrome. 
Diet composition has an impact on the concentration of brain monoamines (Chalon et 
al, 1998; Kim et al, 2013; Fernández-Fernández et al. 2015). Therefore, we studied the 
neurochemical changes induced in hypothalamus, striatum and PFC by long-term access 
to CM and HF.  
Comparisons of HPLC data between non-obesogenic and obesogenic conditions showed 
that the monoamine composition in hypothalamus was unaffected upon long-term CM 
and HF consumption. However, free choice access to CM lead to higher serotonin 
(5HT) levels in hypothalamus of WT mice but reduced the 5HT levels in Ts65Dn as 
compared to their respective SC controls. Even though the changes were not significant, 
possibly due to the low number of samples, we suggest that this result might be 
biologically relevant. Previous studies in rats have shown that serotonin arriving from 
raphe innervating to hypothalamus serves for meal termination (Leibowitz and 
Alexander 1998). Considering the inhibitory effect of serotonin on meal ingestion, a 
deficient hypothalamic serotoninergic tone could contribute to the increased CM intake 
of Ts65Dn mice while the increase 5HT levels in WT might be interpreted as a 
compensatory mechanism. In support of this hypothesis, we observed a strong negative 
relationship between the levels of 5HT in hypothalamus and CM intake (Spearman’s 
rho of - 0.9). Interestingly, this neurochemical change was only detected in CM free 
access, while HF did not increase the concentration of 5HT in the hypothalamus. The 
specificity might be due to an increase of tryptophan, which is a precursor of serotonin 
but also a metabolite of carbohydrates that are present in higher concentrations upon 
CM diet.  
In our experiments, energy-dense diets induced similar changes in DA content in 
striatum in both genotypes. Specifically, mice having access to CM and HF showed 
higher levels of striatal DA and HVA, one of its metabolites, as compared to SC mice. 
The striatum is involved in the assignation of reward value, and thus, has a major role in 
food seeking behaviors (Kessler et al. 2016). Accordingly, the increased DA tone in 
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striatal regions could be participating in the perseveration in consuming highly palatable 
and energy-dense foods beyond the energy needs (Wang et al. 2011) since elevations in 
ventral striatal dopamine positively reinforces actions to obtain food (Adamantidis et al.  
2011). WT showed greater DA levels upon energy-dense long-term access than Ts65Dn 
mice that did not show important change in DA levels. The lack of rise in DA levels 
upon the consumption of HF in trisomic mice could indicate a depressed reward system.  
In the PFC, free access to energy-dense food lead to a lower DA levels in WT mice, 
reproducing previous results from other groups (Carlin et al. 2013) (Wakabayashi et al. 
2015). In the case of the Ts65D mice, HF and CM diets lead to opposite changes: while 
CM increased the DA levels, HF aggravated the hypodopaminergic state that we 
detected in non-obesogenic conditions. The DA levels of CM trisomic group were 
closer to the DA levels of the WT in non-obesogenic environment. The reduction of DA 
might have important behavioral consequences since it has been proposed that an 
inverted-U-type of response function for dopamine underpins the relationship with 
impulsivity (Nutt et al. 2015). In fact, we observed that low PFC-DA negatively 
correlated with higher intake of HF diet but also with adulterated HF consumption 
during the quinine adulteration test. Interestingly, Ts65Dn mice having the lower DA 
levels (SC+HF group) manifests higher inflexibility, reflected by a much stronger 
persistence of feeding bitter HF than bitter CM. 
 
5.3 The involvement of DYRK1A in the Down syndrome obesity phenotypes 
 
DS phenotypes are the result of a trisomy, and thus of the deregulation of an extensive 
number of genes. Among the triplicated genes, accumulating evidences suggest that the 
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (DYRK1A), could be 
implicated in both homeostatic and non-homeostatic aspects of feeding behavior. 
In this Thesis, we explored the specific involvement of DYRK1A in the feeding 
abnormalities contributing to DS obesity.  
 
5.3.1 DYRK1A overexpression does not recapitulate Down syndrome behavior 
abnormalities  
 
As in the Ts65Dn mice, we did not detect increased body weight in mBACTgDyrk1A 
mice when maintained in non-obesogenic conditions (standard chow), as compared to 
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their WT. In our experiments we could not reproduce previous reports showing that 
Dyrk1A transgenic mice exhibited increased food intake than wild type-mice (Hong et 
al. 2012). We neither observed the feeding behavior difficulties that in Ts65Dn mice 
manifested as longer and slower meals. DYRK1A overexpression in mBACTgDyrk1A 
mice did not lead to meal pattern changes compared to their WT, suggesting that 
DYRK1A overexpression alone is not sufficient for recapitulate this phenotype. 
Interestingly, we found that mandible hypoplasia is less pronounced in BACTgDyrk1A 
than in Ts65Dn mice (see Annex II), which could explain the absence of differences on 
meal duration and eating rate compared to their WT. This result could explain why the 
normalization of Dyrk1A overexpression to euploid levels by genetic deletion in 
Ts65Dn mice, did not significantly improve their mandibular dysmorphology (McElya 
et al. 2016). 
One limitation of our interpretation is the possible differences derived from the genetic 
background, which is not the same in transgenic and trisomic mice. However, our PCA 
analysis confirmed that those did not influence the craniofacial alterations observed in 
Ts65Dn and mBACTgDyrk1A as WT mice from both models clustered together. On the 
other hand, the same PCA analysis revealed a complete overlap between Ts65Dn and 
mBACTgDyrk1A mice for the skull morphometric analysis, suggesting that Dyrk1A 
overexpression in mice is sufficient to recapitulate brachycephaly.  
We conclude that DYRK1A overdosage is not sufficient for recapitulating DS feeding 
disturbances. However, our work adds a piece of evidence supporting the role of 
Dyrk1A in craniofacial morphogenesis. Our results do not support a role for Dyrk1A in 
DS obesity. 
 
5.3.2 DYRK1A overexpression leads to diet-specific body weight gain upon free 
access to CM or HF  
 
In our experiments, HF diet promoted weight gain in all mice independent of their 
genetic background. However, while Ts65Dn mice get more obese than their WT 
littermates, mBACTgDyrk1A gained similar body weight than their non-transgenic 
counterparts. This seems to contrast previous results claiming that mBACTgDyrk1A are 
protected against obesity (Rachdi et al. 2014a; Song et al. 2015) at least in HF 
conditions. In fact, mBACTgDyrk1A exposed to CM did not gain weight whereas 
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Ts65Dn and the wild-type mice from both models showed increased body weight gain 
compared to SC mice.  
The discrepancy could be due to differences in the type HF diet used or in the age of the 
animals since Rachdi and collaborators used 4 weeks-old mice that have not yet reached 
a stable weight while in our study we purposely waited until mice reached a plateau in 
their body weight increase, at 5 months of age. In this same work, transgenic mice 
gained were shown to be glucose tolerant and hyperinsulinemic compared to their WT 
(Rachdi et al. 2014a). Also, Song et al related the leaner phenotype of mice 
overexpressing DYRK1A (Song et al. 2015) to DYRK1A phosphorylation of glycogen 
synthase kinase 3 (GSK-3), which would lead to the inhibition of adipogenesis. 
Again, our results suggest that the overweight in Ts65Dn mice cannot be explained by 
the single overexpression of DYRK1A. Indeed, according to our results and based on 
the literature, DYRK1A might rather have a positive effect in body weight regulation. 
The increased body weight in HF free access conditions in Ts65Dn mice suggest that 
other genes might be implicated in adiposity and glucose control. 
 
5.3.3 DYRK1A overexpression leads to an increased preference for high-
carbohydrate meals (CM) 
 
Independently of the genotype, we found that HF was highly preferred against SC in all 
mice, which is supported by accumulating studies showing that the majority of the 
mouse strains always prefer fatter meals over any other nutritional combination (West 
1991) (Levine 2003). However, the most salient result of these experiments was the 
higher preference for the chocolate-mixture (CM) detected in mBACTgDyrk1A as 
compared to WT and Ts65Dn mice. One limitation to the interpretation of this result in 
the context of the DS phenotype is that the WT littermates of mBACTgDyrk1A mice 
also consumed more CM than the WT littermates of Ts65Dn, suggesting a strain effect 
(see Annex II). However, contrary to Ts65Dn mice, mBACTgDyrk1A mice consumed 
almost the same amount of CM than of HF indicated a clear preference for CM that was 
not present in trisomic mice thus reinforcing the implication of Dyrk1A in this 
phenotype, and suggesting that the impact of DYRK1A overexpression may be different 
in a disomic or in a trisomic background. Several studies have shown that neuropeptide 
Y (NPY) expression in the hypothalamus stimulates the ingestion of carbohydrates, 
having little effect on low-carbohydrate meals or fats (Beck 1992). Given that Dyrk1A is 
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expressed in hypothalamus and promotes NPY expression, the increased expression 
level and activity of DYRK1A recently reported in the hypothalamus of 
BACTgDyrk1A mice (Hong et al. 2012; London et al. 2017) could promote this 
preferential effect of NPY on carbohydrate consumption (Stanley 1989) in transgenic 
mice. In this same line, the fact that mRNA levels of NPY in the hypothalamus of 
Ts65Dn mice by qPCR were downregulated compared to WT, could explain their 
reduced CM preference. It is unclear what would be the mechanism underlying NPY 
downregulation in the trisomic model, which overexpresses DYRK1A, suggesting that 
other genes might be probably inhibiting NPY production. We propose that Dyrk1A 
overexpression might have a role in food preferences that might be compensated by 
other molecular pathways that are disturbed in the trisomic context. 
 
5.3.4 DYRK1A overexpression leads to inflexibility and increased binge-like 
responses  
 
When access to energy-dense food was limited, WT and mBACTgDyrk1A mice from 
SC+HF group were unable to compensate their energy intake by increasing their 
consumption of SC, indicating inflexible behavior. Conversely, in the SC+CM group, 
both mBACTgDyrk1A and their WT littermates increased their SC intake close to their 
energy intake of free feeding conditions. This pattern is different from trisomic mice 
that showed inflexibility both upon HF and CM exposure. However, the different 
behaviors showed by WT mice of both strains, that paralleled that of their mutant 
counterparts, suggest that C57BL/6J strain is more flexible to adapt to the available 
food sources than B6EiC3H. This strain effect makes impossible to discern the 
contribution of DYRK1A in the trisomic context.  
Even so, in the quinine adulteration experiment, both Ts65Dn and mBACTgDyrk1A 
showed persistent consumption of adulterated foods compared to their respective WTs, 
suggesting that DYRK1A could had a role in DS compulsive and inflexible behaviors. 
However, this inflexible response was associated with specific diets. As such, both WT 
and mBACTgDyrk1A reduced the consumption of adulterated SC and HF, but the 
consumption of bitter CM, which is well inhibited in WT, was not reduced in 
mBACTgDyrk1A mice. This result again suggests that Dyrk1A overexpression 
promotes inflexible behavior.  
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This CM-specific inflexible response could be related to altered reward-related 
mechanism. In fact, long-term access to CM promoted reduced preference for sucrose in 
WT mice but not in mBACTgDyrk1A that showed a non-significant increase of their 
preference for sucrose (diet x genotype integration ANOVA F (2,47) = 2.57; P = 0.09). 
Accumulating evidence has shown that obesogenic diets lead to reward hypofunction. 
Consequently, mice usually show a reduced preference for sweets solutions upon long-
term access to palatable treats like HF diets (Carlin et al. 2013; Rabasa et al. 2016). In 
agreement with these studies, it has been suggested that obesity might arise from a basal 
reward hyposensitivity where the higher consumption of energy-dense reflects an 
anhedonic state. Similarly, in mouse models both a reduction and an increase in the 
preference for sucrose consumption are thought to reflect aberrant responsiveness to 
reward (Mourlon et al. 2010). The increased sucrose preference in mBACTgDyrk1A 
mice could be an indicator of an increased seeking for sweet rewards, also observed in 
DS patients (Nordstrøm et al. 2015). Interestingly preliminary results of a study 
performed in collaboration with Dr Elena Martín García from the University Pompeu 
Fabra, suggest that mBACTgDyrk1A are more impulsive in a progressive ratio 
paradigm to receive chocolate pellets, which is in line with higher sensitivity for food 
rewards and thus increased craving (Dr Elena Martín, personal communication). 
The involvement of Dyrk1A in reward related mechanism has not been addressed before 
but several studies suggest that DYRK1A influences the dopaminergic system 
(Martínez de Lagrán et al. 2007; Barallobre et al. 2014). Specifically related to reward, 
it has been shown that Dyrk1A dosage participate in the control of the dopaminergic 
neurons survival during development (Barallobre et al. 2014) an effect possibly 
mediated through modulation of the caspase-9, that is phosphorylated by DYRK1A, 
which prevents the subsequent activation of the intrinsic apoptotic pathway (Laguna et 
al. 2008). Although the number of dopaminergic cells is not altered in the ventral 
tegmental area (VTA) of adult mBACTgDyrk1A mice (Barallobre et al. 2014), it was 
proposed that synaptic wiring of the dopaminergic system may be altered upon Dyrk1A 
overexpression, with a potential functional implication in adulthood. 
DYRK1A seems to be related specifically to the modulation of sweet preference and 
could be implicated in food craving and reward seeking.  This may explain in part why 
DS patients over-consume sweets and high-fat diets. However, the comparison with the 
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Ts65Dn model suggests that in the context of the trisomy some of its effects are diluted, 
probably due to the impact of the genetic background. 
 
5.3.5 Possible confounding influence of genetic background on obesity related 
behavioral and metabolic phenotypes 
 
Table 6 shows that Dyrk1A overexpression only recapitulates some of the obesity 
phenotypes described in Ts65Dn mice. However, the association of the phenotypes with 
the overexpression of DYRK1A could not be directly inferred from the similarities 
between the two DS models since the genetic background of mBACTgDyrk1A and 
Ts65Dn mice are different and affect the penetrance of the explored phenotypes (see 
Annex II).  
Preference for sweets solutions is strongly affected by the genetic background (Lush 
1999; Pothion et al. 2004; Lewis et al. 2005). In fact, here again we detected a strain 
effect since wild-type counterparts of DYRK1A transgenic mice (WT(TG) mice showed 
reduced intake for adulterated foods compared to WT(TS) (see Annex II). In fact, it has 
been shown that although both C57BL/6J and C3HeB/FeJ mice are able to detect low 
concentrations of quinine, C3HeB/FeJ (C3) are clearly less sensitive than C57BL/6J 
mice (Boughter 1992), but in our experiments, in non-obesogenic conditions, 
independently of the genotype and the model, mice of both strains had similar 
preference for saccharin and sucrose for the doses tested. 
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Table 6. DS obesity phenotypes in Ts65Dn (TS) and mBACTgDyrk1A (TG) mice. 
OBESITY 
PHENOTYPES 
Ts65Dn (TS) vs. mBACTgDyrk1A (TG) 
Body weight gain 
Long-term HF and CM free access promoted body weight gain in TS mice whereas TG 
mice maintained their body weight (SC+CM group) or gained less weight (SC+HF 
group). 
Body fat mass 
TS mice showed increased body fat mass whilst it has been shown that in TG mice the 
visceral epidydimal fat pads and perirenal fat pads are lower by 60% and by 30%, 
respectively compared with WT mice (Song et al. 2015). 
Glucose homeostasis 
TS mice are glucose intolerant whilst it has been described that TG mice are glucose 
tolerant and hyperinsulinemic (Rachdi et al. 2014b). 
Feeding behaviors in non-
obesogenic conditions 
Compared to WT mice, TS have longer and slower meals whereas the feeding behaviors 
were unchanged in TG mice. 
Feeding behaviors in free 
access to CM 
TS and TG (and their relative WT) showed a reduction of the average duration and an 
increased eating rate for energy-dense foods compared to SC 
Food preference vs. SC: 
Fat food 
Carbohydrate- rich food 
 
Independently of the genotype HF was highly preferred against SC. 
TS mice showed higher HF intake than their WT whereas TG did not. 
The preference for CM against SC was less strong than HF against SC. In TS model, the 
preference was moderate as compared to the TG model. 
Energy compensation 
24 hours of starvation lead to higher hyperphagia upon refeeding in both TS and TG 
mice. 
When HF was restricted to 1h/day during the limited access test TS and TG mice did not 
increased their SC energy intake. When CM was restricted TG did. 
“Binge-like events” 
Both TS and TG showed increased CM intake than WT when is offered in a limited 
access schedule. However, the energy consumed and the pattern of escalation in TG 
mice was more pronounced that in TS mice. 
Inflexibility and 
impulsivity 
Inflexibility in TS mice was revealed though bitter CM and HF intake whereas in TG 
mice was revealed by bitter CM intake. 
Preference for sweets 
solutions 
In both genotypes, SC+CM groups had reduced preference for sucrose compared to SC 
mice. In SC+CM groups, the preference for sucrose was reduced in TS mice and 
increased in TG mice. 
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6. CONCLUSIONS 
  
1. The Ts65Dn mouse model recapitulates some phenotypes of Down syndrome 
obesity including increased adiposity and feeding behavior abnormalities. However, 
trisomic mice do not show increased body weight or BMI in basal conditions, 
suggesting that obesity manifests only in obesogenic environments and thus an 
adequate nutrition could significantly prevent obesity in this population.  
 
2. In obesogenic environments, Ts65Dn mice show more propensity to body weight 
gain and increased intake and preference for energy-dense diets suggesting that 
both impaired control of food intake and motivational aspects might contribute to 
overeating in Down syndrome. 
 
3. In spite of the differential behavioral adaptations detected between Ts65Dn and WT 
mice in obesogenic environments, our neurochemical analysis revealed similar diet-
induced variations in brain monoamines, suggesting that changes on the 
composition would not be the major contributor to the behavioral abnormalities.  
 
4. We detected increased inflexibility and food abnormal craving in Ts65Dn mice that 
could be partially due to a reward deficient profile, since we found correlation with 
prefrontal hypo-dopaminergic function. This might bias food election towards 
energy-dense foods in Down syndrome. 
 
5. Ts65Dn mice present impaired fasting glycaemia and impaired glucose tolerance 
along with hypoinsulinemia that could be due to impaired insulin secretion but also 
to a deficient insulin output since Ts65Dn mice had reduced β-cell mass. 
 
6. The reduction in pancreatic β-cell mass could be related to the finding of increased 
circulating levels of several inflammatory and oxidative markers that are increased 
in obesity, and may reflect autoimmune pancreatic β-cell destruction. 
 
7. Ts65Dn had a significantly higher acute leptin response to oral glucose 
administration and non-significant higher steady-state leptin levels, replicating the 
leptin resistance phenotype of Down syndrome. 
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8. The single overexpression of Dyrk1A cannot explain the overweight observed in 
Ts65Dn mice upon exposure to an obesogenic environment. Indeed, our results 
confirm previous reports showing that DYRK1A might rather have a positive effect 
in body weight regulation.  
 
9. The increased preferences and compulsive responses to carbohydrate-rich foods 
detected in mBACTgDyrk1A mice suggest a specific role of DYRK1A in those 
phenotypes.  
 
10. Dyrk1A overexpression in mice is sufficient to recapitulate the brachycephalic 
phenotype associated to Down syndrome, without altering mandible morphology. 
Our work adds a piece of evidence supporting the role of DYRK1A in craniofacial 
morphogenesis but discard its involvement in Down syndrome feeding behavior 
alterations.  
 
In summary, our work sheds light to some important mechanisms involved in Down 
syndrome obesity, and suggests that prefrontal cortex-derived traits such as impulsivity 
and reward sensitivity are involved in the propensity to overeating in this population. 
This adds to a certain leptin resistance, and possibly to autoimmune pancreatic β-cell 
destruction thought inflammatory and oxidative stress mechanisms. We propose that 
Dyrk1A overexpression might be related to some of the behavioral abnormalities 
associated to overeating, especially for carbohydrate-rich foods, but its overdosage is 
not sufficient to recapitulate Down syndrome obesity. 
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ANNEX I: ABREVIATIONS 
 
AD     adrenaline 
AgRP     agouti-related protein  
ARC     arcuate nucleus  
BW     body weight 
BMI     body mass index 
BF    body fat 
CART    cocaine- and amphetamine-regulated transcript 
°C     Celsius  
CM     chocolate-mixture diet 
cm     centimeter 
CNS     Central Nervous System 
DA     dopamine 
DS     Down syndrome 
DYRK1A  Dual Specificity Tyrosine Phosphorylation Regulated 
Kinase 1A 
DOPAC    3-4dihydroxyphenylacetic acid 
g     gram 
s     second 
HT     hypothalamus 
HF     high-fat diet 
HSA21    Homo sapiens autosome 21 
h     hour 
HPLC     High- performance Liquid Chromatography 
HVA     homovanillic acid 
mBACTgDyrk1A   Transgenic mice overexpressing Dyrk1A 
MHPG    3-methoxy- 4-hydroxyphenylglycol 
min     minute 
ml     milliliter 
mM     millimolar 
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mm     millimeter 
mg     milligram 
MRI     Magnetic resonance imaging  
MMU16    Mus musculus chromosome 16 
MMU17   Mus musculus chromosome 17 
NA     noradrenaline 
NAc      nucleus accumbens 
NMR     nuclear magnetic resonance 
NPY     neuropeptide Y  
n     number 
OGTT    oral glucose tolerance test 
PBS     Phosphate Buffered Saline 
PET     Positron emission tomography 
PFC     prefrontal cortex 
POMC    proopiomelanocortin  
Quin     quinine hydrochloride  
SC     Standard chow 
SC+CM    standard chow + chocolate-mixture diet 
SC+HF    standard chow + high-fat diet 
SEM     Standard Error of the Mean 
ST     striatum 
SPECT    Single-photon emission computed tomography   
TG    Transgenic mice overexpressing Dyrk1A 
Ts65Dn    Trisomic mice 
TS     Trisomic mice 
VTA     vental tegmental area  
WT     Wild Type 
5-HIAA    5-hydroxy-3-indolacetic acid 
5-HT     5-hydroxytryptamine, serotonin  
l     microliter 
m     micrometer  
μCT     X-ray micro computed tomography  
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Abstract 
Down syndrome (DS) is caused by the trisomy of human chromosome 21 and could 
lead to multiple endocrine and nervous system alterations. Those might account for the 
higher prevalence of obesity in DS compared to the general population. Obesity usually 
is accompanied by a sustained inflammatory state. However, the link between adiposity 
and inflammation has not been explored in DS. 
Here we used the Ts65Dn mice, a validated DS mouse model, for the study of obesity 
and obesity-related inflammatory status in lean mice (maintained in standard chow) and 
in obese mice (under high-fat diet). Compared to wild type (WT), lean Ts65Dn mice 
had altered plasma levels of some anorexigenic and orexigenic signals like leptin and 
ghrelin that might affect feeding behavior and energy balance. Independently of the diet, 
Ts65Dn mice have increased body adiposity along with increased energy consumption 
and energy expenditure compared to WT. Concomitantly, Ts65Dn mice had increased 
plasma galectin-3 and HSP72 levels which are markers of inflammation and oxidative 
damage. Our results suggest that an altered immune response in Ts65Dn mice could 
potentially contribute to obesity propensity in DS. 
Highlights 
In non-obesogenic conditions, Ts65Dn mice present increased body adiposity, reduced 
plasma ghrelin in starved conditions and higher leptin levels upon re-feeding than WT 
mice. The levels of galectin-3 and HSP72 in plasma are higher in Ts65Dn mice 
compared to WT suggesting increased inflammatory and oxidative stress in trisomic 
mice. 
Keywords 
Down syndrome, inflammation, obesity, leptin, ghrelin, resistin, interleukin-6, galectin-
3, HSP72 
Abbreviations 
DS: Down syndrome, gal-3: galectin-3, GIP: glucose dependent insulinotropic 
polypeptide; GLP-1: glucagon-like peptide-1(7-36) amide, HF: high-fat, HSP72: heat 
shock protein HSP (72), IL-6: interleukin-6, ROS: reactive oxygen species, PAI-1: 
Plasminogen activator inhibitor 1. 
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1. Introduction 
Down syndrome (DS) is caused by trisomy of chromosome 21 and is associated to 
multiple endocrine and nervous system alterations [1]. Individuals with DS have high 
prevalence of obesity possibly due to metabolic complications, insufficient exercising 
and poor eating habits [2] [3] [4]. DS is associated with high body adiposity [5] [6] 
suggesting that a propensity for fat accumulation could be a major contributor of DS 
obesity. 
In the general population, high adiposity is associated with inflammation and oxidative 
stress markers [7] [8]. Indeed, visceral fat accumulation contributes to pro-oxidant and 
pro-inflammatory states, as well as to alterations in glucose and lipid metabolism [8]. 
Among the mechanisms involved, hormones directly implicated in food intake 
regulation such as leptin, a hormone secreted by the adipose tissue, increase the 
secretion of inflammatory cytokines and stimulates the production of reactive oxygen 
species (ROS), leading to increased inflammation and oxidative stress [9] [10] [11]. 
Recently, it has also been shown that ghrelin levels are negatively correlated with nitric 
oxide concentration in plasma of obese patients [12].  
Conversely, a deficient immune response might increase the vulnerability to obesity 
development. Modulators typically related to immune process such as interleukin-6 (IL-
6) galectin-3 and extracellular heat shock protein 72 (eHSP72), are positively correlated 
with obesity and inflammation in the general population [13] [14] (Krause, Keane et al, 
2014).  
Increased susceptibility to autoimmune disorders, hypothyroidism, celiac disease and 
diabetes mellitus are more common in DS individuals than in non-DS individuals [15], 
all clinical conditions having in common inefficient immune responses or abnormally 
increased inflammation [16]. However, the potential link between adiposity and 
inflammation has not been explored. Here we used the Ts65Dn mice, a validated DS 
mouse model, for the study of the effect of trisomy 21 on adiposity, energy balance and 
inflammatory status in non-obesogenic (standard rodent chow) and obesogenic 
conditions (high-fat chow). 
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2. Methods  
Animals and housing 
4-6 moths-old male Ts(1716)65Dn (Ts65Dn) and wild-type (WT) mice used in this 
study were obtained through crossings of a B6EiC3Sn a/A-Ts (1716)65Dn (Ts65Dn) 
female to B6C3F1/J males purchased from The Jackson Laboratory (Bar Harbor, ME). 
Genotyping was performed by amplifying genomic DNA obtained from the mice tail as 
previously described in [17]. The mouse colony of Ts65Dn mice was bred in the 
Animal Facilities if the Barcelona Biomedical Research Park (PRBB, Barcelona, Spain, 
EU) in controlled laboratory conditions with the temperature maintained at 22 ºC ± 1oC 
and humidity at 55 ± 10% on a 12 hours light/dark cycle (lights off 20:00 hours). Food 
and water were available ad libitum except during food deprived experimental sessions. 
All experimental procedures were approved by the local ethical committee (Comité 
Ético de Experimentación Animal del PRBB (CEEA-PRBB); procedure number MDS-
12-1464P3) and the institutional animal care and use committee of the Paris Diderot 
University (CEEA40), met the guidelines of the local (law 32/2007) and the Standards 
for Use of Laboratory Animals n° A5388-01 (NIH). Both Institutes are authorized to 
work with genetically modified organisms (A/ES/05/I-13 and A/ES/05/14). 
Diets 
Ts65Dn and WT mice were given standard chow, SC (SDS, UK) for the assessment of 
the genotypic differences in body weight, body composition, metabolic phenotyping 
and plasma biomarkers in non-obesogenic conditions. Those parameters were also 
studied in obesogenic conditions, by given Ts65Dn/WT mice ad libitum access for 8 
weeks to a high-fat diet (High-fat/DIO, Test Diet, USA). Supplementary Table 1 shows 
the composition of the different experimental diets. 
Indirect calorimetry and metabolic phenotyping  
Metabolic phenotyping was performed using calorimetric cages (Labmaster, TSE 
Systems GmbH, Bad Homburg, Germany) located in the Functional & Physiological 
Exploration Platform (FPE) of the Functional & Adaptive Biology (BFA) Unit of the 
University Paris Diderot-Paris 7, CNRS UMR 8251. The apparatus combine a set of 
highly sensitive feeding and drinking sensors for automated online measurements, and a 
frame with an infrared light beam based activity monitoring system, allowing 
measurement of total locomotion. The sensors for gases and detection of movement 
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operate efficiently in both light and dark phases, allowing also continuous recording. 
Ratio of gases was determined through an indirect open circuit calorimeter [18] [19]. 
This system monitors O2 and CO2 concentration by volume at the inlet ports of a tide 
cage through which a flow of air (0.4 l/min) is being ventilated and compared regularly 
to a reference empty cage. Whole energy expenditure is calculated according to the 
Weir equation respiratory gas exchange measurements [20]. Sensors were previously 
calibrated with a mixture of known concentrations of O2 and CO2 (Air Liquide, Paris, 
France). 
Mice were individually housed in the calorimetric cage in controlled laboratory 
conditions with the temperature maintained at 22 ºC ± 1oC on a 12 hours light/dark 
cycle (lights off 19:00 hours).  Depending of the experimental condition, Ts65Dn/WT 
mice had ad libitum access to water and standard or high-fat chow diet (SC: WT, n = 
10; Ts65Dn, n = 8; HF: WT, n = 6; Ts65Dn, n = 6). All animals were acclimated for 48 
h and energy intake (KJ/ mouse body weight), locomotor activity (infrared breaks/h), 
oxygen consumption/carbon dioxide production (VO2, VCO2; ml/kg of lean mass/h), 
respiratory exchange rate (RQ ¼ VCO2/VO2) and energy expenditure (KJ/h) were 
established within the next 72 h. Representative 24 h measurements were the mean of 
the three consecutive experimental days. Data were collected every 40 min during the 
experimental times and analysis were performed on excel XP using extracted raw value 
of VO2 consumed, VCO2 production (expressed in ml/h), energy expenditure (KJ/h). 
Subsequently, each value was expressed either by total body weight or whole lean tissue 
mass extracted from the EchoMRI analysis (see below). 
Whole-body composition analysis 
Non-invasive analysis of body composition were estimated in  a cohort of 5 months-old 
male Ts65Dn /WT mice feed with standard chow (WT, n = 10; Ts65Dn, n = 8) and a 
cohort of mice fed with high-fat fed mice for 8 weeks (WT, n = 6; Ts65Dn, n = 6) by 
nuclear magnetic resonance (NMR) technology via a scanner EchoMRI 900 (Echo 
Medical Systems, USA), that creates contrast between soft tissues taking advantage of 
the differences in relaxation times of the hydrogen spins and/or hydrogen density 
(http://www.echomri.com/). Lean mass is equivalent to muscle mass and organs. Body 
fat does not distinguish between different types of fat and fat depositions in every organ 
including the brain, muscles, other organs, bone marrow, and circulating blood lipids, 
and fatty acids. 
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Briefly, the mouse is placed in a specially sized, clear plastic holder without sedation or 
anesthesia and the holder is then inserted into a tubular space in the side of the 
EchoMRI™ system for 1 minute. In our experiment, lean and fat body composition was 
directly obtained from EchoMRI™ measurements in grams. From this data, body 
composition was calculated for each mice and corrected for body weight. 
Bio-Plex Pro Mouse Diabetes Assay 
The evaluation of the incretins activity and the response to glucose of related metabolic 
parameters, was performed in 5 months-old male Ts65Dn/WT mice on a standard chow 
diet prior to food deprivation and after a glucose load. Ghrelin, glucose dependent 
insulinotropic polypeptide (GIP), glucagon-like peptide-1(7-36) amide (GLP-1), 
glucagon, insulin, leptin, Plasminogen activator inhibitor-1 (PAI-1) and resistin were 
measured in Ts65Dn (n = 7) and WT (n = 11) mice, using suspension bead array 
immunoassay kits following manufacturer’s specifications (Bio-Plex Pro Mouse 
Diabetes Assay 8-plex, Biorad, France). Mice were food deprived for 5 hours prior to an 
oral administration of 2g/Kg of 30% glucose (Lavoisier, France). Blood was collected 
from the tail vein before the glucose administration (T0) and 30 minutes after (T30) to 
mimic the postprandial levels. Upon centrifugation of the blood, plasma was stored in 
presence of Linagliptin, a DPP-4 inhibitor (Selleckchem, USA) and Protease inhibitor 
(Roche, France) to inhibit the degradation of incretins.  The samples were measured 
using a Luminex 200 apparatus (Luminex, Austin, TX). 
Hormonal and metabolic determinations 
Galectin-3, HSP72 and interleukin-6 were measured from blood in a cohort of 4-5 
months-old male Ts65Dn /WT mice feed with standard chow (WT, n = 6; Ts65Dn, n = 
5) and a cohort of mice fed with high-fat fed mice for 8 weeks (WT, n = 8; Ts65Dn, n = 
4). Samples were obtained by retro-orbital sinus sampling with heparinized capillaries 
into the tubes containing a 1/10 volume of 3.8% sodium citrate. Plasma was isolated by 
centrifugation at 2500 x g for 15 min at 4°C. Plasma galectin-3 (Abcam ELISA kit, 
France), HSP72 (Enzo Life sciences ELISA kit, Germany) and IL-6 (Enzo Life sciences 
ELISA kit, Germany) were assessed using sandwich ELISA. After removal of unbound 
conjugates, bound enzyme activity was assessed by use of a chromogenic substrate for 
measurement at 450 nm by a microplate reader (Flex Station 3, Molecular Devices, 
Ltd., UK). Alanine aminotransferase (ALT) level was assayed using the Alanine 
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Aminotransferase Activity Assay Kit (Sigma-Aldrich, France), based on the pyruvate 
generated. All assays were performed in duplicate. 
Statistical analyses 
Sample size was estimated based on our previous experience with similar experiments. 
Differences between genotypes and diet groups were determined using 2-tailed unpaired 
Student’s t test. Two-way ANOVA with Bonferroni post hoc test to correct for multiple 
comparison was used to test diet and genotype interaction. Levels of statistical 
significance were set at P<0.05. The statistical analyses were performed using the by 
using Statistical Package for Social Science software (SPSS version 17.0, IBM 
Corporation, USA). 
 
3. Results 
Increased adiposity and positive energy balance in Ts65Dn mice  
The body weight and mass index of 5 months-old Ts65Dn mice fed with standard chow 
was similar to WT littermates (Figure 1 A-B), but Ts65Dn mice presented a significant 
reduction of body length (t (1, 16) = 4.23, P< 0.01, Figure 1C). 
 
Figure 1. Somatometric characteristics of wild type (WT) and Ts65Dn (TS) mice fed with standard 
chow (SC). (A) Body weight (grams), (B) body mass index (BMI; grams/cm
2
) and (C) body length (cm) 
in WT mice (n=10) and TS mice (n=8) fed with standard chow (SC). Student’s T test for independent 
samples ** P<0.01. 
 
Using Nuclear Magnetic Resonance (NMR) we detected reduced lean body mass (t (1, 
16) = 2.92; P = 0.01; Figure 2A) and a higher percentage of body fat per body weight in 
Ts65Dn as compared to WT (t (1, 16) = -2.96, P< 0.01; P<0.05; Figure 2B). These 
features are in agreement with DS human somatometric characteristics that have low 
height and high adiposity as compared to typical development peers [6] [21]. 
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Figure 2. NMR non-invasive analysis of body mass composition in wild-type (WT) and Ts65Dn (TS) 
mice. Bar blots depicted (A) body composition in lean (LM) and fat mass (FM) represented in grams, and 
(B) body composition corrected for body weight (BW) in TS (n = 8) and WT (n = 10) mice. Data 
expressed as mean ± SEM. Student’s T test for independent samples ** P<0.01. 
 
We also measured the energy intake, and locomotor activity, energy expenditure and 
respiratory exchange ratio of Ts65Dn and WT mice. During the active (dark) phase but 
not during the resting (light) phase of the circadian cycle, Ts65Dn mice showed higher 
energy intake compared to WT (t (1, 9) = -2.65; P<0.05; Figure 3A). Locomotor activity 
was similar in both genotypes, but we detected hyperactivity in Ts65Dn mice during 
specific periods of the dark phase (Figure 3B). Even so, Ts65Dn mice still showed a 
significantly higher positive energy balance during the dark phase than WT mice (t (1, 
9) = -2.43; P<0.05, Figure 3C), as measured by indirect calorimetry. To further analyze 
the effect of trisomy on whole-body energy homeostasis, we determined respiratory 
quotient. There were no significant differences between genotypes in total oxygen 
consumption (Figure 3D) or carbon dioxide production (Figure 3E) and consequently, 
the respiratory quotient (RQ = VCO2/VO2) was similar (Figure 3F).  
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Figure 3. Indirect calorimetry in wild-type (WT) and Ts65Dn (TS) mice fed with standard chow. 
Bar blots depicted (A) energy intake (KJ/mouse body weight) during the inactive (light phase) and active 
(dark phase) period of the 12hours light/dark cycle. (B) Daily locomotor activity. (C) Energy balance 
(food intake – estimated resting energy). (D) Volume of total oxygen consumption, VO2. (E) Volume of 
total carbon dioxide production, VCO2. (F) Respiratory quotient in TS (n = 6) and WT (n = 5) mice. Data 
expressed as mean ± SEM. Student’s T test for independent samples * P< 0.05. 
Altered levels of metabolic and inflammatory biomarkers in Ts65Dn mice 
To study the effect of trisomy 21 on inflammation and oxidative stress, and the trisomic 
basal and the postprandial phenotype, the concentrations of ghrelin, GIP, GLP-1, 
glucagon, insulin, leptin, PAI-1 and resistin were measured in Ts65Dn and WT mice 
after a 5 hours starvation (T0) and 30 minutes after an oral glucose load (T30). We 
obtained the metabolic profile of selected markers (Table 1) in Ts65Dn and WT mice 
using the Bio-Plex Pro™ mouse diabetes immunoassay.  
Upon starvation, glucose levels were higher in plasma from Ts65Dn mice (t (1, 17) = -
2.59; P<0.05) compared with WT mice (Table 1), while the levels of insulin (t (1, 17) = 
2.40; P< 0.05) and ghrelin (t (1, 16) = 3.17; P<0.01) were significantly reduced. Upon a 
glucose load, the levels of glucose in Ts65Dn mice remained significantly higher (t (1, 
17) = -2.26, P<0.05) and the levels of insulin were lower than WT, although the 
difference did not reach statistical significance (t (1, 17) = 2.07; P = 0.054). Also, the 
levels of ghrelin were still slightly, though not significantly lower in Ts65Dn mice. 
While leptin levels were similar in both genotypes in starved conditions, after an oral 
glucose load Ts65Dn showed a non-significantly higher plasma leptin levels (t (1, 17) = 
-2.09; P = 0.052) than WT. GLP1 and GIP were not different, suggesting no incretin 
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dysfunction and the rest of the markers studied also exhibit similar profile in Ts65Dn 
and WT mice (Table 1). 
  
Table 1. Plasma levels of obesity biomarkers markers in wild type (WT) and Ts65Dn (TS) mice in 
starved conditions (T0) and 30 minutes after a glucose load (T30). Data are expressed as mean ± SEM. 
WT = 11, TS = 7. WT vs TS; Student’s T test for independent samples * P< 0.05, ** P<0.01. 
 
To see whether these mediators could explain the increased energy intake observed in 
Ts65Dn mice, we calculated the differences between genotypes for the changes of the 
hormone concentrations upon the glucose load (Figure 4). Compared to WT mice, 
Ts65Dn mice showed a significantly higher increase of leptin and resistin levels that 
have been previously associated with impaired glucose tolerance [22] and central leptin 
resistance [23]. No significant differences for the changes on the plasma concentrations 
of the rest of the markers were observed between genotypes after refeeding. 
 
   
Ghrelin 
(pg/ml) 
 
GIP 
(pg/ml) 
 
GLP-1 
(pg/ml) 
 
Glucagon  
(pg/ml) 
 
Insulin 
(ng/ml) 
 
Leptin 
(pg/ml) 
 
PAI-1 
(pg/ml) 
 
Resistin  
(pg/ml) 
 
Glucose 
(mg/dl) 
 
 
 
T0 
 
WT 
 
5595.74 ± 
360.27 
** 
 
518.16 ± 
12.48 
 
55.43 ± 
2.28 
 
387.07 ± 
15.62 
 
3658.11 ± 
122.07 
* 
 
7193.91±  
541.18 
 
2876.12 
± 154.90 
 
50159.32 ±   
1696.01 
 
195.5 ± 
5.86 
* 
 TS 1540.14 ± 
2.41.39 
584.42 ± 
30.78 
54.53 ±  
2 
386 ±  
19.51 
2528.17 ± 
135.78 
10173.25± 
848.14 
2605.35 
± 221.52 
48765.63 ± 
1810.21 
251.33 ± 
4.55 
 
 
T30 
 
WT 
 
6382.22 ± 
476.85 
 
575.37 ± 
11.42 
 
121.15 ± 
7.41 
 
696.22 ± 
37.63 
 
6332.15 ± 
200.37 
 
12763.55 ± 
1004.05 
 
5155 ± 
254.42 
 
79604.79 ± 
2515.79 
 
340 ±  
13.72 
* 
 TS 3421.21 ± 
327.81 
673.40 ± 
31.77 
135.86 ± 
6.26 
511.03 ± 
22.28 
4709.02 ± 
193.55 
20783.37 ± 
1174.96 
4416.92 
± 635.62 
97005.72 ± 
3480.49 
470.67 ± 
22.03 
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Figure 4. Changes in plasma levels of obesity biomarkers in wild type (WT) and Ts65Dn (TS) mice 
30 minutes after a glucose load. Data are expressed as mean ± SEM. WT = 11, TS = 7. WT vs TS; 
Student’s T test for independent samples * P< 0.05. 
 
Body weight increase, body composition and indirect calorimetry upon HF diet access 
8-weeks of access to high-fat (HF) diet promoted body weight gain in both genotypes 
being significantly higher in Ts65Dn mice (t (1, 10) = -3.32; P< 0.01; Figure 5A). We 
confirmed by NMR that both genotypes increased their body fat mass in a similar 
manner. However, when corrected by body weight, Ts65Dn again showed higher 
percentage of body fat compared to WT mice (t (1, 10) = -3.40; P< 0.01; Figure 5B), as 
we already observed in standard chow conditions. 
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Figure 5. Body weight gain and fat body composition in obese wild type (WT) and Ts65Dn (TS) 
mice. (A) Body weight gain upon 8 weeks of HF. (B) Lean /body weight (g) and fat mass/ body weight 
(g) in the 8th week. WT = 6, TS = 6. Data expressed as mean ± SEM. Student’s T test for independent 
samples ** P<0.01.  
To assess if obesity development in Ts65Dn mice was associated to metabolic changes, 
we performed indirect calorimetry. Again, Ts65Dn mice showed higher energy intake 
(KJ consumed per mouse body weight; t (1, 8) = -3.51; P<0.01, Figure 6A) while the 
ambulatory activity was similar between genotypes (Figure 6B). Both genotypes had 
negative energy balance (during light phase and positive during the dark period (Figure 
6C). Measurements of oxygen consumption and carbon dioxide production were 
increased for Ts65Dn mice fed a HF diet relative to WT (TS vs. WT (VO2) t (1,8) = -
3.7; P<0.01; TS vs. WT (VCO2), t (1,8) = -3.81; P<0.01; Figure 6D-E). However, the 
metabolic exchange (RQ = CO2/O2) was similar between genotypes (Figure 6F). 
 
  
Figure 6. Indirect calorimetry in wild-type (WT) and Ts65Dn (TS) mice fed with high-fat diet (HF). Bar 
blots depicted (A) Energy intake (KJ/mouse body weight) during the inactive (light phase) and active 
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(dark phase) period of the 12hours light/dark cycle. (B) Daily locomotor activity. (C) Energy balance 
(food intake – estimated resting energy). (D) Volume of total oxygen consumption, VO2. (E) Volume of 
total carbon dioxide production, VCO2.  (F) Respiratory quotient in TS (n = 5) and WT (n = 5) mice. Data 
expressed as mean ± SEM. Student’s T test for independent samples, ** P<0.01.  
 
Trisomy 21 in mice is associated with higher plasma levels of galectin-3 and HSP72 
There is clear evidence that inflammatory signaling contributes to obesity-associated 
insulin resistance in peripheral tissues [24]. Hence, plasma levels of molecules 
responding upon an insult such as galectin-3, HSP72, and interleukin-6 (IL-6) have 
been shown to positively correlate with human obesity [13] [14]. 
We observed that Ts65Dn had higher levels of both galectin-3 and HSP72 
independently of the diet compared to WT (genotype effect for galectin 3, ANOVA, F 
(1, 23) = 23.31, P<0.001; Figure 7A; and for HSP72 ANOVA, F (1, 23) = 7.2, P<0.05; 
Figure 7B). Upon 8 weeks of HF diet, we only observed in WT mice a non-significant 
increase for HSP72, along with unchanged levels of circulating galectin-3 (Figure 7B). 
The plasma IL-6 levels of Ts65Dn SC fed mice were lower compared to WT mice, 
Figure 7C) reproducing some previous studies in DS patients [25]. However, both 
genotypes showed similar IL-6 levels upon HF diet that were higher than those of mice 
fed with standard chow (diet effect, ANOVA F (1, 23) = 18.25, P<0.001). 
  
Figure 7. Measured level of inflammatory markers in wild type (WT) and Ts65Dn (TS) mice in 
non-obesogenic (standard chow, SC) and obesogenic conditions (high-fat diet, HF) fed conditions. 
Data are expressed as mean ± SEM. WT (SC) = 6, WT (HF) = 8; TS (SC) = 5, TS (HF) = 4. Two-way 
ANOVA. A-B) ANOVA # P< 0.05; ## P< 0.01; ### P< 0.01; C) & P< 0.001 genotype effect.  
 
4. Discussion 
DS obesity has been mainly attributed to insufficient exercising and reduced energy 
metabolism or to poor eating habits [26] [27]. However, there is ample evidence of the 
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involvement of oxidative stress and inflammation that are associated with increased 
propensity for fat accumulation in the general population [24] [28]. 
Here we showed that Ts65Dn mice, a mouse model of DS, had increased percentage of 
body fat compared to WT, indicating higher propensity to fat accumulation and 
reproducing human data [5] [6]. Ts65Dn had increased energy intake and a positive 
energy balance which supports hyperphagia, despite their significantly increased 
locomotor activity. The contribution of energy metabolism and energy expenditure in 
DS obesity is controversial. Some reports have shown that resting metabolism is 
reduced in DS [29] [30] [31], possibly due to defects on thyroid gland function, which is 
prevalent in DS [32]. DS neonates and children have significantly decreased VO2, 
VCO2, and resting energy expenditure (REE) when compared with controls [30] but the 
reduced REE was not explained by thyroid function or adiposity (Allison, Gomez et al. 
1995). Moreover, having a lower REE at baseline, was not predictive of gain in fat mass 
over time [30]. Indeed, others have not found differences when compared to non-DS 
people [33] [34]. In our experiments, the similar positive energy balance in mice of both 
genotypes suggests that the hyperphagia observed in Ts65Dn mice is not a consequence 
of an increased metabolism. 
Ts65Dn showed higher circulating glucose compared to WT both in starved conditions 
and upon glucose load, in agreement with previous studies in Ts65Dn mice, but also in 
Ts16 mice, a mouse model with complete trisomy of chromosome 16 [35]. We also 
detected reduced insulin plasma levels in fasting and glucose loaded conditions. The 
prevalence of type 1 diabetes in DS is higher compared to the general population [36] 
[37]. Therefore, the hypoinsulinemia of Ts65Dn mice could be due to the beginning of 
the autoimmune beta cell destruction leading to reduced beta cell mass, which are 
common pathological marks of the disease [38].  
It has been shown that elevated serum leptin concentrations in human significantly 
predict the development of obesity and metabolic syndrome [39]. Ts65Dn had a 
significant higher acute leptin response to oral glucose administration and non-
significant higher steady-state leptin levels. However, Ts65Dn mice exhibited 
hyperphagia, suggesting that they might be less reactive to the inhibiting appetite effects 
of leptin.  
High plasma glucose levels in Ts65Dn mice could lead to increased leptin levels since 
in adipose tissue, mRNA levels of the ob gene, that encodes for leptin, are positively 
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correlated with glucose levels in lean animals after glucose loading, presumably leading 
to increased leptin secreted in plasma [40]. Greater leptin production per unit of adipose 
tissue has been proposed in DS humans [41] and could also explain this phenotype in 
Ts65Dn mice. 
One important limitations of our study is that we did not explore directly the leptin 
resistance in our mice. However, the finding of hyperleptinemia along with hyperphagia 
in Ts65Dn mice lead to speculate that diminished leptin sensitivity might increase the 
risk of obesity development when exposed to an obesogenic environment. In support of 
this hypothesis, we detected a higher body weight gain and increased energy intake in 
Ts65Dn mice upon high-fat diet. It has been shown similar results in rats since those 
having greater absolute leptin response to intravenous glucose administration, also had 
increased energy intake and gained more weight upon 6 weeks of high-fat diet [42]. 
Moreover, although two studies have reported lower leptin levels in DS adults [43] and 
fetus [44] compared to non-DS controls, the majority of the existing DS human reports 
also support the leptin resistance phenotype. It has been shown that leptin levels 
correlates with adiposity in DS children and adolescents [45] [46] and free feeding 
leptin levels are higher in DS compared to unaffected siblings [41] [43].  
In summary, according to our results, we propose that DS is a case of leptin resistance 
phenotype and thus healthy dietary habits could be a key strategy in preventing obesity 
development of obesity in DS despite their higher propensity to adiposity. 
We here also detected significantly lower plasma ghrelin levels in Ts65Dn mice 
compared to WT mice. We only found one report of ghrelin levels in DS individuals 
showing no differences between typical developing peers [41]. In fact, in our 
experiments, the genotype-dependent differences were only significant in starved 
conditions. Interestingly, it has been shown that obese patients have usually lower 
plasma levels of ghrelin than lean individuals [47]. Besides the effect of leptin and 
ghrelin on appetite, several studies have shown that ghrelin acts also as an anti-
inflammatory and antioxidant modulator [48] while leptin is implicated in the release of 
inflammatory cytokines and stimulates the production of reactive oxygen species 
(ROS), leading to increased inflammation and oxidative stress [49]. We could thus 
speculate that hyperleptinemia and hypoghrelinemia could be involved in the increased 
inflammation and oxidative damage associated to trisomy 21. 
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There are obviously other possible mechanisms related to obesity propensity in DS. 
Plasminogen activator inhibitor (PAI-1), which is regulated by the accumulation of 
visceral fat and associated with insulin resistance at high concentrations [50], has been 
shown to be reduced in blood of DS individuals compared with controls, probably 
thought action of DS-related proteins such as DYRK1A and RCAN1 that might 
attenuate the PAI-1 expression via the NGF-Calcineurin/NFAT pathway [51]. However, 
we here did not observe increased PAI-1 levels in Ts65Dn mice compared to WT.  
The relationship between resistin and obesity is controversial. It has been shown that the 
levels of resistin in amniotic fluid of DS pregnancies are lower and it has been proposed 
that it could have an inhibitory effect on fat accumulation and to contribute to the 
tendency to childhood obesity in this population [52]. However, in general population 
other reports have also shown that high peripheral resistin levels are associated with 
impaired glucose tolerance, reduced insulin [22] and central leptin resistance  [23] 
which is the case in Ts65Dn based on the measurement. Accordingly, we here found 
slightly higher levels in Ts65Dn mice, but even more important, a significant increase in 
resistin levels in Ts65Dn compared WT mice upon glucose overload. This may explain 
the paradox of Ts65Dn mice being lean but insulin resistant/hyperglycemic. 
Incretins are also important regulators of feeding behavior. As a result, reduced GLP-1, 
GIP secretion and impaired incretin effect have been observed in obese subjects [53]. 
Glucagon has been also associated to increased inflammation in obese patients [54]. We 
did not find studies comparing the levels of GIP, GLP-1, and glucagon in plasma of DS 
and non-DS individuals. However, in our experiments, GIP, GLP-1, glucagon showed 
no difference between Ts65Dn and WT mice, suggesting no incretin dysfunction. 
Although obesity and autoimmune diseases are common in DS (Giménez-Barcons, 
Casteràs et al. 2014), this relationship had not been addressed before in DS mouse 
models. Here we found that Ts65Dn mice had higher levels of pro-inflammatory and 
pro-obesogenic markers such as plasma galectin-3 and HSP72 compared to WT mice. 
Galectin-3 is a lectin which levels are highly increased during inflammation in both 
humans and obese mice [55]. Moreover, it has been showed that its administration 
causes insulin resistance and glucose intolerance in mice [56], possibly by diminishing 
monocyte to dendritic cell differentiation and T-cell antigen presentation [57]. Although 
we did not find previous reports on galectin-3 levels in DS individuals, it has been 
reported that it is significantly increased in patients with Alzheimer's disease [58]. 
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Galectin-1, a lectin from the same family as galectin-3, is present in the placenta of DS 
pregnancies [59]. Therefore, our result suggest that galectin-3 could be a new interesting 
target for DS. 
High levels of the stress heat shock protein 70 (HSP72) in plasma has been associated 
with autoimmunity [60] [61] and accumulating data show that HSP72 extracellular 
levels correlate with oxidative damage [62] [63]. According to our results, trisomy 21 
seem the first example of a natural high level of plasma HSP72 which is in accordance 
with the high prevalence of autoimmune diseases in DS individuals. 
Finally, Interleukin-6 (IL-6) is positively correlated with fat adiposity and inflammation 
in the general population and also in DS individuals in several studies. [64] [65] [66]. 
However, in our hands, Ts65Dn fed with SC had lower plasma IL-6 level compared to 
WT. We suspect that would parallel the depressed levels of IL-6 described before in DS 
children [25] [67]. As they proposed, that could favor the anti-inflammatory state and 
cause recurrent infection [25]. In support of this, it has been shown that mice lacking 
IL-6 expression develop systemic insulin resistance and late-onset obesity [68] [69]. 
Taken together our results suggest that Ts65Dn mice have a pro-obesogenic and pro-
inflammatory phenotype. Accordingly to our prediction, when exposed to high-fat (HF) 
diet, although Ts65Dn mice showed similar metabolic exchange compared to WT, they 
showed higher energy intake and increased weight gain and fat mass. It has been shown 
in mice that high-fat diet increased the circulating galectin-3 and the effect was 
attenuated after macrophages depletion [56]. Higher circulating HSP72 levels have been 
also observed in medical conditions such as obesity and diabetes (Krause, Keane et al, 
2014). We here found that upon HF, the levels of galectin-3 and HSP72 were higher in 
Ts65Dn mice compared to WT, similar to what observed in non-obesogenic conditions. 
Indeed, in our hands, diet intervention did not affect the levels of these inflammatory 
markers, probably due to a ceiling effect in Ts65Dn mice. Only the levels of IL-6 
increased upon HF, which is in agreement with the literature [64] [65] [66].   
 
In conclusion, in this study we found that lean Ts65Dn mice have increased body 
adiposity and altered inflammatory plasma profile compared to WT mice. We also 
observed altered plasma levels of some anorexigenic and orexigenic signals like leptin 
and ghrelin in Ts65Dn mice that might affect feeding behavior and energy balance. 
Similar to what has been shown in DS humans, Ts65Dn mice showed increased energy 
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consumption and energy expenditure along with increased leptin levels, which suggests 
leptin resistance. Concomitantly, we detected that Ts65Dn mice had altered plasma 
profile for some markers of inflammation and oxidative damage. Specifically, we here 
first described that Ts65Dn mice show increased plasma galectin-3 and HSP72 levels 
compared to WT that might explain their increased incidence of autoimmune disorders 
and potentially, obesity propensity.  
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Supplementary Table 1. Composition of the experimental diets (g/Kg total) used. 
 
Nutrients Standard chow 
(SC) 
High-fat diet   
(HF) 
Protein (%) 17.49 23.7 
Fat (%) 7.42 34.7 
Carbohydrates (%) 75.09 29.6 
Sugar (%) 4.05 6.36 
Starch – fiber (%) 44.97 5.4 
Energy (Kcal/g) 2.85 5.25 
Energy (KJ/g) 10.76 22 
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2. Comparative analysis of some obesity and feeding behavioral phenotypes of the 
wild-type mice from the two Down syndrome mouse models 
 
Accumulated data have confirmed that both trisomic and Dyrk1A overexpressing 
transgenic mice recapitulate several anatomic and functional hallmarks of DS robustly 
enough regardless the strain. However, since this is the first report of feeding behavior 
and obesity related phenotypes, in this supplementary result we have compared the 
wild-type mice that are used as controls of Ts65Dn and mBACTgDyrk1A, to establish 
to what extent the differences detected between this two DS models could depend on 
the genetic background: B6EiC3H for Ts65Dn [WT(TS)] and C57Bl6/J for 
mBACTgDyrk1A [WT(TG)].  
Body weight and feeding behavior 
In non-obesogenic conditions, WT(TG) mice presented reduced body weight compared 
to WT(TS) mice (Student's t test, t (1,49) = 4.40; P<0.01; Supplementary Figure 1A). 
Both strains gained weight but upon 8 weeks of free choice access to CM, but WT(TG) 
mice still had lower body weight than WT(TS) (Mann-Whitney-U-test, P<0.05; 
Supplementary Figure 1B). Instead, WT(TG) body weights were similar to WT(TS) 
upon 8 weight of HF access (Supplementary Figure 1C), indicating a more important 
body weight gain in the transgenic strain and certain resistance to CM-driven weight 
increase. 
 
Supplementary Figure 1. Body weight in non-obesogenic and obesogenic conditions of B6EiC3H 
[WT(TS)] and C57Bl6/J [WT(TG)] mice. Body weights of WT(TG) and WT(TS) receiving SC (A), 
SC+CM (B) or SC+HF (C). SC mice: WT(TS) n = 27; WT(TG) n = 24; SC + CM mice: WT(TS) n = 10; 
WT(TG) n = 8 SC + HF mice: WT(TS) n = 9; WT(TG) n = 8. The lines represent the mean of the group, 
individual values are plotted. Student’s t test, Mann-Whitney-U-test *P< 0.05, *** P<0.001. 
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In non-obesogenic conditions, meal pattern analysis revealed no major differences 
between WT(TS) and WT(TG) (Supplementary Figure 2A-E), with similar eating rate 
(Supplementary Figure 2A) and number of meals in 24 hours (Supplementary Figure 
2B). However, WT(TG) presented higher energy intake (Mann-Whitney-U-test = 3; P = 
0.11, Supplementary Figure 2C), and longer meals (Mann-Whitney-U-test = 4; P<0.05, 
Supplementary Figure 2D) along with reduced intermeal interval (Mann-Whitney-U-
test, = 1; P<0.05, Supplementary Figure 2E) compared to WT (TS).  
 
 
Supplementary Figure 2. Feeding behaviors of B6EiC3H [WT(TS)] and C57Bl6/J [WT(TG)] mice. 
(A) Eating rate (mg/s), (B) number of SC meals in 24 hours, (C) Energy intake (KJ/g body weight), (D) 
average meal duration (min) and (E) time between feeding bouts (average intermeal interval, min) in 
WT(TS) and WT (TG). Data are expressed as mean ± SEM. SC mice: WT(TS) n = 8; WT(TG) n = 5; 
Mann-Whitney-U-test * P<0.05. 
 
When energy-dense foods were accessible, WT(TG) showed increased CM daily energy 
intake compared to WT(TS) (Mann-Whitney-U-test P<0.01, Supplementary Figure 3A), 
suggesting increased preference for CM in C57Bl6/J compared to B6EiC3H. Although 
no significant, WT(TG) mice showed higher number of CM meals than WT(TG) mice 
during the active phase (Bonferroni as a post-hoc, P = 0.06). During the inactive phase, 
the number of CM was similar to the number of SC meals in both C57Bl6/J and 
B6EiC3H mice (Supplementary Figure 3B-C). This would indicate a preference for CM 
that is also detected in transgenic mBACTgDyrk1A mice, thus suggesting that the sweet 
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preference in this model could be partially driven by the genetic background. The 
energy intake of HF in the SC+HF group was similar (Supplementary Figure 3A). 
 
Supplementary Figure 3. Energy intake in B6EiC3H [WT(TS)] and C57Bl6/J [WT(TG)] mice given 
free access to energy-dense food. (A) Daily energy intake (KJ/body weight) (B) representation of 
weekly SC and CM intake average in grams of SC and in WT(TS) and WT(TG). The grey squares on the 
bottom depict the dark (active) periods.  Data are expressed as mean ± SEM.  SC + CM mice: WT (TS) n 
= 9; WT (TG) n = 8; SC + HF mice: WT (TS) n = 9; WT (TG) n = 8. Mann-Whitney-U-test ** P<0.01. 
 
Meal pattern analysis in SC+CM group revealed no differences between WT from both 
mouse models (Supplementary Figure 4A-D). CM diet led to reduced meal duration and 
increased eating rate compared to SC in both WT (Supplementary Figure 4B-C). 
  
Supplementary Figure 4. Changes induced by chocolate-mixture free access in B6EiC3H [WT(TS)] 
and C57Bl6/J [WT(TG)] mice. Bar plots represent the meal patterns for each type of food for each 
experimental group [yellow (SC) and in brown (CM)] upper panel shows WT(TS) mice values, and lower 
panel results of WT(TG). (A) The average duration (min) of meals in 24 hours. (B) The eating rate 
(mg/s). (C) The number of meals in 24 hours.  (D) The satiety ratio after correcting for body weight (BW) 
of the animal (g) for CM and SC. Data are expressed as mean ± SEM. SC + CM mice: WT (TS) n = 9; 
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WT (TG) n = 8. Paired Mann-Whitney-U-test for within genotype comparisons (SC vs. CM) * P<0.05, ** 
P<0.01, *** P<0.001. 
We also compared the behaviors of WT mice across the battery of tests addressed to 
detect compulsive and inflexible behaviors to understand the contribution of the genetic 
background. 
Starvation 
After 24 hours of starvation, WT(TG) showed increased SC intake upon refeeding 
compared to WT(TS) (Mann-Whitney-U-test z <0.01, Supplementary Figure 5A). In 
SC+CM mice the increase of SC and CM intake upon refeeding was similar in all WT 
mice (Supplementary Figure 5B), as was also the increase of SC and HF intake upon 
refeeding in the SC+HF group (Supplementary Figure 5C).   
 
Supplementary Figure 5. Energy intake upon 24 hours of starvation in B6EiC3H [WT(TS)] and 
C57Bl6/J [WT(TG)] mice. Bar plots show the increase in energy intake calculated as the KJ 
consumed/BW (grams) 24h after refeeding - KJ consumed/BW (grams) in 24 hours in free feeding 
conditions. (A) Increase in daily energy upon refeeding in the SC group (B) the SC+CM group, and (C) 
the SC+HF mice. Data are expressed as mean ± SEM. SC mice: WT (form TS) = 8; WT (from TG) = 8; 
SC+CM mice: WT (form TS) = 9; WT (from TG) = 8 SC+HF mice: WT (form TS) = 9; WT (from TG) = 
8. Only the comparisons between WT are depicted in the figure since those within subjects have been 
already discussed in the 4.1 and 4.5 of this Thesis). Mann-Whitney-U-test * P<0.05; ** P<0.01. 
 
Limited access to energy-dense food 
Mice consumed less energy during the periods of CM/HF restriction than in ad libitum 
conditions (F(1,29) = 19.28; P<0.001). However, ANOVA analysis revealed that 
WT(TG) mice ate more SC than WT(TS) mice, which reflects energy compensation 
(Two-way ANOVA, genotype and diet interaction; F(1,32) = 10. 62; P< 0.01). In 
SC+CM mice, WT (TG) from SC+CM group consumed more energy from SC than 
WT(TS) (Bonferroni as a post-hoc, P< 0.01) during the days CM was restricted. In 
SC+HF mice, also WT(TG) consumed more SC than WT(TS) (Bonferroni as a post-
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hoc, P< 0.05). WT (TG) from the SC+CM group consumed significantly more SC than 
those of the SC+HF group (Bonferroni as a post-hoc, P<0.01; Supplementary Figure 6). 
 
Supplementary Figure 6. SC energy intake in B6EiC3H [WT(TS)] and C57Bl6/J [WT(TG)] mice 
during the periods of absence of energy-dense foods. (A)  The bars plots show the mean values of 
energy intake of SC in ad libitum feeding conditions (when CM and HF are freely available, “ad lib”) and 
when energy-dense foods are not available (limited, “LMT”). WT (TS) are depicted in white and 
WT(TG) in grey. Data are expressed as mean ± SEM. SC+CM mice: WT (form TS) = 9; WT (from TG) 
= 8 SC+HF mice: WT (form TS) = 9; WT (from TG) = 8. ANOVA, Bonferroni as a post-hoc; **P< 0.01. 
 
When analyzing separately the CM/HF consumption along the three days of the 
experiment, in the SC+CM group, we found a nonsignificant trend for increasing the 
consumption of CM in the limited access periods in WT mice from both strains 
(Supplementary Figure 7A). In SC+HF mice, WT (TG) mice showed higher HF intake 
across the days (F (1,14) = 34.18; P<0.001, Supplementary Figure 7B).  
CM/HF energy increase between the ad libitum conditions and during the third day of 
the limited access was similar in wild-type mice from both strains (Supplementary 
Figure 7C), suggesting similar small “binge-like” events. 
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Supplementary Figure 7. Energy intake during limited access to energy-dense food in B6EiC3H 
[WT(TS)] and C57Bl6/J [WT(TG)] mice. (A) Time course of the energy intake of CM (A) and (B) HF 
during the periods of access. (C) CM/HF energy increase between the ad libitum conditions and during 
the third day of the limited access. ad lib= ad libitum; Day 1, Day 2 and Day 3 are the three consecutive 
days of restricted access (1h) to CM/HF. Data are expressed as mean ± SEM. SC + CM group: WT (form 
TS) = 10; WT (from TG) = 8; SC + HF mice: WT (form TS) = 9; WT (from TG) = 8. 
 
Food adulteration with quinine hydrochloride 
Quinine hydrochloride had stronger inhibitory effect on energy intake in WT from both 
models than in their TG and TG littermates. However, WT mice from TG model, ate 
less adulterated food than WT from TG model being significant for both SC and HF 
diets (bitter SC WT (TS) vs. WT (TG), Mann-Whitney-U-test, z = 0, P<0.001, and 
bitter HF WT (TS) vs. WT (TG), Mann-Whitney-U-test, z = 0, P<0.001; Supplementary 
Figure 8). 
 
Supplementary Figure 8. Energy intake upon quinine food adulteration in B6EiC3H [WT(TS)] and 
C57Bl6/J [WT(TG)] mice. Bar plots show food intake (KJ/g of body weight) in 24 hours in non-
adulterated conditions (ad libitum, “ad lib”) and the intake after quinine hydrochloride adulteration 
(Quin) of SC (A), CM (B) and HF (C). Adulterated food is marked by “*”. In (A) light orange SC* = 
bitter SC; in (B) dark orange CM* = bitter CM and in (C) light blue HF* = bitter HF. (A) SC adulteration 
in SC group. (B) CM adulteration in SC+CM group. (C) HF adulteration in SC+HF group. Data are 
expressed as mean ± SEM. SC mice: WT (form TS) = 8; WT (from TG) = 8; SC+CM mice: WT (form 
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TS) = 9; WT (from TG) = 8 SC+HF mice: WT (form TS) = 9; WT (from TG) = 8. Only the comparisons 
between WT are depicted in the figure since those within subjects have been already discussed in the 4.1 
and 4.5 of this Thesis. Mann-Whitney-U-test ** P<0.01. 
 
Preference for sweet solutions 
The genetic background had no effect on the preference for sweet solutions in non-
obesogenic conditions. Diet had no effect on saccharin preference in WT from both 
strains (Two-way, diet effect, F(2,51) = 3.01; P = 0.06, Supplementary Figure 9A).  
Mice fed with energy-dense diets showed reduced sucrose preference that was only 
significant in WT(TS), while WT(TG) showed similar preference independently of the 
diet and preference for sucrose in SC+CM mice was higher compared to WT(TS) (Two-
way ANOVA, diet x genotype interaction (F(2,50) = 3.3, P<0.05; Bonferroni as a post-
hoc P < 0.01; Bonferroni as a post-hoc P < 0.001;  Supplementary Figure 9B). This 
result suggests a background effect that might be a confounder for the assumptions of a 
reward sensitivity phenotype between models. 
Supplementary Figure 9. Preference for sweets solutions is reduced upon long-term access to 
energy-dense diets in B6EiC3H [WT(TS)] and C57Bl6/J [WT(TG)] mice. (A) Bar blots show the 
preference for saccharin against water [ml saccharin/total liquid intake (water + saccharin)] in SC, 
SC+CM and SC+HF mice. (B) Preference for sucrose against water [ml sucrose /total liquid intake (water 
+ sucrose)] in SC, SC+CM and SC+HF mice. Data are expressed as means ± SEM. Data are expressed as 
mean ± SEM. SC mice: WT (form TS) = 8; WT (from TG) = 8; SC+CM mice: WT (form TS) = 10; WT 
(from TG) = 8 SC+HF mice: WT (form TS) = 9; WT (from TG) = 8. Two-way ANOVA, Ω for genotype 
x diet interaction, Bonferroni as a post-hoc *** P <0.01. 
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Morphometric analyses of the skull and the mandible 
The morphometric analyses revealed that shape of the skull (Procrustes distances among 
groups for skull: 0.0001; P = ns) and mandible (Procrustes distances among groups for 
mandible: 0.0002, P = ns) are similar between the wild-type mice from both DS models 
(Supplementary Figure 10).  
 
Supplementary Figure 10. Results of the Principal Component Analysis (PCA) based on the 
configuration skull and mandible anatomical landmarks of B6EiC3H [WT(TS)] and C57Bl6/J 
[WT(TG)] mice. The PCA was performed on the covariance matrix generated from the Procrustes 
distances coordinates. (A) Morphometric analysis of the skull.  (B) Morphometric analysis of the 
mandible. The three dimensional morphings from the skull and mandible reconstructions have been 
performed using the software Landmark. Red dots = WT (from TG) = 5; blue dots = The WT (form TS) = 
12. 
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3. Exploring the effect of Dyrk1A overexpression on the morphometry of the skull 
and the mandible: implications for meal pattern 
 
Meal pattern analysis of Ts65Dn mice revealed longer and slower meals as compared to 
their wild-type (WT) littermates. Orofacial dysmorphologies associated to DS are 
recapitulated in Ts65Dn mice [1] and have been proposed to contribute to feeding and 
swallowing difficulties in this population [2]. In a recent paper [3] it has been shown 
that the modulation of the DYRK1A activity in Ts65Dn mice either through treatment 
or by genetic deletion of one extra copy, partially restores the altered craniofacial 
phenotype. However, these anatomical alterations have not been confirmed in 
monogenic models of DS with only Dyrk1A overexpression and in our experiments, 
mBACTgDyrk1A mice did not show feeding behavior alterations. 
Thus, we hypothesized that the craniofacial abnormalities of mBACTgDyrk1A mice 
might be less severe than those from Ts65Dn mice. To test our hypothesis, we obtained 
X-ray micro computed tomography (μCT) scans on a subsample of mBACTgDyrk1A 
(TG) and Ts65Dn (TS) mice and their relative wild-types. We performed a comparative 
shape analysis of the skull and the mandible of mBACTgDyrk1A mice and their wild-
type littermates using Geometric Morphometrics (GM). We also compared TG and TS 
mice and wild-types of these two DS models to understand the implication of Dyrk1A 
overexpression on the phenotype and the effect of the genetic background. 
This work was done in collaboration with Greetje Vande Velde, (KU Leuven – 
University of Leuven, Belgium), Rubén González Colom and Neus Martínez Abadías 
(Center for Genomic Regulation, Spain). 
 
Method 
The morphometric skull measurements were obtained through X-ray micro computed 
tomography (μCT) technology using a Skyscan 1278 scanner 
(https://www.bruker.com), a  dedicated high resolution and low dose small-animal μCT 
scanner. For the analysis, we used mBACTgDyrk1A (TG, n = 4) mice and their wild-
type controls (WT (TG), n = 4). The skull reconstructions were made using the NRecon 
software (V1.6.10.4, Bruker-microCT). The visualization of the reconstructed μCTs and 
the landmarking were performed using the Amira software (Amira 
(http://www.fei.com/software/amira-3d-for-life-sciences/). Then we use GM, a 
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sophisticated body of robust statistical tools developed for measuring and comparing 3D 
shapes with increased precision and efficiency [4] [5]. The GM analysis started with the 
recording of 3D landmark coordinates of homologous anatomical points to precisely 
capture the shape of the skull and the mandible. Here we used a set of landmarks 
previously used to assess the skull anatomical differences among adults of the DS 
mouse model Ts65Dn and euploid mice [1]. The skull and mandible of each mouse 
were manually annotated using the Amira software. Next, to superimpose the 3D 
coordinate data collected in all specimens and to extract shape information, we applied a 
General Procrustes analysis [6]. This procedure removes the influence of size and 
adopts a single orientation for all specimens by shifting the landmark configurations to a 
common position, scaling them to a standard size and rotating them until achieving a 
least-squares fit of corresponding landmarks. Centroid size, computed as the square root 
of the summed squared distances between each landmark coordinate and the centroid of 
the configuration, was used as a measure of size [6]. We performed Principal 
Components Analyses (PCA) to analyze shape variation within and among WT, TG and 
TS mice. PCA is a data exploration technique that performs an orthogonal 
decomposition of the data and transforms variance covariance matrices into a smaller 
number of uncorrelated variables called Principal Components (PCs), which 
successively account for the largest amount of variation in the data [6]. GM analyses 
were performed separately for the skull and the mandible using MorphoJ 
(http://www.flywings.org.uk/morphoj_page.htm) [7]. If there are no dysmorphologies 
associated with DS and overexpression of Dyrk1A, the WT, and TG mice will overlap 
in the PCA scatterplot, showing similar cranial and mandibular phenotypes. If there are 
significant dysmorphologies, the WT and the TG mice will be separated from each 
other, showing a differing phenotype. 
To statistically compare the mean shape differences between the genotypes we used a 
permutation test under the null hypothesis of no shape differences between the groups. 
This is a type of statistical test based on the iterative and aleatory redistribution of 
values between the groups. In each iteration, the distance between the means of each 
group is calculated in order to generate the distribution for this parameter. Afterwards, 
the original distance between the means can be tested using a T-test according with the 
estimated distribution. The resulting P-value is directly correlated with the probability 
that both groups derive from the same mean. In our study, the groups were resampled 
10,000 times using a computer simulation, and the parameter tested was the differences 
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between the mean shapes of each group (i.e. the Procrustes distances between the 
groups). 
 
Results 
The morphometric analyses revealed significant differences between the 
mBACTgDyrk1A and the WT mice regarding both the skull shape (Procrustes distances 
among groups:  0.047; P<0.01, Supplementary Figure 11A) and the mandible shape 
(Procrustes distances among groups: 0.040, P<0.01, Supplementary Figure 11B). 
mBACTgDyrk1A and WT mice were separated along the first principal component 
(PC1), which explains 46% of the total morphological variation. The skull shape 
changes associated to PC1 were related with changes in the length and width of the 
skulls. WT mice fell on the positive side of PC1, which is associated with narrower and 
elongated skulls; whereas mBACTgDyrk1A mice fell on the negative side of PC1, 
which is associated with wider and shorter skulls (Supplementary Figure 11A). 
Therefore, in comparison to WT mice, mBACTgDyrk1A mice presented shorter and 
more globular brachycephalic skulls, which correspond to the most common 
craniofacial traits in DS individuals [8]. This result suggests that in adult mice the 
overexpression of Dyrk1A is enough to produce the typical craniofacial alterations 
associated with DS. 
Regarding the shape of the mandible, mBACTgDyrk1A and WT mice were also 
separated along PC1, which explains 40% of the total morphological variation. WT 
mice were associated with wider, more robust and less curved mandibles, with more 
pronounced coronoid and condylar processes. In contrast, mBACTgDyrk1A mice 
showed smaller, thicker and more curved mandibles, with smaller and less pronounced 
coronoid and condylar processes (Supplementary Figure 11B). 
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Supplementary Figure 11. Results of the Principal Component Analysis (PCA) based on the 
configuration of skull anatomical landmarks (top) and mandible anatomical landmarks (bottom) 
for comparing wild-type (WT) and mBACTgDyrk1A (TG) mice. The PCA was performed on the 
covariance matrix generated from the Procrustes distances coordinates. (A) Morphometric analysis of the 
skull. (B) Morphometric analysis of the mandible. The three dimensional morphings from the skull and 
mandible reconstructions have been performed using the software Landmark. 
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We took advantage of unpublished skull and mandible measurements in Ts65Dn from 
our laboratory to compare these phenotypes between the two models of DS. The PCA 
analysis based on the skull morphology revealed a complete overlap between Ts65Dn 
and mBACTgDyrk1A mice (Supplementary Figure 12A), indicating that both models of 
DS have a very similar craniofacial phenotype. However, the PCA analysis based on the 
mandible morphology showed that mBACTgDyrk1A mice fell between WT and 
Ts65Dn mice, suggesting an intermediate, less severe phenotype (Supplementary Figure 
12B). 
 
Supplementary Figure 12. Results of the Principal Component Analysis (PCA) based on the 
configuration of the skull and mandible anatomical landmarks for the wild-type (WT), 
mBACTgDyrk1A (TG) and Ts65Dn mice (TS). (A) TS and TG fell together on the positive side of PC1 
whereas WT mice fell in the negative, in that case, associated to narrower and elongated skulls. (B)  
However, the three genotypes were separated along the PC1 for mandible morphology being the TG in 
between the WT and the TS mice. 
   
The longer and slower meals of Ts65Dn could be due to different anatomical problems. 
Among those, the craniofacial contribution to mastication is supported by our results. 
Our morphometric analysis in skulls of mBACTgDyrk1A mice suggest that the 
overexpression of Dyrk1A is sufficient for the recapitulation of brachycephaly. 
However, mandible hypoplasia is less pronounced in mBACTgDyrk1A than in Ts65Dn 
mice, which could explain the more similar feeding behaviors between WT and 
mBACTgDyrk1A mice than in comparison to WT and Ts65Dn mice. 
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